
<html lang="en"     class="pb-page"  data-request-id="7e3fcef3-6e91-4bf7-b7f0-52b2cb14aa2a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-5;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.8b01263;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Clearance in Drug Design" /></meta><meta name="dc.Creator" content="Dennis&#xA;A.  Smith" /></meta><meta name="dc.Creator" content="Kevin  Beaumont" /></meta><meta name="dc.Creator" content="Tristan S.  Maurer" /></meta><meta name="dc.Creator" content="Li  Di" /></meta><meta name="dc.Description" content="Due to its implications for both dose level and frequency, clearance rate is one of the most important pharmacokinetic parameters to consider in the design of drug candidates. Clearance can be clas..." /></meta><meta name="Description" content="Due to its implications for both dose level and frequency, clearance rate is one of the most important pharmacokinetic parameters to consider in the design of drug candidates. Clearance can be clas..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 3, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01263" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01263" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01263" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01263" /></link>
        
    
    

<title>Clearance in Drug Design | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01263" /></meta><meta property="og:title" content="Clearance in Drug Design" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0010.jpeg" /></meta><meta property="og:description" content="Due to its implications for both dose level and frequency, clearance rate is one of the most important pharmacokinetic parameters to consider in the design of drug candidates. Clearance can be classified into three general categories, namely, metabolic transformation, renal excretion, and hepatobiliary excretion. Within each category, there are a host of biochemical and physiological mechanisms that ultimately determine the clearance rate. Physiochemical properties are often indicative of the rate-determining mechanism, with lipophilic molecules tending toward metabolism and hydrophilic, polar molecules tending toward passive or active excretion. Optimization of clearance requires recognition of the major clearance mechanisms and use of the most relevant in vitro and in vivo tools to develop structure–clearance relationships. The reliability of methods to detect and predict human clearance varies across mechanisms. While methods for metabolic and passive renal clearance have proven reasonably robust, there is a clear need for better tools to support the optimization of transporter-mediated clearance." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01263"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01263">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01263&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01263&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01263&amp;href=/doi/10.1021/acs.jmedchem.8b01263" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2245-2255</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01210" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.8b01303" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Clearance in Drug Design</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Dennis A. Smith</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dennis A. Smith</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">4 The Maltings, Walmer, Kent CT14 7AR, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dennis%0AA.++Smith">Dennis A. Smith</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kevin Beaumont</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kevin Beaumont</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Beaumont">Kevin Beaumont</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tristan S. Maurer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tristan S. Maurer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tristan+S.++Maurer">Tristan S. Maurer</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Li Di</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Li Di</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#521e3b7c163b1202343b2837207c113d3f"><span class="__cf_email__" data-cfemail="165a7f38527f5646707f6c73643855797b">[email protected]</span></a>. Phone: 860-715-6172.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Li++Di">Li Di</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6117-9022" title="Orcid link">http://orcid.org/0000-0001-6117-9022</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01263&amp;href=/doi/10.1021%2Facs.jmedchem.8b01263" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2245–2255</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 3, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 August 2018</li><li><span class="item_label"><b>Published</b> online</span>3 October 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 March 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01263" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01263</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2245%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDennis%250AA.%2BSmith%252C%2BKevin%2BBeaumont%252C%2BTristan%2BS.%2BMaurer%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D5%26contentID%3Dacs.jmedchem.8b01263%26title%3DClearance%2Bin%2BDrug%2BDesign%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2255%26publicationDate%3DMarch%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01263"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">12721</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">32</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01263" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Clearance in Drug Design&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Dennis\nA.&quot;,&quot;last_name&quot;:&quot;Smith&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Beaumont&quot;},{&quot;first_name&quot;:&quot;Tristan&quot;,&quot;last_name&quot;:&quot;S. Maurer&quot;},{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Di&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;2245-2255&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01263&quot;},&quot;abstract&quot;:&quot;Due to its implications for both dose level and frequency, clearance rate is one of the most important pharmacokinetic parameters to consider in the design of drug candidates. Clearance can be classified into three general categories, namely, metabolic transformation, renal excretion, and hepatobiliary excretion. Within each category, there are a host of biochemical and physiological mechanisms that ultimately determine the clearance rate. Physiochemical properties are often indicative of the rate-determining mechanism, with lipophilic molecules tending toward metabolism and hydrophilic, polar molecules tending toward passive or active excretion. Optimization of clearance requires recognition of the major clearance mechanisms and use of the most relevant in vitro and in vivo tools to develop structure–clearance relationships. The reliability of methods to detect and predict human clearance varies across mechanisms. While methods for metabolic and passive renal clearance have proven reasonably robust, there is&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01263&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01263" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01263&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01263" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01263&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01263" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01263&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01263&amp;href=/doi/10.1021/acs.jmedchem.8b01263" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01263" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01263" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01263%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DSmith%26date%3D2019%26atitle%3DClearance%2Bin%2BDrug%2BDesign%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D5%26spage%3D2245%26epage%3D2255%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/jmcmar.2019.62.issue-5/20190314/jmcmar.2019.62.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_0010.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Due to its implications for both dose level and frequency, clearance rate is one of the most important pharmacokinetic parameters to consider in the design of drug candidates. Clearance can be classified into three general categories, namely, metabolic transformation, renal excretion, and hepatobiliary excretion. Within each category, there are a host of biochemical and physiological mechanisms that ultimately determine the clearance rate. Physiochemical properties are often indicative of the rate-determining mechanism, with lipophilic molecules tending toward metabolism and hydrophilic, polar molecules tending toward passive or active excretion. Optimization of clearance requires recognition of the major clearance mechanisms and use of the most relevant in vitro and in vivo tools to develop structure–clearance relationships. The reliability of methods to detect and predict human clearance varies across mechanisms. While methods for metabolic and passive renal clearance have proven reasonably robust, there is a clear need for better tools to support the optimization of transporter-mediated clearance.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28077" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28077" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The importance of pharmacokinetics (PK) in the design of medicines has been well established.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> An effective drug needs to have an acceptable delivery route, sufficient access to the site of action, and a residence time sufficient for the desired duration of action. Modulation of the potential PK of a candidate series is a key aspect of the modern medicinal chemistry strategy. Previously in this series, the importance of half-life and volume of distribution in drug disposition has been discussed.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> This review will examine the basic theoretical and practical considerations relevant to rational drug design aspects of clearance.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Definition of Clearance</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63351" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63351" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Clearance is an important PK parameter to consider in both pharmaceutical research and clinical practice. It quantitates the irreversible removal of a drug from the measured matrix (typically blood or plasma). The key word in this definition is “irreversible”, which separates distribution into tissues (which is reversible) from clearance, where there is a permanent change to the molecule or removal from the body. The clearance parameter (CL) is one that links the measured concentration of the drug to the rate of elimination (<a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>). The units of CL are in volume per time, reflecting the volume of blood or plasma from which drug is completely eliminated per time. While CL is typically constant, the rate of drug elimination is concentration dependent. This is the basis for the typical exponential (log–linear) decline in drug concentration with time.<span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_m001.gif" alt="" id="_i5" /></img><span class="labelSpan">(1)</span></span></div><div class="NLM_p">A typical plasma concentration versus time curve following intravenous (iv) administration is shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. This exemplifies the information required to calculate clearance. By measurement of the concentration of drug in plasma over a time course, the area under the plasma concentration versus time course (AUC) can be calculated. This can be converted to clearance (CL) by relating to the dose through <a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a>.<span class="NLM_disp-formula" id="eq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_m002.gif" alt="" id="_i6" /></img><span class="labelSpan">(2)</span></span></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Typical iv plasma concentration versus time curve for a compound in human.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In this theoretical example, the dose was administered by the iv route. Under these circumstances, the entire dose has been placed into the systemic circulation, which is where the PK is measured. Consequently, the clearance calculated from this experiment is often quoted as systemic clearance (CL<sub>s</sub>). In addition, the matrix of analysis was (as often) plasma and so can also be quoted as plasma clearance (CL<sub>p</sub>). If blood were measured, then clearance would be blood clearance (CL<sub>b</sub>). The latter distinction is important since, depending upon the blood-to-plasma ratio (<i>R</i><sub>b</sub>) of a compound, clearance can be different when measured in plasma or blood. This reflects the ratio of concentration in whole blood (blood cells + plasma) versus that in plasma alone. It is not to be confused with the concentration in blood cells versus that in plasma. The relationship between CL<sub>b</sub> and CL<sub>p</sub> is given by <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>.<span class="NLM_disp-formula" id="eq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_m003.gif" alt="" id="_i7" /></img><span class="labelSpan">(3)</span></span></div><div class="NLM_p">As such, when <i>R</i><sub>b</sub> is unity (i.e., the drug is distributed evenly between the blood cells and plasma), the CL<sub>p</sub> equals CL<sub>b</sub>. Certain drugs, such as UK-224671,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> can specifically bind to components within the erythrocyte and drive to high <i>R</i><sub>b</sub>. In these cases, the concentration of drug in blood is significantly higher than in plasma and CL<sub>b</sub> is lower than CL<sub>p</sub>. Therefore, blood is a more appropriate matrix to measure clearance than plasma. In the case of UK-224671, 89% of the compound resides in the blood cell and blood clearance is significantly lower than plasma clearance. Conversely, many acidic molecules are significantly more highly bound in plasma than in the blood cells as blood cells do not expressed high concentrations of acid binding albumin. Therefore, even though the unbound drug will distribute into the blood cell (assuming passive membrane permeability), the acid will predominantly reside on the albumin, meaning that <i>R</i><sub>b</sub> values will collapse to the hematocrit (e.g., ∼0.6). In these cases, CL<sub>b</sub> can be up to 2-fold higher than CL<sub>p</sub>.</div><div class="NLM_p">The analytical matrix chosen to measure during PK experiments is an important consideration. Measurement of plasma clearly entails discarding of the blood cell fraction, which is appropriate if <i>R</i><sub>b</sub> approaches unity. When drug is extensively distributed into blood cells, then the majority of the drug in the blood sample will be discarded if plasma is the matrix of measurement. In these cases it is important to correct for <i>R</i><sub>b</sub> to account for CL<sub>b</sub>, since it is blood that circulates through organs, not plasma. If <i>R</i><sub>b</sub> is significantly greater than 1, measurement of blood rather than plasma should be considered. When <i>R</i><sub>b</sub> approaches 1 or below, it is recommended to measure plasma and correct the CL<sub>p</sub> to CL<sub>b</sub> using <i>R</i><sub>b</sub>.</div><div class="NLM_p last">The route of drug administration is critical for clearance assessment. As stated above, the iv route guarantees that all of the administered dose reaches the systemic circulation (or the blood compartment) where it can be measured. For all other routes of measurement, there are potential barriers that can prevent drug molecules from reaching the systemic circulation. This is the case for oral administration (po), where the dose is applied to the gastrointestinal (gi) tract and has to be absorbed and avoid first pass extraction by the gut wall and liver prior to reaching the systemic circulation. The AUC following po is often lower than that following iv of the same dose due to incomplete absorption, first-pass intestinal extraction, and/or hepatic extraction. The corollary to this is that clearance following po (CL<sub>po</sub>) is most often higher than CL<sub>s</sub>. The relationship between oral clearance and systemic clearance relies on an understanding of oral bioavailability (<i>F</i>) and is explained by <a class="ref internalNav" href="#eq4" aria-label="eq 4">eq 4</a>.<span class="NLM_disp-formula" id="eq4"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_m004.gif" alt="" id="_i8" /></img><span class="labelSpan">(4)</span></span></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Importance of Clearance in Drug Disposition</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35137" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35137" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Clearance is typically the most important PK parameter for a medicinal chemist to modulate in a chemical series. This is because clearance is a determinant of every other PK parameter of relevance in design, including half-life, oral bioavailability, and efficacious dose.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> (a) Effect of Clearance on Half-Life</h3><div class="NLM_p last">Together with volume of distribution (<i>V</i><sub>d</sub>), clearance governs the elimination rate (<i>k</i><sub>el</sub>) of a drug, and ultimately half-life (<i>t</i><sub>1/2</sub>). <a class="ref internalNav" href="#eq5" aria-label="Equations 5">Equations 5</a> and <a class="ref internalNav" href="#eq6" aria-label="6">6</a> provide a useful approximation of half-life from <i>V</i><sub>d</sub> and CL (which is exact in the case of a one compartmental PK model with linear clearance). From this relationship, a medicinal chemistry strategy that lowers systemic clearance within a series while maintaining volume of distribution should increase elimination phase half-life in a series.<span class="NLM_disp-formula" id="eq5"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_m005.gif" alt="" id="_i11" /></img><span class="labelSpan">(5)</span></span><span class="NLM_disp-formula" id="eq6"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_m006.gif" alt="" id="_i12" /></img><span class="labelSpan">(6)</span></span></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> (b) Effect of Clearance on Oral Bioavailability</h3><div class="NLM_p">Many small molecule drugs are administered by the oral route. If solubility and/or permeability is not optimal, absorption of the administered dose may be incomplete. During absorption, drugs are exposed to a host of metabolizing enzymes in the GI tract which can further extract a portion of the administered dose. Finally, the liver can also extract a portion of the administered dose by metabolism and/or transport due to the fact that drugs directly enter the liver via the hepatic portal vein before reaching systemic circulation. This process is termed hepatic first-pass extraction.</div><div class="NLM_p last">If a drug is cleared from the blood by the liver, then the hepatic extraction is a key component of both oral bioavailability and clearance (<a class="ref internalNav" href="#eq7" aria-label="eqs 7">eqs 7</a> and <a class="ref internalNav" href="#eq8" aria-label="8">8</a>), where the terms are defined as <i>F</i>, fraction bioavailable; <i>F</i><sub>a</sub>, fraction absorbed; <i>F</i><sub>g</sub>, fraction escaping gut wall extraction; <i>E</i><sub>h</sub>, hepatic extraction ratio; and <i>Q</i>, hepatic blood flow. As clearance of a drug approaches hepatic blood flow, hepatic extraction ratio approaches 1 and oral bioavailability approaches zero. Consequently, minimizing hepatic extraction by lowering clearance is a key component in optimizing oral bioavailability. Other parameters, such as solubility, permeability, and transporter affinity, affect oral bioavailability.<span class="NLM_disp-formula" id="eq7"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_m007.gif" alt="" id="_i14" /></img><span class="labelSpan">(7)</span></span><span class="NLM_disp-formula" id="eq8"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_m008.gif" alt="" id="_i15" /></img><span class="labelSpan">(8)</span></span></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (c) Effect of Clearance on Efficacious Dose</h3><div class="NLM_p last">The importance of clearance in the relationship between steady-state concentration and dose was recognized early by Wagner in 1965 (<a class="ref internalNav" href="#eq9" aria-label="eq 9">eq 9</a>),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> where <i>C</i><sub>ss,av</sub> is the average concentration at steady state (related to potency and target concentration) and τ is dose interval. Unlike the other determinant parameters, clearance optimization is expected to pay dividends in both the numerator (decreased CL) and denominator (increased <i>F</i>). Consequently, modulation of clearance has a direct effect on efficacious dose within a particular chemical series.<span class="NLM_disp-formula" id="eq9"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_m009.gif" alt="" id="_i17" /></img><span class="labelSpan">(9)</span></span></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">First Concepts and the Well-Stirred Model</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36150" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36150" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the evolution of PK, the concept of clearance was an important milestone. Borrowing heavily from engineering, a relatively simple and generally relevant mathematical model was developed to describe the removal of drugs from the body. A single organ of clearance such as the liver can be envisaged as having a flow of drug through which is defined by the blood flow to the organ (<i>Q</i>), the intrinsic ability of the organ to clear drug independent of flow or binding limitations (CL<sub>int,u</sub>), and the unbound fraction (<i>f</i><sub>u</sub>) of drug available for clearance (<a class="ref internalNav" href="#eq10" aria-label="eq 10">eq 10</a>).<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8−10)</a> This is known as the well-stirred model of drug clearance. Although other mathematical models of clearance (e.g., parallel-tube and dispersion models) have been described, the well-stirred model has been shown to be broadly relevant and is perhaps the most commonly used and conceptually useful of the available models.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a><span class="NLM_disp-formula" id="eq10"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_m010.gif" alt="" id="_i19" /></img><span class="labelSpan">(10)</span></span></div><div class="NLM_p">For an orally delivered and hepatically cleared small molecule, the well-stirred model equation (<a class="ref internalNav" href="#eq10" aria-label="eq 10">eq 10</a>) can be combined with the dose and oral bioavailability equations (<a class="ref internalNav" href="#eq7" aria-label="eqs 7">eqs 7</a> and <a class="ref internalNav" href="#eq9" aria-label="9">9</a>, respectively) to produce a dose equation that neatly describes the fundamentals of clearance modulation in small molecule drug discovery (<a class="ref internalNav" href="#eq11" aria-label="eq 11">eq 11</a>).<span class="NLM_disp-formula" id="eq11"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_m011.gif" alt="" id="_i20" /></img><span class="labelSpan">(11)</span></span>This equation relates dose to steady state unbound average concentration (<i>C</i><sub>ss,av,u</sub>), unbound intrinsic clearance (CL<sub>int,u</sub>), dose interval (τ), fraction absorbed (<i>F</i><sub>a</sub>), and fraction escaping gut-wall extraction (<i>F</i><sub>g</sub>). In order to reduce the dose within a small molecule chemical series for orally administrated drugs, one can modulate one or a combination of the following properties:<table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">(1)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Increase the potency against the pharmacological target (decrease target unbound concentration, <i>C</i><sub>ss,av,u</sub>).</p></td></tr><tr class="li1"><td valign="top">(2)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Lower the rate of metabolism and/or uptake clearance by the liver (lower CL<sub>int,u</sub>).</p></td></tr><tr class="li1"><td valign="top">(3)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Give the compound more often (lower τ).</p></td></tr><tr class="li1"><td valign="top">(4)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Increase oral absorption (<i>F</i><sub>a</sub>) or fraction escaping intestinal extraction (<i>F</i><sub>g</sub>).</p></td></tr></table></div><div class="NLM_p last">For the purposes of this review on clearance, we have arrived at the fundamental parameter of unbound intrinsic clearance (CL<sub>int,u</sub>) that is the major driver for compound optimization in small molecule drug discovery. CL<sub>int,u</sub> is best described as the rate of removal of unbound drug by an organ (in this case the liver) in the absence of any blood flow or protein binding limitations. <a class="ref internalNav" href="#eq11" aria-label="Equation 11">Equation 11</a> also points to two very important aspects of modulation of dose to improve drug disposition in a small molecule series. First, CL<sub>int,u</sub> is an unbound parameter, and so any assay designed to be used to investigate this parameter needs to correct for any binding in that experiment. Second, there is no factor in <a class="ref internalNav" href="#eq11" aria-label="eq 11">eq 11</a> for fraction unbound in plasma, despite its presence in the equations used in the derivation. Simply put, fraction unbound has no impact on unbound steady-state average concentrations and therefore is not expected, generally speaking, to impact dose requirements (i.e., protein binding is not a parameter to optimize<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a>). This aspect will be discussed in detail later. Overall, in order to improve dose via hepatic clearance within a chemical series, medicinal chemists should only focus on reducing CL<sub>int,u</sub>.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Mechanisms of Clearance</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35750" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35750" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In order to be able to reduce CL<sub>int,u</sub> in a particular series, it is important to understand the mechanisms by which molecules within the series can be removed from the blood (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The liver and the kidney are the two major organs of drug clearance. Passive and active processes, such as metabolism by enzymes and uptake/efflux by transporters, are the major mechanisms for drug clearance.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Simple model of clearance for an organ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Clearance by the Kidney</h3><div class="NLM_p">The major purpose of the kidney is to produce urine in order to excrete the byproducts of intermediary metabolism. Renal clearance is also a route for excretion of drugs and metabolites. Urine is produced by filtration of blood at the Bowman’s capsule (glomerular filtration) which allows any molecule with molecular weight of less than 50 kDa to pass through into the proximal convoluted tubule. Any useful products (such as glucose) are reabsorbed from the proximal convoluted tubule, and the balance of water and ions is modulated through the loop of Henle, before the urine passes through the ureter to the bladder. Any drug that is not bound to plasma protein will also be filtered into the proximal convoluted tubule. The rate of filtration is dependent on the flow to the glomeruli (rate of glomerular filtration, GFR ∼ 1–2 mL min<sup>–1</sup> kg<sup>–1</sup> in humans) and the unbound fraction of drug in blood (<i>f</i><sub>u,b</sub>) as given by <a class="ref internalNav" href="#eq12" aria-label="eq 12">eq 12</a>.<span class="NLM_disp-formula" id="eq12"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_m012.gif" alt="" id="_i23" /></img><span class="labelSpan">(12)</span></span></div><div class="NLM_p last">In accordance with Fick’s law, passive reabsorption of filtered drug is driven by permeability and the chemical potential created by the near complete (∼99%) reabsorption of filtrate over length of the nephron. As such, polar, poorly permeable drugs may be cleared at rates approximating the product of GFR and <i>f</i><sub>u,b</sub>. At the other extreme, highly permeable drugs may be cleared at rates approximating 1% of the product of GFR and <i>f</i><sub>u,b</sub>. Compounds can also be actively secreted to renal tubules by transporters (OATs, OCTs, P-gp) expressed at the proximal convoluted tubule that can remove drugs from the renal blood flow and deposit them into the urine for excretion. Depending upon the extent of reabsorption, this can result in CL<sub>r</sub> value exceeding the product of <i>f</i><sub>u,b</sub> and GFR, with a theoretical upper limit approximating renal blood flow (RBF ∼ 16 mL min<sup>–1</sup> kg<sup>–1</sup> in humans).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Clearance by the Liver</h3><div class="NLM_p">The liver is the major drug clearance organ. It is highly perfused receiving approximately 25% of the cardiac blood output. The architecture of liver allows for maximal mixing of the blood with the liver cells (hepatocytes). The hepatocytes possess an array of uptake/efflux transporters (e.g., OATPs, P-gp, BCRP, and MRPs) and many drug metabolizing enzymes (e.g., CYPs and UGTs) that can promote hepato biliary secretion or metabolic clearance of a drug (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Hepatobiliary clearance is generally an active process, whereby a compound with relatively poor passive membrane permeability is recognized by a specific transporter on the sinusoidal (blood) side of the hepatocyte. Uptake of the drug into the hepatocyte is promoted by the transporter. The drug can then be actively secreted into the bile by bile canalicular transporters. By virtue of this mechanism, drugs can be rapidly cleared from blood and excreted in the bile.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic of the hepatobiliary system.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Alternatively, once a compound enters the hepatocyte (by active or passive processes) they can be subject to metabolism by CYPs, UDP-glucuronyl transferases, or one of the many drug metabolizing enzymes present in the hepatocyte. The metabolites formed by these enzymes can then be secreted into the bile (and excreted) or removed into the blood for excretion in urine.</div><div class="NLM_p">Due to the importance of the liver as a drug clearance organ, much work on optimizing in vitro assays using subcellular fractions has been completed. Liver obtained post-mortem from animals and humans can be treated in different ways to provide a variety of cellular and subcellular fractions that can be used to study metabolism and transport in vitro (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). A simple collagenase digest of liver tissue will liberate hepatocytes which can be cryopreserved or treated in a variety of ways to study drug metabolism and hepatic uptake. Homogenization of liver tissue in buffer followed by a slow speed (9000<i>g</i>) spin produces a pellet containing mitochondria and lysosomes. The supernatant (or S9 fraction) contains the majority of the phase 1 and phase 2 drug metabolizing enzymes of the hepatocytes (in a relatively dilute solution). A further high speed (100 000<i>g</i>) spin of the S9 fraction in the presence of calcium produces a supernatant containing all of the soluble enzymes present in the cytosol of the hepatocyte. The pellet contains the remnants of the cellular endoplasmic reticulum which in the presence of calcium have snapped back onto themselves to form spheres of membranes called microsomes. As such, microsomes do not occur in nature but are artifacts of hepatic subcellular fraction preparation. They have been a major driver of fully understanding hepatic metabolic clearance in vitro, since they contain all the membrane bound proteins, such as CYPs and UGTs.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Preparation of hepatic subcellular fractions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Hepatocytes and microsomes form the basis of two very useful in vitro reagents for study and prediction of metabolic intrinsic clearance. Ideally, study of the Michaelis–Menten kinetics of any metabolic step would be completed at optimized enzyme and substrate concentrations. However, this would represent a considerably time-consuming experiment to complete for one compound let alone a series of compounds in a drug discovery project. To make this experiment more amenable for use in a drug discovery setting, some compromises have been made. The disappearance of a compound by metabolism in an in vitro incubation can be completed at a set enzyme and substrate concentration. When the substrate concentration is below the <i>K</i><sub>m</sub> (Michaelis constant) for the metabolic enzyme, the disappearance will be a first-order process. The plot of substrate concentration versus time will be an exponential decline and a natural log transform will produce a straight line (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The slope of this line is related to the <i>V</i><sub>max</sub>/<i>K</i><sub>m</sub> (<i>V</i><sub>max</sub>, maximum reaction rate) of the molecule and can be transformed into the apparent intrinsic clearance (CL<sub>int,app</sub>) of that molecule accounting for cell number (for hepatocytes) or protein concentration (for microsomes) used in the incubation. (<a class="ref internalNav" href="#eq13" aria-label="eq 13">eq 13</a> and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<span class="NLM_disp-formula" id="eq13"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_m013.gif" alt="" id="_i25" /></img><span class="labelSpan">(13)</span></span></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vitro metabolism experiment following parent depletion in linear and log scales.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Scaling human liver microsomal and hepatocyte CL<sub>int,app</sub> to human blood CL<sub>b</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This methodology has been extensively explained previously.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> Here it is important to remember that this is an apparent value that needs to be corrected for the unbound fraction in the in vitro incubation (<i>f</i><sub>u,inc</sub>) in order to arrive at the unbound intrinsic clearance (CL<sub>int,u</sub>, <a class="ref internalNav" href="#eq14" aria-label="eq 14">eq 14</a>). This is an important consideration because highly bound compounds may have a low CL<sub>int,app</sub> by virtue of a low <i>f</i><sub>u,inc</sub>, leading to an underestimation of the clearance rate. Ultimately, CL<sub>int,u</sub> is the appropriate value to incorporate into the well-stirred model equation (<a class="ref internalNav" href="#eq10" aria-label="eq 10">eq 10</a>) to predict the human hepatic clearance of that compound.<span class="NLM_disp-formula" id="eq14"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_m014.gif" alt="" id="_i26" /></img><span class="labelSpan">(14)</span></span></div><div class="NLM_p">The value of CL<sub>int,u</sub> at this point still has the units associated with the incubation (μL/min/mg protein for microsomes and μL/min/million cells for hepatocytes). In order to be useful for predicting in vivo CL, it needs to be scaled to the entire body by multiplying by the number of cells (or the microsomal protein concentration) per gram of liver and the number of grams of liver per kg body weight in the species of interest (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). This generates a predicted unbound intrinsic clearance value (units mL min<sup>–1</sup> kg<sup>–1</sup>) which can be used in the well-stirred model to predict the CL of the molecule in that particular series.</div><div class="NLM_p last">Clearly, the most important parameter to modulate in human in vitro metabolism experiments is the CL<sub>int,u</sub> as reducing this parameter will directly lead to improvements in requisite dose level and frequency. Herein lies the paradox with respect to clearance optimization in modern drug discovery. Medicinal chemists have become very adept at reducing metabolic intrinsic clearance within chemical series. This has led to a number of challenges, perhaps the most significant of which is a rise in the awareness and relative significance of other clearance mechanisms such as hepatobiliary transport.</div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Evolution of Liver Clearance Concept from Metabolism to Enzyme–Transporter Interplay</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65627" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65627" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Decades ago in drug discovery, there was limited DMPK input into the optimization and selection of compounds for drug development. Compounds were largely optimized for potency against the pharmacological target. Since potency can (in part) be driven by lipophilicity, these early candidates tended to be large and significantly lipophilic. Such compounds tended to be good substrates for CYPs, and significant development candidate attrition was due to inappropriate PK (too short a half-life or too low oral bioavailability or poor exposure).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Starting in the 1990s, significant scholarship on the effect of physicochemical properties on PK<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17−19)</a> was completed and the in vitro metabolic assays (such as microsomal and hepatocyte stability) became available.<a onclick="showRef(event, 'ref15 ref20'); return false;" href="javascript:void(0);" class="ref ref15 ref20">(15,20)</a> For the latter, there were a significant number of CYP substrates with human clearance values that validated the use of such assays in prediction of human clearance.</div><div class="NLM_p">The concepts of physicochemical properties (notably the positive correlation between lipophilicity and CL<sub>int,u</sub>) and availability of clinically validated in vitro metabolic clearance assays enabled optimization in drug discovery which now took into account metabolic intrinsic clearance in addition to target potency. There was a clear reduction in human PK attrition in the following decade.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Subsequently, further scholarship on physicochemical properties driving toxicology led to an even greater emphasis on lipophilicity reduction.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> At the extreme, reductions in lipophilicity led to a reduction in membrane permeability and uncovered series of compounds where entry to the hepatocyte (either by passive or active processes) rather than metabolism is the rate-determining step in defining the clearance of these molecules. This is underlined in a comparison of clearance in hepatocytes and microsomes.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> As expected, compounds predominately metabolized by CYP-mediated mechanisms gave comparable intrinsic clearance values in microsomes and hepatocytes when passive permeability was high. However, when hepatic passive permeability was low, intrinsic clearance in microsomes was faster than that in hepatocytes due to limited access to the enzymes within the cell. For certain non-CYP metabolism (e.g., aldehyde oxidase, reductases) that is not present microsomes, intrinsic clearance in hepatocytes will be higher. Some of the non-CYP enzymes have high extrahepatic expression, making it challenging to develop quantitative in vitro–in vivo correlation and accurately predict human PK due to lack of appropriate tools and species differences. Medicinal chemists need to pay attention to the impact of extrahepatic clearance in lead optimization.</div><div class="NLM_p">In addition, early observations indicated that application of the previously described scaling approach to CL<sub>int,u</sub> values derived from hepatocytes tended to underpredict the clearance of drug known to be substrates of uptake transport mechanism (e.g., OATPs) due to the lower activity of these transporters in hepatocyte preparations optimized for metabolic clearance estimation.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> These observations have led to an emphasis on the study of hepatic uptake as a potential rate-determining step in the clearance on molecules. The validation of in vitro assays for predicting hepatic uptake limited clearance has been limited by the relative paucity of compounds for which hepatic uptake is proven to be the rate-determining step in human clearance. Hepatocytes can be grown in culture under conditions where they will express drug uptake transporters and potential form bile ducts (e.g., plated hepatocytes or sandwich culture hepatocytes).<a onclick="showRef(event, 'ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27">(24−27)</a> The intrinsic clearance values determined for uptake substrates tend to be much lower than would be required to explain the hepatic clearance of these compounds in vivo (for the few compounds where the full data set is available).<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> Thus, extensive empirical scaling factors are currently required for prospective human clearance prediction.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> On a mechanistic level, the interplay between metabolism and transport is captured by what is called the extended clearance concept. This concept expands the hepatic CL<sub>int,u</sub> parameter into its component parts to provide a better understanding of the rate determining mechanisms of clearance (<a class="ref internalNav" href="#eq15" aria-label="eq 15">eq 15</a>, which assumes all parameters represent the unbound values for the sake of simplicity). More specifically, in this concept, the rate determining mechanism of clearance is depicted as a complex function of passive clearance rate (PS<sub>inf,passive</sub>), active uptake rate (PS<sub>inf,active</sub>), metabolic intrinsic clearance (CL<sub>int,met</sub>), active sinusoidal clearance (PS<sub>eff,active</sub>), and biliary intrinsic clearance (CL<sub>int,bile</sub>). It is clear from this equation that the rate determining mechanism is not dependent upon the absolute value of any one rate but rather the rates of these individual mechanisms in relation to one another.<span class="NLM_disp-formula" id="eq15"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_m015.gif" alt="" id="_i28" /></img><span class="labelSpan">(15)</span></span></div><div class="NLM_p">Given the complexity of sorting the relative values of each process, classification systems that are based on experimentally obtainable data and/or physiochemical properties (e.g., ionization state) have been proposed as a means for predicting the likely rate-determining clearance mechanisms and consequently directing researchers to the most appropriate systems by which to predict the composite clearance rate. The clearance parameters of the extended clearance model can be determined experimentally through a variety of approaches including the following:<table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">(a)</td><td colspan="5" valign="top" class="paragraph"><p class="last">PS<sub>inf,active</sub> and PS<sub>inf,passsive</sub> in suspension or plated human hepatocytes with and without uptake transporter inhibitors or at 4 °C;</p></td></tr><tr class="li1"><td valign="top">(b)</td><td colspan="5" valign="top" class="paragraph"><p class="last">CL<sub>int,met</sub> in human liver microsomal or hepatocyte incubations;</p></td></tr><tr class="li1"><td valign="top">(c)</td><td colspan="5" valign="top" class="paragraph"><p class="last">CL<sub>int,bile</sub> in human sandwich-cultured hepatocyte incubations (generally assuming that metabolism in this system is negligible).</p></td></tr></table></div><div class="NLM_p last">As shown previously, this methodology is based on a relatively new concept in the prediction of the human clearance of transporter-mediated uptake substrate both with and without further metabolism or biliary excretion (mixed clearance pathways). In contrast to purely metabolism rate limited clearance, the absolute scalability of parameters estimated in this way is still under investigation. More work is required to establish the scalability of these more complex approaches covering nonmetabolic or mixed mechanisms governing the rate of clearance.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Importance of Physicochemical Properties in Determining Clearance Mechanism</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64865" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64865" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">On the basis of the above, providing the correct CL<sub>int,u</sub> data to estimate the clearance of a drug is highly enabled if physicochemical properties are considered. Permeability through lipid membranes determines not only the ability of a drug to be absorbed and reach an intracellular target, it also governs the fate of a molecule. Drugs with high permeability will be reabsorbed in the kidney tubule (following filtration at the Bowman’s capsule) and traverse the cell membranes at high intrinsic passive flux rates with minimal influence of transporters. Under these circumstances, clearance by the kidney can be discounted as such compounds will be cleared by metabolism. As permeability declines, so the rate of membrane flux declines and the transfer of the drug across lipid membranes is more impacted by transporters. Access to intracellular targets becomes problematic and the clearance fate of the molecule becomes more complex with potential for drug transporter involvement. Physicochemical measurements or calculations give good guidance into the likely permeability characteristics of a molecule. Low permeability is the result of low lipophilicity or high polar surface area (PSA). The role of physicochemical properties in determining many aspects of drug clearance and performance is shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>. Many of these concepts have been incorporated into a variety of drug disposition classification systems,<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> some of which (e.g., BDDCS, ECCS, ECCCS) seek to define the likely rate-limiting mechanisms of clearance (e.g., hepatic metabolism, hepatobiliary transport, renal excretion, or mixed mechanisms) from physicochemical properties (e.g., ionization state, molecular weight) and in vitro measures (e.g., membrane permeability, solubility, intrinsic clearance). Each has strengths and weaknesses with regard to theoretical and practical aspects as well as retrospective performance. While an extensive review of these classification systems is beyond the scope of this work,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> it is worth noting that the primary utility of these systems is to direct early discovery research efforts intended to characterize, predict, and optimize clearance of lead matter.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Permeability controls the effects of transporter efflux or influx.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Influence of Physicochemical Properties and Permeability on Factors Determining Drug Disposition</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" rowspan="2" align="center" valign="middle">Membrane permeability and physicochemical properties</th><th class="colsep0 rowsep0" align="center">Low</th><th class="colsep0 rowsep0" align="center">Medium</th><th class="colsep0 rowsep0" align="center">High</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Low log <i>D</i> < 0</th><th class="colsep0 rowsep0" align="center">Log <i>D</i> > 0 (PSA > 75 Å<sup><b>2</b></sup>)</th><th class="colsep0 rowsep0" align="center">Log <i>D</i> > 0 (PSA < 75 Å<sup>2</sup>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Absorption</td><td class="colsep0 rowsep0" align="left">Low unless MW < 250 Da and absorbed by paracellular route (atenolol)</td><td class="colsep0 rowsep0" align="left">Variable. Influenced by permeability and transporters (nelfinavir)</td><td class="colsep0 rowsep0" align="left">High via transcellular route (propranolol)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Access to target proteins</td><td class="colsep0 rowsep0" align="left">Extracellular including cell surface</td><td class="colsep0 rowsep0" align="left">Total body water but may be concentrated or effluxed from intracellular cytosol</td><td class="colsep0 rowsep0" align="left">Total body water. Drug will show similar unbound concentrations to that present in plasma</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Rapid equilibrium with unbound drug in circulation</td><td class="colsep0 rowsep0" align="left">May have slower equilibrium with unbound drug in circulation</td><td class="colsep0 rowsep0" align="left">Rapid equilibrium with unbound drug in circulation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Clearance</td><td class="colsep0 rowsep0" align="left">Renal or biliary (possible transporter involvement)</td><td class="colsep0 rowsep0" align="left">Uptake and efflux transporters and metabolism</td><td class="colsep0 rowsep0" align="left">Metabolism</td></tr></tbody></table></div></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">Allometric Scaling of Clearance</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76360" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76360" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Establishing in vitro to in vivo correlation in preclinical species for metabolic clearance and extended clearance is important to reduce uncertainty for human translation from in vitro to in vivo. In the absence of a simple in vitro assay to optimize and predict human clearance for hepatic uptake substrates, the fallback approach is often to use preclinical species PK scaling to predict human clearance. This practice has been known for many years and is termed allometric scaling.</div><div class="NLM_p">A true allometric scaling experiment requires iv administration to multiple preclinical species. The clearance of the compound (expressed as mL/min) is plotted against body weight (BWt) as shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>. When plotted versus body weight, the values for clearance in preclinical species can be extrapolated to human body weight to give a prediction of human clearance for that compound. It has been well-known for many years that physiological parameters (such as blood flow, heart rate, liver weight) scale with an exponent of less than 1 when plotted versus body weight.<a onclick="showRef(event, 'ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35 ref36">(33−36)</a> The same is often true of clearance (i.e., it is not a one to one relationship). For this reason, and the labor-intensive nature of generating multiple species PK profiles, some authors have suggested single species scaling with a fixed allometric exponent of approximately 0.7, as a pragmatic method for human clearance prediction of discovery compounds.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> However, it must be noted that fixing the allometric exponent is highly controversial.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Small deviations in the exponent from the fixed value can lead to major mispredictions of human clearance, due to the large weight difference between some species (such as rodents) and human.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Basics of an allometric scaling experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The accuracy in prediction of human clearance by allometric scaling is dependent upon the clearance route and the extent of clearance. The best evaluation of allometric scaling prediction was completed by Tang et al.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> They examined 103 small molecule drugs with literature citations containing iv PK studies in at least three preclinical species and human. They found that errors in prediction of human clearance ranged from 0 (exact prediction) to greater than 3000% (major misprediction). Prediction accuracy was improved for high clearance molecules by metabolism and biliary secretion as well as molecules predominantly cleared by renal elimination. Predictability was poor for lower clearance molecules, especially where metabolism was a major player. This is not surprising since renal elimination is most likely by passive filtration at GFR, and according to the well-stirred model, high CL<sub>int,u</sub> compounds will tend toward hepatic blood flow clearance. Since blood flow scales well allometrically, compounds where clearance is dependent upon blood flow will predict well by this method. When extraction is toward the low level with respect to hepatic blood flow, clearance will be highly dependent on CL<sub>int,u</sub>. It is well-known that CL<sub>int,u</sub> values for a given compound in animals often are much higher than in human, and so allometric scaling for metabolized compounds is likely to overpredict the observed human clearance.<a onclick="showRef(event, 'ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43">(41−43)</a> The same is likely true for hepatic uptake cleared compounds as the drug transporters expressed in animals and humans are different.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Overall, the use of animal PK experiments to predict human clearance is a useful approach. On a pragmatic level, if the clearance in animals is low with respect to liver blood flow in that species, it is likely that the human clearance will also be low. However, due to species differences in CL<sub>int,u</sub>, it is not unusual for clearance in animals to be high relative to liver blood flow and low in humans, and this approach may miss some important chemical series.</div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">Pitfalls in Assessing Clearance</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57804" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57804" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">From the above discussion, it is understood that optimization of small molecule candidates for acceptable human clearance is an essential part of the drug discovery process. It is also clear that clearance is a complicated property to assess, with many potential ways a compound can be cleared from blood and many potential species differences. Many oral drugs are required to be dosed once daily, leading to a requirement for high oral bioavailability and a half-life that matches the dose regimen. Consequently, the ability to assess and modulate human clearance within a series is essential. There are some potential pitfalls that can be encountered in assessing clearance in the drug discovery phase.</div></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Tips To Address Pitfalls in Clearance Assessment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07732" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07732" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec10_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (a) Understanding Extent of Binding of Molecules</h3><div class="NLM_p">As shown above, only compound that is unbound in an in vitro incubation is available to be metabolized or transported into hepatocytes to generate the true unbound intrinsic clearance (CL<sub>int,u</sub>). Compounds that are highly bound under the incubation conditions (binding to microsomes and hepatocytes) will tend toward low values for CL<sub>int,app</sub> but are very likely to be susceptible to rapid metabolism of the unbound drug due to high lipophilicity. Consequently, optimization of a series in the absence of understanding the extent of binding in the incubation will lead to apparent low in vitro intrinsic clearance that leads to high CL<sub>int,u</sub> in vivo.</div><div class="NLM_p last">Similar issues apply to in vivo studies. PK studies exclusively measure total drug concentrations in blood or plasma, and CL<sub>s</sub> is a total parameter. However, only unbound drug is available to exert a pharmacological effect, and according to the well-stirred model, CL<sub>int,u</sub> is the major driver of exposure to unbound drug. Consequently, a high plasma protein binding (low <i>f</i><sub>u</sub>) will affect CL<sub>s</sub> but will not affect CL<sub>int,u</sub>, meaning that it is possible to generate a low CL<sub>s</sub> with a highly plasma protein bound compound, but exposure to unbound drug will be low. In general, driving CL<sub>s</sub> lower by increasing plasma protein binding is not a good strategy, unless CL<sub>int,u</sub> is lowered or the compound has a high degree of pharmacological potency (i.e., low dose). The converse is also true. Lowering plasma protein binding in a highly bound chemical series does not improve exposure to unbound concentration, unless CL<sub>int,u</sub> is also lowered. Many groups have claimed to have improved drug properties by lowering plasma protein binding,<a onclick="showRef(event, 'ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47">(45−47)</a> but in all these cases the strategy to lower plasma protein binding was to lower lipophilicity with a consequent reduction in CL<sub>int,u</sub>. The effect of plasma protein binding on clearance and dose properties has been extensively studied,<a onclick="showRef(event, 'ref13 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref13 ref48 ref49">(13,48,49)</a> and in almost all circumstance, plasma protein binding modulation is not a viable method to improve a compound series.</div></div><div id="sec10_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (b) Using the Correct in Vitro Assay</h3><div class="NLM_p">As noted above, there are numerous mechanisms that can drive the clearance of any particular chemical series (e.g., metabolism, uptake, renal). The in vitro assays that have been developed often separate these mechanisms such that one assay tends to focus on one particular mechanism. During the process of optimization of the clearance of a particular small molecule series, it is important to ensure that the in vitro assay used reflects the true mechanism of clearance of that series. If the assay does not have the appropriate mechanism, e.g., optimizing for metabolism when uptake is the issue or optimizing CYP when UGT is the main pathway, the translation to in vivo studies will be flawed. Also, in the process of compound optimization, if the structural changes made within a series drive to a different clearance pathway, then the in vitro assay used needs to reflect this. For example, the most likely response to high CL<sub>int</sub> due to metabolism is to lower lipophilicity in a chemical series. At some point, lowering lipophilicity will drive to poor membrane permeability and the rate-determining step could change to hepatic uptake or renal clearance rather than metabolism.</div><div class="NLM_p last">Another issue with in vitro assays is often detection limits. Under certain circumstances even compounds that are cleared at the lower limit for the assay will scale to predicted in vivo clearance values that are higher than required for the optimal dose regimen. Good examples of this are the in vitro assays for metabolic clearance. Hepatocyte and microsomal incubations are limited by the length of incubation time and ability to detect disappearance of the parent compound. Low clearance does not mean no clearance. A novel approach to increasing the incubation time for hepatocyte assays has been proposed as a method to lower the limit of determination and enable investigation of CL<sub>int</sub> values that are 10-fold lower than the standard methods used.<a onclick="showRef(event, 'ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref50 ref51 ref52">(50−52)</a></div></div><div id="sec10_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (c) Focus on Low Dose</h3><div class="NLM_p last">In progressing to in vivo PK studies, care must be taken to maintain as low a dose as possible. When clearance is an active process (such as metabolism or hepatic uptake), it will obey Michaelis–Menten principles. This means that clearance will only be dose- and concentration-independent at unbound concentrations that are significantly below the <i>K</i><sub>m</sub> for the clearance mechanism. High dose studies (such as those used in toxicity studies) are not appropriate studies to generate PK parameters (such as clearance) as this requirement cannot be met and clearance mechanisms will often be saturated.</div></div><div id="sec10_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (d) Use the Correct Terminology</h3><div class="NLM_p">Unfortunately the term clearance in its various forms is used incorrectly in many discussions. Drugs with a short half-life are often termed to be too rapidly cleared, whereas clearance may in fact be low, but the duration is compromised by a low volume of distribution. In other discussions, clearance is confused with recovery of the total dose (e.g.,<sup>14</sup>C labeled material) in urine and feces.<named-content content-type="anchor" rid="box1" type="simple"></named-content></div><div class="boxed-text-float" id="box1"><div class="NLM_label" id="">Box 1</div><div id="" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Key Messages</h4><div class="NLM_p last"><table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">(1)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Understand the binding of a molecule both in vitro and in vivo, but do not optimize on binding. Rather optimize on unbound intrinsic clearance.</p></td></tr><tr class="li1"><td valign="top">(2)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Make sure the enzymes that metabolize the compound series are present in the in vitro system used for optimization.</p></td></tr><tr class="li1"><td valign="top">(3)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Pay attention to enzyme–transporter interplay and optimize compound series based on rate-determining mechanisms.</p></td></tr><tr class="li1"><td valign="top">(4)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Maintain unbound concentrations below the <i>K</i><sub>m</sub> of the enzymes/transporters clearing the series of molecules. Keep the dose/concentration relatively low.</p></td></tr><tr class="li1"><td valign="top">(5)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Understand the (many) terms used to describe clearance.</p></td></tr></table></div></div></div></div></div><div id="sec11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">Perspective</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46610" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46610" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Clearance is the most important PK parameter for drug disposition since it impacts half-life (or duration of action), oral bioavailability, and dose. It can only be calculated from inspection of the blood (or plasma) concentration versus time curve following iv administration. Measurement of blood (or plasma) means that clearance is a parameter based on total (both bound and unbound) drug. However, the unbound concentration of a drug is the driver of pharmacology and only unbound drug is available for clearance from the blood. Modulation of the human clearance within a small molecule chemical series is a key aspect of compound optimization during drug discovery. For clearance optimization, medicinal chemists need to focus on the unbound intrinsic clearance (CL<sub>int,u</sub>) which is effectively the maximal rate of clearance of drug by a clearing organ in the absence of flow and binding limitations. The major organ of drug clearance in the body is the liver. Subcellular hepatic fractions have been used to prepare in vitro assays for metabolic clearance. These assays, along with understanding of the effect of physicochemical properties on clearance, have enabled drug discoverers to minimize metabolic CL<sub>int,u</sub> in chemical series and on the whole driven to molecules with lower clearance in human. However, by driving to lower lipophilicity, the rate of membrane penetration has potentially become a rate-determining step in clearance from the blood and the impact of transporters is more significant. With this trend, improved reagents, and an ever increasing understanding of the relevance of transporters in drug disposition, more compounds are being identified as drug transporter substrates and uptake has become a major player in clearance of small molecules. While this shift has been recognized in the thinking behind the extended clearance model, the in vitro assays required to lower CL<sub>int,u</sub> by uptake transport are still in their infancy. The next evolution of modulation of clearance in drug discovery will follow much greater experience in the application of these drug transporter assays.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01263" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16500" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16500" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Di</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetics,
Dynamics and Metabolism, Pfizer Inc., Groton, Connecticut 06340, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6117-9022" title="Orcid link">http://orcid.org/0000-0001-6117-9022</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#074b6e29436e4757616e7d62752944686a"><span class="__cf_email__" data-cfemail="f4b89ddab09db4a4929d8e9186dab79b99">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis
A. Smith</span> - <span class="hlFld-Affiliation affiliation">4 The Maltings, Walmer, Kent CT14
7AR, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Beaumont</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetics,
Dynamics and Metabolism, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tristan S. Maurer</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetics,
Dynamics and Metabolism, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75104" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75104" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Dennis
A. Smith</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=BIO-d7e1854-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Dennis A. Smith</b> worked in the pharmaceutical industry for 32 years after gaining his Ph.D. from the University of Manchester. During this period he directly helped in the discovery and development of eight marketed NCEs. More recently his roles include advisory boards or expert panels with many drug research based organizations, both industrial and academic, including Medicines for Malaria Venture and Cancer Research UK. His research interests and publications span all aspects of Drug Discovery and Development, particularly where drug metabolism knowledge can impact on the design of more efficacious and safer drugs.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Kevin Beaumont</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=BIO-d7e1859-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Kevin Beaumont</b> has worked extensively in the discovery and development drug metabolism field throughout his 30 years in the pharmaceutical industry. His major area of expertise is in the modulation of physicochemistry to affect drug disposition and prediction of human PK. He is author on over 40 peer reviewed publications. Overall, Kevin has worked on many drug discovery and development projects throughout his career. He has been responsible for the DMPK input to at least 30 FIH studies as well as 10 phase II compounds, including 1 marketed agent. Kevin now provides DMPK input to the Inflammation and Immunology and Rare Disease Research Units, based in Cambridge, MA.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Tristan S. Maurer</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=BIO-d7e1864-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Tristan S. Maurer</b> received his Pharm.D. from the University of Georgia in 1993 and his Ph.D. from the University of Buffalo, State University of New York in 1999. During his 18 year tenure with Pfizer, his work has focused on the development and application of quantitatively rigorous, biologically based methods to predict human pharmacokinetics and pharmacodynamics from preclinical data. He has coauthored over 60 manuscripts illustrating the utility of these methods to drug design and early clinical development. Currently, Dr. Maurer sits on the Medicine Design leadership team responsible for scientific and operational strategies spanning from idea to loss of exclusivity. He also leads a modeling and simulation group responsible for both computational chemistry and quantitative translational pharmacology across Pfizer’s small molecule portfolio.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Li Di</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=BIO-d7e1869-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Li Di</b> has about 20 years of experience in the pharmaceutical industry including Pfizer, Wyeth, and Syntex. She is currently a Research Fellow at Medicine Design Department, Pfizer Global Research and Development, Groton, CT. Her research interests include the areas of drug metabolism, absorption, transporters, pharmacokinetics, blood–brain barrier, and drug–drug interactions. She has over 135 publications including two books and presented more than 85 invited lectures. She is a recipient of the Thomas Alva Edison Patent Award, the New Jersey Association for Biomedical Research Outstanding Woman in Science Award, the Wyeth President’s Award, Peer Award for Excellence and Publication Award.</p></figure></div><table summary="" class="NLM_def-list" id="dl2"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">BCRP</td><td class="NLM_def"><p class="first last">breast cancer resistance protein</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CL<sub>b</sub></td><td class="NLM_def"><p class="first last">blood clearance</p></td></tr><tr><td class="NLM_term">CL<sub>int,app</sub></td><td class="NLM_def"><p class="first last">apparent intrinsic clearance</p></td></tr><tr><td class="NLM_term">CL<sub>int,bile</sub></td><td class="NLM_def"><p class="first last">biliary intrinsic clearance</p></td></tr><tr><td class="NLM_term">CL<sub>int,met</sub></td><td class="NLM_def"><p class="first last">metabolic intrinsic clearance</p></td></tr><tr><td class="NLM_term">CL<sub>int,u</sub></td><td class="NLM_def"><p class="first last">unbound intrinsic clearance</p></td></tr><tr><td class="NLM_term">CL<sub>p</sub></td><td class="NLM_def"><p class="first last">plasma clearance</p></td></tr><tr><td class="NLM_term">CL<sub>po</sub></td><td class="NLM_def"><p class="first last">oral clearance</p></td></tr><tr><td class="NLM_term">CL<sub>r</sub></td><td class="NLM_def"><p class="first last">renal clearance</p></td></tr><tr><td class="NLM_term">CL<sub>s</sub></td><td class="NLM_def"><p class="first last">systemic clearance</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>ss,av</sub></td><td class="NLM_def"><p class="first last">average concentration at steady state</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>ss,av,u</sub></td><td class="NLM_def"><p class="first last">unbound average concentration at steady state</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">DMPK</td><td class="NLM_def"><p class="first last">drug metabolism and pharmacokinetics</p></td></tr><tr><td class="NLM_term"><i>E</i><sub>h</sub></td><td class="NLM_def"><p class="first last">hepatic extraction ratio</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">bioavailability</p></td></tr><tr><td class="NLM_term"><i>F</i><sub>a</sub></td><td class="NLM_def"><p class="first last">fraction absorbed</p></td></tr><tr><td class="NLM_term"><i>F</i><sub>g</sub></td><td class="NLM_def"><p class="first last">fraction escaping gut wall extraction</p></td></tr><tr><td class="NLM_term"><i>f</i><sub>u</sub></td><td class="NLM_def"><p class="first last">unbound fraction</p></td></tr><tr><td class="NLM_term"><i>f</i><sub>u,b</sub></td><td class="NLM_def"><p class="first last">fraction unbound in blood</p></td></tr><tr><td class="NLM_term"><i>f</i><sub>u,inc</sub></td><td class="NLM_def"><p class="first last">unbound fraction in in vitro incubation</p></td></tr><tr><td class="NLM_term">GFR</td><td class="NLM_def"><p class="first last">glomerular filtration rate</p></td></tr><tr><td class="NLM_term">GI</td><td class="NLM_def"><p class="first last">gastrointestinal</p></td></tr><tr><td class="NLM_term"><i>k</i><sub>el</sub></td><td class="NLM_def"><p class="first last">elimination rate constant</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>m</sub></td><td class="NLM_def"><p class="first last">Michaelis constant</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">MRP</td><td class="NLM_def"><p class="first last">multidrug-resistance protein</p></td></tr><tr><td class="NLM_term">OAT</td><td class="NLM_def"><p class="first last">organic anion transporter</p></td></tr><tr><td class="NLM_term">OATP</td><td class="NLM_def"><p class="first last">organic anion transporting polypeptide</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02030" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02030" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 52 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span>; <span class="NLM_string-name">Allerton, C.</span>; <span class="NLM_string-name">Kalgutkar, A. S.</span>; <span class="NLM_string-name">van de Waterbeemd, H.</span>; <span class="NLM_string-name">Walker, D. K.</span></span> <i>Pharmacokinetics and Metabolism in Drug Design</i>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1002%2F9783527645763" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=D.+A.+Smith&author=C.+Allerton&author=A.+S.+Kalgutkar&author=H.+van+de+Waterbeemd&author=D.+K.+Walker&title=Pharmacokinetics+and+Metabolism+in+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2F9783527645763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527645763%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26btitle%3DPharmacokinetics%2520and%2520Metabolism%2520in%2520Drug%2520Design%26pub%3DWiley-VCH%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span>; <span class="NLM_string-name">Kerns, E.
H.</span></span> <i>Drug-like Properties: Concepts, Structure Design, and Methods</i>; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">London, U.K.</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=L.+Di&author=E.%0AH.+Kerns&title=Drug-like+Properties%3A+Concepts%2C+Structure+Design%2C+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26btitle%3DDrug-like%2520Properties%253A%2520Concepts%252C%2520Structure%2520Design%252C%2520and%2520Methods%26pub%3DElsevier%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khojasteh, S. C.</span>; <span class="NLM_string-name">Wong, H.</span>; <span class="NLM_string-name">Hop, C.
E. C. A.</span></span> <i>Drug Metabolism and Pharmacokinetics Quick Guide</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1007%2F978-1-4419-5629-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+C.+Khojasteh&author=H.+Wong&author=C.%0AE.+C.+A.+Hop&title=Drug+Metabolism+and+Pharmacokinetics+Quick+Guide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-5629-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4419-5629-3%26sid%3Dliteratum%253Aachs%26aulast%3DKhojasteh%26aufirst%3DS.%2BC.%26btitle%3DDrug%2520Metabolism%2520and%2520Pharmacokinetics%2520Quick%2520Guide%26pub%3DSpringer%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Volume of distribution in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5691</span>– <span class="NLM_lpage">5698</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00201</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00201" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFSlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5691-5698&author=D.+A.+Smithauthor=K.+Beaumontauthor=T.+S.+Maurerauthor=L.+Di&title=Volume+of+distribution+in+drug+design&doi=10.1021%2Facs.jmedchem.5b00201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Volume of Distribution in Drug Design</span></div><div class="casAuthors">Smith, Dennis A.; Beaumont, Kevin; Maurer, Tristan S.; Di, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5691-5698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Vol. of distribution is one of the most important pharmacokinetic properties of a drug candidate.  It is a major determinant of half-life and dosing frequency of a drug.  For a similar log P, a basic mol. will tend to exhibit higher vol. of distribution than a neutral mol.  Acids often exhibit low vols. of distribution.  Although a design strategy against vol. of distribution can be advantageous in achieving desirable dosing regimen, it must be well-directed in order to avoid detrimental effects to other important properties.  Strategies to increase vol. of distribution include adding lipophilicity and introducing basic functional groups in a way that does not increase metabolic clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP7QwgPahf4bVg90H21EOLACvtfcHk0liozdmEABDrUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFSlsb0%253D&md5=2c7289b3602a8edef2d9ef0e6a82e483</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00201%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DVolume%2520of%2520distribution%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5691%26epage%3D5698%26doi%3D10.1021%2Facs.jmedchem.5b00201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Relevance of half-life in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4273</span>– <span class="NLM_lpage">4282</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00969</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00969" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslOnsrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4273-4282&author=D.+A.+Smithauthor=K.+Beaumontauthor=T.+S.+Maurerauthor=L.+Di&title=Relevance+of+half-life+in+drug+design&doi=10.1021%2Facs.jmedchem.7b00969"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Relevance of Half-Life in Drug Design</span></div><div class="casAuthors">Smith, Dennis A.; Beaumont, Kevin; Maurer, Tristan S.; Di, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4273-4282</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Drug half-life has important implications for dosing regimen and peak-to-trough ratio at the steady state.  A half-life of 12-48 h is generally ideal for once daily dosing of oral drugs.  If the half-life is too short, it may require more frequent dosing in order to maintain desired exposures and avoid unnecessarily high peak concns.  This may pose challenges to achieving optimal efficacy, safety, and patient compliance.  If the half-life is too long, the time over which accumulation and subsequent elimination occur may be prolonged.  This may pose problems with managing adverse effects and the design of efficient clin. trials.  Half-life is a key parameter for optimization in research and development.  Structural modification to affect clearance, and to a lesser extent vol. of distribution, is the preferred means of modulating half-life.  An effective approach to half-life optimization requires an understanding of the many pitfalls assocd. with its estn. and interpretation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7kT9hNLRzb7Vg90H21EOLACvtfcHk0liozdmEABDrUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslOnsrnN&md5=ff748cbebc765f4fa3c3d7b3831f51c8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00969%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DRelevance%2520of%2520half-life%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4273%26epage%3D4282%26doi%3D10.1021%2Facs.jmedchem.7b00969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, S.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics and metabolism of a sulphamide NK2 antagonist in rat, dog and human</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">642</span>, <span class="refDoi"> DOI: 10.1080/004982500406453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1080%2F004982500406453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10923864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFCltL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2000&pages=627-642&author=K.+Beaumontauthor=A.+Harperauthor=D.+A.+Smithauthor=S.+Abel&title=Pharmacokinetics+and+metabolism+of+a+sulphamide+NK2+antagonist+in+rat%2C+dog+and+human&doi=10.1080%2F004982500406453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and metabolism of a sulphamide NK2 antagonist in rat, dog and human</span></div><div class="casAuthors">Beaumont, K.; Harper, A.; Smith, D. A.; Abel, S.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">627-642</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">1. UK-224,671 is a sulfamide-contg. NK2 antagonist with moderate lipophilicity and basicity.  2. The physicochem. properties of UK-224,671 are reflected in its pharmacokinetics following i.v. administration.  The compd. partitioned extensively into red blood cells in all species examd. and the blood clearance was moderate to low with respect to liver blood flow and distribution into tissues was extensive.  3. UK-224,671 exhibited species differences in oral bioavailability.  In dog, the compd. exhibited moderate bioavailability (55%), whereas in rat and man oral bioavailability was < 10%.  4. In rat and dog, the major excreted form after i.v. administration was unchanged UK-224,671 in both urine and feces.  In addn., of three metabolites obsd., the most abundant was the N-descyclopropylmethyl (UK-280,045).  5. The profile of radioactivity in rat following oral administration of [14C]-UK-224,671 was not consistent with a 10% absorbed compd. with 40% of the dose present as metabolites.  This suggests that the low bioavailability of UK-224,671 in rat is due to a combination of moderate intestinal permeability and extensive first-pass metab. by the gut and does not result from poor gastrointestinal absorption per se.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpns74iTwf5PbVg90H21EOLACvtfcHk0li9wExKr3iPPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFCltL4%253D&md5=5d6a03b5b2b7060be7e6c4c6fb0f1af0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1080%2F004982500406453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F004982500406453%26sid%3Dliteratum%253Aachs%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DHarper%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DAbel%26aufirst%3DS.%26atitle%3DPharmacokinetics%2520and%2520metabolism%2520of%2520a%2520sulphamide%2520NK2%2520antagonist%2520in%2520rat%252C%2520dog%2520and%2520human%26jtitle%3DXenobiotica%26date%3D2000%26volume%3D30%26spage%3D627%26epage%3D642%26doi%3D10.1080%2F004982500406453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northam, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alway, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, O. S.</span></span> <span> </span><span class="NLM_article-title">Blood levels of drug at the equilibrium state after multiple dosing</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>207</i></span>,  <span class="NLM_fpage">1301</span>– <span class="NLM_lpage">1302</span>, <span class="refDoi"> DOI: 10.1038/2071301a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1038%2F2071301a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=5884654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A280%3ADyaF287ksVSntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=1965&pages=1301-1302&author=J.+G.+Wagnerauthor=J.+I.+Northamauthor=C.+D.+Alwayauthor=O.+S.+Carpenter&title=Blood+levels+of+drug+at+the+equilibrium+state+after+multiple+dosing&doi=10.1038%2F2071301a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Blood levels of drug at the equilibrium state after multiple dosing</span></div><div class="casAuthors">Wagner J G; Northam J I; Alway C D; Carpenter O S</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">5003</span>),
    <span class="NLM_cas:pages">1301-2</span>
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkXM4pbz4uL8uCWE5mhx1RfW6udTcc2eY16n79Ux8Icbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF287ksVSntQ%253D%253D&md5=de878fcb3ee5b632be74a12d50dfcfa7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F2071301a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F2071301a0%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DJ.%2BG.%26aulast%3DNortham%26aufirst%3DJ.%2BI.%26aulast%3DAlway%26aufirst%3DC.%2BD.%26aulast%3DCarpenter%26aufirst%3DO.%2BS.%26atitle%3DBlood%2520levels%2520of%2520drug%2520at%2520the%2520equilibrium%2520state%2520after%2520multiple%2520dosing%26jtitle%3DNature%26date%3D1965%26volume%3D207%26spage%3D1301%26epage%3D1302%26doi%3D10.1038%2F2071301a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, M.</span></span> <span> </span><span class="NLM_article-title">Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance</span>. <i>J. Pharmacokinet. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">653</span>, <span class="refDoi"> DOI: 10.1007/BF01059688</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1007%2FBF01059688" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=599411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADyaE1cXhtFGjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1977&pages=625-653&author=K.+S.+Pangauthor=M.+Rowland&title=Hepatic+clearance+of+drugs.+I.+Theoretical+considerations+of+a+%E2%80%9Cwell-stirred%E2%80%9D+model+and+a+%E2%80%9Cparallel+tube%E2%80%9D+model.+Influence+of+hepatic+blood+flow%2C+plasma+and+blood+cell+binding%2C+and+the+hepatocellular+enzymatic+activity+on+hepatic+drug+clearance&doi=10.1007%2FBF01059688"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic clearance of drugs.  I.  Theoretical considerations of a "well-stirred" model and a "parallel tube" model.  Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance</span></div><div class="casAuthors">Pang, K. Sandy; Rowland, Malcolm</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacokinetics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">625-53</span>CODEN:
                <span class="NLM_cas:coden">JPBPBJ</span>;
        ISSN:<span class="NLM_cas:issn">0090-466X</span>.
    </div><div class="casAbstract">Two commonly used models of hepatic drug clearance were examd.  The well-stirred model (model I) views the liver as a well-stirred compartment with concn. of drug in the liver in equil. with that in the emergent blood.  The parallel tube model (model II) regards the liver as a series of parallel tubes with enzymes distributed evenly around the tubes and the concn. of drug declining along the length of the tube.  Both models were examd. under steady-state considerations in the absence of diffusional limitations (i.e., cell membranes not limiting the movement of drug mols.).  Equations involving the determinants of hepatic drug clearance (hepatic blood flow, fraction of drug in blood unbound, and the hepatocellular enzymic activity) and various pharmacokinetic parameters were derived.  Similarities and differences between the models were explored.  Although both models predict similar hepatic drug clearances under a variety of conditions, marked differences between them become apparent in their predictions of the influence of changes in the determinants of drug clearance on various pharmacokinetic parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDpZaENZqfCbVg90H21EOLACvtfcHk0li9wExKr3iPPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhtFGjtLs%253D&md5=6a9e9bf46d9ce3571d8da77495cc9e19</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2FBF01059688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01059688%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DK.%2BS.%26aulast%3DRowland%26aufirst%3DM.%26atitle%3DHepatic%2520clearance%2520of%2520drugs.%2520I.%2520Theoretical%2520considerations%2520of%2520a%2520%25E2%2580%259Cwell-stirred%25E2%2580%259D%2520model%2520and%2520a%2520%25E2%2580%259Cparallel%2520tube%25E2%2580%259D%2520model.%2520Influence%2520of%2520hepatic%2520blood%2520flow%252C%2520plasma%2520and%2520blood%2520cell%2520binding%252C%2520and%2520the%2520hepatocellular%2520enzymatic%2520activity%2520on%2520hepatic%2520drug%2520clearance%26jtitle%3DJ.%2520Pharmacokinet.%2520Biopharm.%26date%3D1977%26volume%3D5%26spage%3D625%26epage%3D653%26doi%3D10.1007%2FBF01059688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, G. G.</span></span> <span> </span><span class="NLM_article-title">Clearance concepts in pharmacokinetics</span>. <i>J. Pharmacokinet. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1007/BF01059626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1007%2FBF01059626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=4764426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A280%3ADyaE2c%252FmtVKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1973&pages=123-136&author=M.+Rowlandauthor=L.+Z.+Benetauthor=G.+G.+Graham&title=Clearance+concepts+in+pharmacokinetics&doi=10.1007%2FBF01059626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Clearance concepts in pharmacokinetics</span></div><div class="casAuthors">Rowland M; Benet L Z; Graham G G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacokinetics and biopharmaceutics</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-36</span>
        ISSN:<span class="NLM_cas:issn">0090-466X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSz4Zcsmz7GkKe0F5ixvZgXfW6udTcc2eZWNOLIzbavgbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE2c%252FmtVKisw%253D%253D&md5=bf6ffefba3dd092a61fb55bca443973a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2FBF01059626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01059626%26sid%3Dliteratum%253Aachs%26aulast%3DRowland%26aufirst%3DM.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26aulast%3DGraham%26aufirst%3DG.%2BG.%26atitle%3DClearance%2520concepts%2520in%2520pharmacokinetics%26jtitle%3DJ.%2520Pharmacokinet.%2520Biopharm.%26date%3D1973%26volume%3D1%26spage%3D123%26epage%3D136%26doi%3D10.1007%2FBF01059626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shand, D. G.</span></span> <span> </span><span class="NLM_article-title">Commentary: a physiological approach to hepatic drug clearance</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1002/cpt1975184377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1002%2Fcpt1975184377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1164821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A280%3ADyaE28%252FitFemsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1975&pages=377-390&author=G.+R.+Wilkinsonauthor=D.+G.+Shand&title=Commentary%3A+a+physiological+approach+to+hepatic+drug+clearance&doi=10.1002%2Fcpt1975184377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Commentary: a physiological approach to hepatic drug clearance</span></div><div class="casAuthors">Wilkinson G R; Shand D G</div><div class="citationInfo"><span class="NLM_cas:title">Clinical pharmacology and therapeutics</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">377-90</span>
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">A physiological approach has been developed recognizing that hepatic blood flow, the activity of the overall elimination process (intrinsic clearance), drug binding in the blood, and the anatomical arrangement of the hepatic circulation are the major biological determinants of hepatic drug clearance.  This approach permits quantitative prediction of both the unbound and total drug concentration/time relationships in the blood after intravenous and oral administration, and any changes that may occur as a result of alterations in the above biological parameters.  These considerations have led to a classification of drug metabolism based on the hepatic extraction ratio.  The proposed classification allows prediction and interpretation of the effects of individual variations in drug-metabolizing activity, route of administration, pharmacokinetic interactions, and disease states on hepatic drug elimination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3aFnQ1cqrfp0d-O_J5C0AfW6udTcc2eZWNOLIzbavgbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE28%252FitFemsA%253D%253D&md5=3ff5e564e044c18f22f48ba0af48259c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fcpt1975184377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpt1975184377%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DG.%2BR.%26aulast%3DShand%26aufirst%3DD.%2BG.%26atitle%3DCommentary%253A%2520a%2520physiological%2520approach%2520to%2520hepatic%2520drug%2520clearance%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1975%26volume%3D18%26spage%3D377%26epage%3D390%26doi%3D10.1002%2Fcpt1975184377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, Y.</span></span> <span> </span><span class="NLM_article-title">Prediction of hepatic clearance in human from in vitro data for successful drug development</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">262</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1208/s12248-009-9103-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1208%2Fs12248-009-9103-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=19408130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWqs7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=262-276&author=M.+Chibaauthor=Y.+Ishiiauthor=Y.+Sugiyama&title=Prediction+of+hepatic+clearance+in+human+from+in+vitro+data+for+successful+drug+development&doi=10.1208%2Fs12248-009-9103-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of hepatic clearance in human from in vitro data for successful drug development</span></div><div class="casAuthors">Chiba, Masato; Ishii, Yasuyuki; Sugiyama, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">262-276</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The in vivo metabolic clearance in human has been successfully predicted by using in vitro data of metabolic stability in cryopreserved prepns. of human hepatocytes.  In the predictions by human hepatocytes, the systematic underpredictions of in vivo clearance have been commonly obsd. among different datasets.  The regression-based scaling factor for the in vitro-to-in vivo extrapolation has mitigated discrepancy between in vitro prediction and in vivo observation.  In addn. to the elimination by metabolic degrdn., the important roles of transporter-mediated hepatic uptake and canalicular excretion have been increasingly recognized as a rate-detg. step in the hepatic clearance.  It has been, therefore, proposed that the in vitro assessment should allow the evaluation of clearances for both transporter(s)-mediated uptake/excretion and metabolic degrdn.  This review first outlines the limited ability of subcellular fractions such as liver microsomes to predict hepatic clearance in vivo.  It highlights the advantages of cryopreserved human hepatocytes as one of the versatile in vitro systems for the prediction of in vivo metabolic clearance in human at the early development state.  The following section discusses the mechanisms underlying the systematic underprediction of in vivo intrinsic clearance by hepatocytes.  It leads to the proposal for the assessment of hepatic uptake clearance as one of the kinetically important determinants for accurate predictions of hepatic clearance in human.  The judicious combination of advanced technologies and understandings for the drug disposition allows us to rationally optimize new chem. entities to the drug candidate with higher probability of success during the clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC52lEOUdlKLVg90H21EOLACvtfcHk0ljCJOgJ_VEWIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWqs7rI&md5=8c2b3366285c690ba1055d46f52f0b6b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1208%2Fs12248-009-9103-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-009-9103-6%26sid%3Dliteratum%253Aachs%26aulast%3DChiba%26aufirst%3DM.%26aulast%3DIshii%26aufirst%3DY.%26aulast%3DSugiyama%26aufirst%3DY.%26atitle%3DPrediction%2520of%2520hepatic%2520clearance%2520in%2520human%2520from%2520in%2520vitro%2520data%2520for%2520successful%2520drug%2520development%26jtitle%3DAAPS%2520J.%26date%3D2009%26volume%3D11%26spage%3D262%26epage%3D276%26doi%3D10.1208%2Fs12248-009-9103-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hallifax, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houston, J. B.</span></span> <span> </span><span class="NLM_article-title">Prediction of human metabolic clearance from in vitro systems: retrospective analysis and prospective view</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2150</span>– <span class="NLM_lpage">2161</span>, <span class="refDoi"> DOI: 10.1007/s11095-010-0218-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1007%2Fs11095-010-0218-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=20661765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt12rsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2010&pages=2150-2161&author=D.+Hallifaxauthor=J.+A.+Fosterauthor=J.+B.+Houston&title=Prediction+of+human+metabolic+clearance+from+in+vitro+systems%3A+retrospective+analysis+and+prospective+view&doi=10.1007%2Fs11095-010-0218-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of Human Metabolic Clearance from In Vitro Systems: Retrospective Analysis and Prospective View</span></div><div class="casAuthors">Hallifax, David; Foster, Joanne A.; Houston, J. Brian</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2150-2161</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: To provide a definitive assessment of prediction of in vivo CLint from human liver in vitro systems for assessment of typical underprediction.  Methods: A database of published predictions of clearance from human hepatocytes and liver microsomes was compiled, including only i.v. CLb.  The influence of liver model (well-stirred (WS) or parallel tube (PT)), plasma protein binding and clearance level on the relationship between in vitro and in vivo CLint was examd.  Results: Av. prediction bias was about 5- and 4-fold for microsomes and hepatocytes, resp.  Reduced bias using the PT model, in preference to the popular WS model, was only marginal across a wide range of clearance with a consequential minor impact on prediction.  Increasing underprediction with decreasing fub, or increasing CLint, was found only for hepatocytes, suggesting fundamental in vitro artifacts rather than failure to model potentially unequilibrated binding during rapid extn.  Conclusions: In contrast to microsomes, hepatocytes give a disproportionate prediction with increasing clearance suggesting limitations either at the active site, such as cofactor exhaustion, or with intracellular concn. equil., such as rate-limiting cell permeability.  A simple log linear empirical relationship can be used to correct hepatocyte predictions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2OFAIV4xbqrVg90H21EOLACvtfcHk0lg4l33gvzoSAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt12rsLs%253D&md5=eacc0536e048fee3cab292ae2b52f608</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs11095-010-0218-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-010-0218-3%26sid%3Dliteratum%253Aachs%26aulast%3DHallifax%26aufirst%3DD.%26aulast%3DFoster%26aufirst%3DJ.%2BA.%26aulast%3DHouston%26aufirst%3DJ.%2BB.%26atitle%3DPrediction%2520of%2520human%2520metabolic%2520clearance%2520from%2520in%2520vitro%2520systems%253A%2520retrospective%2520analysis%2520and%2520prospective%2520view%26jtitle%3DPharm.%2520Res.%26date%3D2010%26volume%3D27%26spage%3D2150%26epage%3D2161%26doi%3D10.1007%2Fs11095-010-0218-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span> <span> </span><span class="NLM_article-title">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1038/nrd3287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1038%2Fnrd3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=21119731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=929-939&author=D.+A.+Smithauthor=L.+Diauthor=E.+H.+Kerns&title=The+effect+of+plasma+protein+binding+on+in+vivo+efficacy%3A+misconceptions+in+drug+discovery&doi=10.1038%2Fnrd3287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span></div><div class="casAuthors">Smith, Dennis A.; Di, Li; Kerns, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">929-939</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Data from in vitro plasma protein binding expts. that det. the fraction of protein-bound drug are frequently used in drug discovery to guide structure design and to prioritize compds. for in vivo studies.  However, we consider that these practices are usually misleading, because in vivo efficacy is detd. by the free (unbound) drug concn. surrounding the therapeutic target, not by the free drug fraction.  These practices yield no enhancement of the in vivo free drug concn.  So, decisions based on free drug fraction could result in the wrong compds. being advanced through drug discovery programs.  This Perspective provides guidance on the application of plasma protein binding information in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOa3ippodhGbVg90H21EOLACvtfcHk0lg4l33gvzoSAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI&md5=a45d00f68ab44580fa38a6acef49493a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3287%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26atitle%3DThe%2520effect%2520of%2520plasma%2520protein%2520binding%2520on%2520in%2520vivo%2520efficacy%253A%2520misconceptions%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D929%26epage%3D939%26doi%3D10.1038%2Fnrd3287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Houston, J.
B.</span></span> <span> </span><span class="NLM_article-title">Relevance of in vitro kinetic parameters to in vivo metabolism of xenobiotics</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.1016/0887-2333(94)90002-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1016%2F0887-2333%2894%2990002-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1994&pages=507-512&author=J.%0AB.+Houston&title=Relevance+of+in+vitro+kinetic+parameters+to+in+vivo+metabolism+of+xenobiotics&doi=10.1016%2F0887-2333%2894%2990002-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2F0887-2333%2894%2990002-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0887-2333%252894%252990002-7%26sid%3Dliteratum%253Aachs%26aulast%3DHouston%26aufirst%3DJ.%2BB.%26atitle%3DRelevance%2520of%2520in%2520vitro%2520kinetic%2520parameters%2520to%2520in%2520vivo%2520metabolism%2520of%2520xenobiotics%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D1994%26volume%3D8%26spage%3D507%26epage%3D512%26doi%3D10.1016%2F0887-2333%2894%2990002-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10534321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1350-1359&author=R.+S.+Obach&title=Prediction+of+human+clearance+of+twenty-nine+drugs+from+hepatic+microsomal+intrinsic+clearance+data%3A+an+examination+of+in+vitro+half-life+approach+and+nonspecific+binding+to+microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1350-1359</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Twenty-nine drugs of disparate structures and physicochem. properties were used in an examn. of the capability of human liver microsomal lability data ("in vitro T1/2" approach) to be useful in the prediction of human clearance.  Addnl., the potential importance of nonspecific binding to microsomes in the in vitro incubation milieu for the accurate prediction of human clearance was investigated.  The compds. examd. demonstrated a wide range of microsomal metabolic labilities with scaled intrinsic clearance values ranging from less than 0.5 mL/min/kg to 189 mL/min/kg.  Microsomal binding was detd. at microsomal protein concns. used in the lability incubations.  For the 29 compds. studied, unbound fractions in microsomes ranged from 0.11 to 1.0.  Generally, basic compds. demonstrated the greatest extent of binding and neutral and acidic compds. the least extent of binding.  In the projection of human clearance values, basic and neutral compds. were well predicted when all binding considerations (blood and microsome) were disregarded, however, including both binding considerations also yielded reasonable predictions.  Including only blood binding yielded very poor projections of human clearance for these two types of compds.  However, for acidic compds., disregarding all binding considerations yielded poor predictions of human clearance.  It was generally most difficult to accurately predict clearance for this class of compds.; however the accuracy was best when all binding considerations were included.  Overall, inclusion of both blood and microsome binding values gave the best agreement between in vivo clearance values and clearance values projected from in vitro intrinsic clearance data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWp2hUTOxyubVg90H21EOLACvtfcHk0lg4l33gvzoSAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D&md5=7804cd4dfb131caac45aff9b7a1df901</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPrediction%2520of%2520human%2520clearance%2520of%2520twenty-nine%2520drugs%2520from%2520hepatic%2520microsomal%2520intrinsic%2520clearance%2520data%253A%2520an%2520examination%2520of%2520in%2520vitro%2520half-life%2520approach%2520and%2520nonspecific%2520binding%2520to%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landis, J.</span></span> <span> </span><span class="NLM_article-title">Opinion: can the pharmaceutical industry reduce attrition rates?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">711</span>– <span class="NLM_lpage">716</span>, <span class="refDoi"> DOI: 10.1038/nrd1470</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1038%2Fnrd1470" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=711-716&author=I.+Kolaauthor=J.+Landis&title=Opinion%3A+can+the+pharmaceutical+industry+reduce+attrition+rates%3F&doi=10.1038%2Fnrd1470"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnrd1470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1470%26sid%3Dliteratum%253Aachs%26aulast%3DKola%26aufirst%3DI.%26aulast%3DLandis%26aufirst%3DJ.%26atitle%3DOpinion%253A%2520can%2520the%2520pharmaceutical%2520industry%2520reduce%2520attrition%2520rates%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D711%26epage%3D716%26doi%3D10.1038%2Fnrd1470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0livT3KOXriYQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
de Waterbeemd, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, B. C.</span></span> <span> </span><span class="NLM_article-title">Lipophilicity in PK design: methyl, ethyl, futile</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1023/A:1008192010023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1023%2FA%3A1008192010023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=11289080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitlWjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=273-286&author=H.+Van%0Ade+Waterbeemdauthor=D.+A.+Smithauthor=B.+C.+Jones&title=Lipophilicity+in+PK+design%3A+methyl%2C+ethyl%2C+futile&doi=10.1023%2FA%3A1008192010023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in PK design: methyl, ethyl, futile</span></div><div class="casAuthors">Van de Waterbeemd, Han; Smith, Dennis A.; Jones, Barry C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-286</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review with 39 refs.  Lipophilicity, often expressed as distribution coeffs. (log D) in octanol/water, is an important physicochem. parameter influencing processes such as oral absorption, brain uptake and various pharmacokinetic (PK) properties.  Increasing log D values increases oral absorption, plasma protein binding and vol. of distribution.  However, more lipophilic compds. also become more vulnerable to P 450 metab., leading to higher clearance.  Mol. size and hydrogen bonding capacity are two other properties often considered as important for membrane permeation and pharmacokinetics.  Interrelationships among these physicochem. properties are discussed.  Increasing size (mol. wt.) often gives higher potency, but inevitably also leads to either higher lipophilicity, and hence poorer dissoln./soly., or to more hydrogen bonding capacity, which limits oral absorption.  Differences in optimal properties between gastrointestinal absorption and uptake into the brain are addressed.  Special attention is given to the desired lipophilicity of CNS drugs.  In examples using β-blockers, Ca channel antagonists and peptidic renin inhibitors we will demonstrate how potency and pharmacokinetic properties need to be balanced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohNJonr7f2hbVg90H21EOLACvtfcHk0livT3KOXriYQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitlWjtLo%253D&md5=04f94add93edc2b1a211bb53f676d908</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008192010023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008192010023%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bde%2BWaterbeemd%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DJones%26aufirst%3DB.%2BC.%26atitle%3DLipophilicity%2520in%2520PK%2520design%253A%2520methyl%252C%2520ethyl%252C%2520futile%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2001%26volume%3D15%26spage%3D273%26epage%3D286%26doi%3D10.1023%2FA%3A1008192010023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
de Waterbeemd, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. K.</span></span> <span> </span><span class="NLM_article-title">Property-based design: optimization of drug absorption and pharmacokinetics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1313</span>– <span class="NLM_lpage">1333</span>, <span class="refDoi"> DOI: 10.1021/jm000407e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000407e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BD3MXit1Whu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1313-1333&author=H.+van%0Ade+Waterbeemdauthor=D.+A.+Smithauthor=K.+Beaumontauthor=D.+K.+Walker&title=Property-based+design%3A+optimization+of+drug+absorption+and+pharmacokinetics&doi=10.1021%2Fjm000407e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Property-based design: optimization of drug absorption and pharmacokinetics</span></div><div class="casAuthors">van de Waterbeemd, Han; Smith, Dennis A.; Beaumont, Kevin; Walker, Don K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1313-1333</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 223 refs.  The authors discuss some aspects of the properties of biol. barriers.  In different sections the estn. of drug absorption via important barriers including gastrointestinal tract, blood-brain barrier, and skin are reviewed.  Various approaches for the measurement and computation of physicochem. and mol. properties currently used in the optimization of absorption as well as the use of physicochem. properties in the design of optimal pharmacokinetic profiles are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaQwsmoX0-mbVg90H21EOLACvtfcHk0livT3KOXriYQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXit1Whu7c%253D&md5=3183baedca70020f4ce27f306ba0997e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm000407e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000407e%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bde%2BWaterbeemd%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DWalker%26aufirst%3DD.%2BK.%26atitle%3DProperty-based%2520design%253A%2520optimization%2520of%2520drug%2520absorption%2520and%2520pharmacokinetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D1313%26epage%3D1333%26doi%3D10.1021%2Fjm000407e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Houston, J. B.</span></span> <span> </span><span class="NLM_article-title">Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1469</span>– <span class="NLM_lpage">1479</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(94)90520-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1016%2F0006-2952%2894%2990520-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=8185657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADyaK2cXkt1Kju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1994&pages=1469-1479&author=J.+B.+Houston&title=Utility+of+in+vitro+drug+metabolism+data+in+predicting+in+vivo+metabolic+clearance&doi=10.1016%2F0006-2952%2894%2990520-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance</span></div><div class="casAuthors">Houston, J. Brian</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1469-79</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A review with 54 refs.  The aim of the commentary is to present a strategy to achieve the prediction of in vivo clearance from in vitro data based on the current understanding of metabolite kinetics in vitro and in vivo.  Hepatic microsomes and hepatocyte suspension are the main in vitro system addressed.  The theor. basis of the strategy is outlined and its general applicability evaluated, using a data base of 25 drugs drawn from the literature.  Finally, the prospective value of the approach is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFHqQ8gCJ6lrVg90H21EOLACvtfcHk0lgO-7CuZFPdvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkt1Kju7c%253D&md5=a6d0abdbd2f0b238a6a01ba63ee67739</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2894%2990520-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252894%252990520-7%26sid%3Dliteratum%253Aachs%26aulast%3DHouston%26aufirst%3DJ.%2BB.%26atitle%3DUtility%2520of%2520in%2520vitro%2520drug%2520metabolism%2520data%2520in%2520predicting%2520in%2520vivo%2520metabolic%2520clearance%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1994%26volume%3D47%26spage%3D1469%26epage%3D1479%26doi%3D10.1016%2F0006-2952%2894%2990520-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T.</span></span> <span> </span><span class="NLM_article-title">Physicochemical drug properties associated with in vivo toxicological outcomes: a review</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">921</span>– <span class="NLM_lpage">931</span>, <span class="refDoi"> DOI: 10.1517/17425250903042318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1517%2F17425250903042318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=19519283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVCjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=921-931&author=D.+A.+Priceauthor=J.+Blaggauthor=L.+Jonesauthor=N.+Greeneauthor=T.+Wager&title=Physicochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes%3A+a+review&doi=10.1517%2F17425250903042318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical drug properties associated with in vivo toxicological outcomes: a review</span></div><div class="casAuthors">Price, David A.; Blagg, Julian; Jones, Lyn; Greene, Nigel; Wager, Travis</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">921-931</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The genesis of any toxicol. or safety outcome is multifactorial and complex; for this reason, it can be difficult for drug discovery projects to factor the avoidance of toxicity outcomes into their target design.  A focus on readily measurable parameters from high-throughput in vitro assays (e.g., primary potency, clearance) is easier to handle and have become the mainstays of drug discovery projects.  However, the fundamental origins of adverse safety or toxicity findings can be considered as deriving from four parameters, all of which are in the control of the drug designer.  These can be described as primary pharmacol., off target pharmacol., the presence of a defined structural fragment that can be assocd. with adverse outcomes and the overall physicochem. properties of the mol. that may predispose it to adverse outcomes.  In the drug discovery community, there has been recognition for many years of the influence of physicochem. drug properties (in particular lipophilicity) on the toxicol. profile of compds., and recent research is now beginning to quantify that risk in a probabilistic sense.  This review focuses on the overall properties of classes of mols. that are assocd. with an increased probability of adverse outcomes in in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU8kwwUsaFIrVg90H21EOLACvtfcHk0lgO-7CuZFPdvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVCjtb0%253D&md5=bd1cca3634afda14de2f8aa115d7d55e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1517%2F17425250903042318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425250903042318%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DL.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DWager%26aufirst%3DT.%26atitle%3DPhysicochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%253A%2520a%2520review%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2009%26volume%3D5%26spage%3D921%26epage%3D931%26doi%3D10.1517%2F17425250903042318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keefer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckworth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">448</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.06.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1016%2Fj.ejmech.2012.06.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=22840492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslaqu77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2012&pages=441-448&author=L.+Diauthor=C.+Keeferauthor=D.+O.+Scottauthor=T.+J.+Strelevitzauthor=G.+Changauthor=Y.-A.+Biauthor=Y.+Laiauthor=J.+Duckworthauthor=K.+Fennerauthor=M.+D.+Troutmanauthor=R.+S.+Obach&title=Mechanistic+insights+from+comparing+intrinsic+clearance+values+between+human+liver+microsomes+and+hepatocytes+to+guide+drug+design&doi=10.1016%2Fj.ejmech.2012.06.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design</span></div><div class="casAuthors">Di, Li; Keefer, Christopher; Scott, Dennis O.; Strelevitz, Timothy J.; Chang, George; Bi, Yi-An; Lai, Yurong; Duckworth, Jonathon; Fenner, Katherine; Troutman, Matthew D.; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">441-448</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Metabolic stability of drug candidates are often detd. in both liver microsome and hepatocyte assays.  Comparison of intrinsic clearance values between the two assays provides addnl. information to guide drug design.  Intrinsic clearance values from human liver microsomes and hepatocytes were compared for a set of com. drugs with known metabolic pathways and transporter characteristics.  The results showed that for compds. that were predominately metabolized by CYP mediated mechanisms, the intrinsic clearance values from the two assays were comparable.  For compds. with non-CYP pathways, such as UGT and AO, intrinsic clearance was faster in hepatocytes than in microsomes.  Substrates of uptake or efflux transporters in this study did not have significant differences of intrinsic clearance between microsomes and hepatocytes, when uptake into the hepatocytes was not the rate-limiting step.  When hepatic uptake was rate limiting, intrinsic clearance in microsomes was faster than that in hepatocytes, which was more prevalent for compds. with rapid metab.  Low passive permeability can limit the exposure to drug mols. to the metabolizing enzymes in the hepatocytes in relationship to the rate of metab.  The faster the rate of metab., the higher permeability is needed for mol. to enter the cells and not becoming rate-limiting.  The findings are very useful for drug discovery programs to gain addnl. insights on mechanistic information to help drug design without added expts.  Follow-up studies can then be designed to address specific questions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpotepvZ_arBrVg90H21EOLACvtfcHk0lgO-7CuZFPdvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslaqu77M&md5=37b89dbe98fecdd067453ce49042d668</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.06.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.06.043%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKeefer%26aufirst%3DC.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DBi%26aufirst%3DY.-A.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DDuckworth%26aufirst%3DJ.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DMechanistic%2520insights%2520from%2520comparing%2520intrinsic%2520clearance%2520values%2520between%2520human%2520liver%2520microsomes%2520and%2520hepatocytes%2520to%2520guide%2520drug%2520design%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D57%26spage%3D441%26epage%3D448%26doi%3D10.1016%2Fj.ejmech.2012.06.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niosi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosa, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litchfield, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Novel method to predict in vivo liver-to-plasma Kpuu for OATP substrates using suspension hepatocytes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">576</span>– <span class="NLM_lpage">580</span>, <span class="refDoi"> DOI: 10.1124/dmd.116.074575</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1124%2Fdmd.116.074575" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=576-580&author=K.+Riccardiauthor=J.+Linauthor=Z.+Liauthor=M.+Niosiauthor=S.+Ryuauthor=W.+Huaauthor=K.+Atkinsonauthor=R.+E.+Kosaauthor=J.+Litchfieldauthor=L.+Di&title=Novel+method+to+predict+in+vivo+liver-to-plasma+Kpuu+for+OATP+substrates+using+suspension+hepatocytes&doi=10.1124%2Fdmd.116.074575"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fdmd.116.074575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.116.074575%26sid%3Dliteratum%253Aachs%26aulast%3DRiccardi%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DNiosi%26aufirst%3DM.%26aulast%3DRyu%26aufirst%3DS.%26aulast%3DHua%26aufirst%3DW.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DKosa%26aufirst%3DR.%2BE.%26aulast%3DLitchfield%26aufirst%3DJ.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DNovel%2520method%2520to%2520predict%2520in%2520vivo%2520liver-to-plasma%2520Kpuu%2520for%2520OATP%2520substrates%2520using%2520suspension%2520hepatocytes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2017%26volume%3D45%26spage%3D576%26epage%3D580%26doi%3D10.1124%2Fdmd.116.074575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y.-a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scialis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathialagan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keefer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vildhede, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremaine, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V. S.</span></span> <span> </span><span class="NLM_article-title">Reliable rate measurements for active and passive hepatic uptake using plated human hepatocytes</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.1208/s12248-017-0051-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1208%2Fs12248-017-0051-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=28188574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivFSqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=787-796&author=Y.-a.+Biauthor=R.+Scialisauthor=S.+Lazzaroauthor=S.+Mathialaganauthor=E.+Kimotoauthor=J.+Keeferauthor=H.+Zhangauthor=A.+M.+Vildhedeauthor=C.+Costalesauthor=A.+D.+Rodriguesauthor=L.+M.+Tremaineauthor=M.+V.+S.+Varma&title=Reliable+rate+measurements+for+active+and+passive+hepatic+uptake+using+plated+human+hepatocytes&doi=10.1208%2Fs12248-017-0051-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Reliable Rate Measurements for Active and Passive Hepatic Uptake Using Plated Human Hepatocytes</span></div><div class="casAuthors">Bi, Yi-an; Scialis, Renato; Lazzaro, Sarah; Mathialagan, Sumathy; Kimoto, Emi; Keefer, Julie; Zhang, Hui; Vildhede, Anna M.; Costales, Chester; Rodrigues, A. David; Tremaine, Larry M.; Varma, Manthena V. S.</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">787-796</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Transporter-mediated hepatic uptake is proven to be the rate-detg. step in the systemic clearance of several drugs.  Therefore, accurate measurement of active and passive uptake clearances in vitro is crit. to facilitate pharmacokinetics and drug-drug interaction predictions.  Here, we evaluated the plated human hepatocytes (PHH) and studied the effect of incubation temp. and inhibitor concn. on uptake measurements, in order to reliably est. hepatic uptake components.  Uptake rates measured using PHH, at 37°C without and with rifamycin SV, were comparable with those obtained from suspension hepatocytes and sandwich-cultured hepatocytes for a set of 10-13 compds.  Apparent permeability across monolayers of low-efflux Madin-Darby canine kidney cells was measured at 4, 10, and 37°C.  Of the 23 compds. evaluated, 13 compds. showed >2-fold redn. in passive permeability at 4°C compared to 37°C, inferring that low-temp. incubations may underestimate passive uptake.  Inhibition studies using transporter-transfected cells suggested that ∼20 μM rifamycin SV completely inhibited org. anion-transporting polypeptides (OATPs), while no significant inhibition was noted for other hepatic uptake transporters.  On the basis of inhibition profiles, the contribution of active vs. passive and OATP vs. non-OATP transport to the PHH uptake was discerned for various endogenous substrates and statins.  With the exception of fluvastatin, the statins studied were predominantly transported by OATPs in PHH and the non-OATP transporters, such as Na+-taurocholate co-transporting polypeptide, played a minimal role.  In conclusion, PHH is useful for uptake measurements, and rifamycin SV employed at different concns. can reliably est. active and passive uptake and characterize OATP-dependent active uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZp938mtplg7Vg90H21EOLACvtfcHk0lhkqqkClTWmvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivFSqtbg%253D&md5=aafedb94cb981fcde209de3632a46e2d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1208%2Fs12248-017-0051-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-017-0051-2%26sid%3Dliteratum%253Aachs%26aulast%3DBi%26aufirst%3DY.-a.%26aulast%3DScialis%26aufirst%3DR.%26aulast%3DLazzaro%26aufirst%3DS.%26aulast%3DMathialagan%26aufirst%3DS.%26aulast%3DKimoto%26aufirst%3DE.%26aulast%3DKeefer%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DVildhede%26aufirst%3DA.%2BM.%26aulast%3DCostales%26aufirst%3DC.%26aulast%3DRodrigues%26aufirst%3DA.%2BD.%26aulast%3DTremaine%26aufirst%3DL.%2BM.%26aulast%3DVarma%26aufirst%3DM.%2BV.%2BS.%26atitle%3DReliable%2520rate%2520measurements%2520for%2520active%2520and%2520passive%2520hepatic%2520uptake%2520using%2520plated%2520human%2520hepatocytes%26jtitle%3DAAPS%2520J.%26date%3D2017%26volume%3D19%26spage%3D787%26epage%3D796%26doi%3D10.1208%2Fs12248-017-0051-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Claire, R. L.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, K. L. R.</span></span> <span> </span><span class="NLM_article-title">Prediction of altered bile acid disposition due to inhibition of multiple transporters: an integrated approach using sandwich- cultured hepatocytes, mechanistic modeling, and simulations</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">324</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.1124/jpet.116.231928</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1124%2Fjpet.116.231928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=27233294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCqtbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2016&pages=324-333&author=C.+Guoauthor=K.+Yangauthor=K.+R.+Brouwerauthor=R.+L.+St.+Claireauthor=K.+L.+R.+Brouwer&title=Prediction+of+altered+bile+acid+disposition+due+to+inhibition+of+multiple+transporters%3A+an+integrated+approach+using+sandwich-+cultured+hepatocytes%2C+mechanistic+modeling%2C+and+simulations&doi=10.1124%2Fjpet.116.231928"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of altered bile acid disposition due to inhibition of multiple transporters: an integrated approach using sandwich- cultured hepatocytes, mechanistic modeling, and simulations</span></div><div class="casAuthors">Guo, Cen; Yang, Kyunghee; Brouwer, Kenneth R.; St. Claire, Robert L., III; Brouwer, Kim L. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">324-333</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Transporter-mediated alterations in bile acid disposition may have significant toxicol. implications.  Current methods to predict interactions are limited by the interplay of multiple transporters, absence of protein in the exptl. system, and inaccurate ests. of inhibitor concns.  An integrated approach was developed to predict altered bile acid disposition due to inhibition of multiple transporters using the model bile acid taurocholate (TCA).  TCA pharmacokinetic parameters were estd. by mechanistic modeling using sandwich-cultured human hepatocyte data with protein in the medium.  Uptake, basolateral efflux, and biliary clearance ests. were 0.63, 0.034, and 0.074 mL/min/g liver, resp.  Cellular total TCA concns. (Ct,Cells) were selected as the model output based on sensitivity anal.  Monte Carlo simulations of TCA Ct,Cells in the presence of model inhibitors (telmisartan and bosentan) were performed using inhibition consts. for TCA transporters and inhibitor concns., including cellular total inhibitor concns. ([I]t,cell) or unbound concns., and cytosolic total or unbound concns.  For telmisartan, themodel prediction was accurate with an av. fold error (AFE) of 0.99-1.0 when unbound inhibitor concn. ([I]u) was used; accuracy dropped when total inhibitor concn. ([I]t) was used.  For bosentan, AFEwas 1.2-1.3 using either [I]u or [I]t.  This difference was evaluated by sensitivity anal. of the cellular unbound fraction of inhibitor (fu,cell,inhibitor), which revealed higher sensitivity of fu,cell,inhibitor for predicting TCA Ct,Cells when inhibitors exhibited larger ([I]t,cell/IC50) values.  In conclusion, this study demonstrated the applicability of a framework to predict hepatocellular bile acid concns. due to drug-mediated inhibition of transporters using mechanistic modeling and cytosolic or cellular unbound concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0MZBuSC-1X7Vg90H21EOLACvtfcHk0lhkqqkClTWmvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCqtbfN&md5=c69a2b924eed2b12a1b1677beb6879cb</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.231928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.231928%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DBrouwer%26aufirst%3DK.%2BR.%26aulast%3DSt.%2BClaire%26aufirst%3DR.%2BL.%26aulast%3DBrouwer%26aufirst%3DK.%2BL.%2BR.%26atitle%3DPrediction%2520of%2520altered%2520bile%2520acid%2520disposition%2520due%2520to%2520inhibition%2520of%2520multiple%2520transporters%253A%2520an%2520integrated%2520approach%2520using%2520sandwich-%2520cultured%2520hepatocytes%252C%2520mechanistic%2520modeling%252C%2520and%2520simulations%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D358%26spage%3D324%26epage%3D333%26doi%3D10.1124%2Fjpet.116.231928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsunaga, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imawaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamai, I.</span></span> <span> </span><span class="NLM_article-title">Sandwich-cultured hepatocytes for mechanistic understanding of hepatic disposition of parent drugs and metabolites by transporter-enzyme interplay</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">680</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1124/dmd.117.079236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1124%2Fdmd.117.079236" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=680-691&author=N.+Matsunagaauthor=Y.+Fukuchiauthor=H.+Imawakaauthor=I.+Tamai&title=Sandwich-cultured+hepatocytes+for+mechanistic+understanding+of+hepatic+disposition+of+parent+drugs+and+metabolites+by+transporter-enzyme+interplay&doi=10.1124%2Fdmd.117.079236"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fdmd.117.079236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.117.079236%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DN.%26aulast%3DFukuchi%26aufirst%3DY.%26aulast%3DImawaka%26aufirst%3DH.%26aulast%3DTamai%26aufirst%3DI.%26atitle%3DSandwich-cultured%2520hepatocytes%2520for%2520mechanistic%2520understanding%2520of%2520hepatic%2520disposition%2520of%2520parent%2520drugs%2520and%2520metabolites%2520by%2520transporter-enzyme%2520interplay%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2018%26volume%3D46%26spage%3D680%26epage%3D691%26doi%3D10.1124%2Fdmd.117.079236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosa, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremaine, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V. S.</span></span> <span> </span><span class="NLM_article-title">Hepatobiliary clearance prediction: species scaling from monkey, dog, and rat, and in vitro-in vivo extrapolation of sandwich-cultured human hepatocytes using 17 drugs</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">2795</span>– <span class="NLM_lpage">2804</span>, <span class="refDoi"> DOI: 10.1016/j.xphs.2017.04.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1016%2Fj.xphs.2017.04.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=28456723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslGnsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2017&pages=2795-2804&author=E.+Kimotoauthor=Y.-A.+Biauthor=R.+E.+Kosaauthor=L.+M.+Tremaineauthor=M.+V.+S.+Varma&title=Hepatobiliary+clearance+prediction%3A+species+scaling+from+monkey%2C+dog%2C+and+rat%2C+and+in+vitro-in+vivo+extrapolation+of+sandwich-cultured+human+hepatocytes+using+17+drugs&doi=10.1016%2Fj.xphs.2017.04.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatobiliary Clearance Prediction: Species Scaling From Monkey, Dog, and Rat, and In Vitro-In Vivo Extrapolation of Sandwich-Cultured Human Hepatocytes Using 17 Drugs</span></div><div class="casAuthors">Kimoto, Emi; Bi, Yi-An; Kosa, Rachel E.; Tremaine, Larry M.; Varma, Manthena V. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2795-2804</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Hepatobiliary elimination can be a major clearance pathway dictating the pharmacokinetics of drugs.  Here, we first compared the dose eliminated in bile in preclin. species (monkey, dog, and rat) with that in human and further evaluated single-species scaling (SSS) to predict human hepatobiliary clearance.  Six compds. dosed in bile duct-cannulated (BDC) monkeys showed biliary excretion comparable to human; and the SSS of hepatobiliary clearance with plasma fraction unbound correction yielded reasonable predictions (within 3-fold).  Although dog SSS also showed reasonable predictions, rat overpredicted hepatobiliary clearance for 13 of 24 compds.  Second, we evaluated the translatability of in vitro sandwich-cultured human hepatocytes (SCHHs) to predict human hepatobiliary clearance for 17 drugs.  For drugs with no significant active uptake in SCHH studies (i.e., with or without rifamycin SV), measured intrinsic biliary clearance was directly scalable with good predictability (abs. av. fold error [AAFE] = 1.6).  Drugs showing significant active uptake in SCHH, however, showed improved predictability when scaled based on extended clearance term (AAFE = 2.0), which incorporated sinusoidal uptake along with a global scaling factor for active uptake and the canalicular efflux clearance.  In conclusion, SCHH is a useful tool to predict human hepatobiliary clearance, whereas BDC monkey model may provide further confidence in the prospective predictions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnnfbBzDYp4rVg90H21EOLACvtfcHk0lgdekKVIS1MKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslGnsbc%253D&md5=7b059b55d39b86abafbb5791c16bc15f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.xphs.2017.04.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.xphs.2017.04.043%26sid%3Dliteratum%253Aachs%26aulast%3DKimoto%26aufirst%3DE.%26aulast%3DBi%26aufirst%3DY.-A.%26aulast%3DKosa%26aufirst%3DR.%2BE.%26aulast%3DTremaine%26aufirst%3DL.%2BM.%26aulast%3DVarma%26aufirst%3DM.%2BV.%2BS.%26atitle%3DHepatobiliary%2520clearance%2520prediction%253A%2520species%2520scaling%2520from%2520monkey%252C%2520dog%252C%2520and%2520rat%252C%2520and%2520in%2520vitro-in%2520vivo%2520extrapolation%2520of%2520sandwich-cultured%2520human%2520hepatocytes%2520using%252017%2520drugs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2017%26volume%3D106%26spage%3D2795%26epage%3D2804%26doi%3D10.1016%2Fj.xphs.2017.04.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y.-a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempshall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kattan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houston, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galetin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenner, K. S.</span></span> <span> </span><span class="NLM_article-title">Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1007</span>– <span class="NLM_lpage">1017</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.042994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1124%2Fdmd.111.042994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=22344703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1KnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1007-1017&author=H.+M.+Jonesauthor=H.+A.+Bartonauthor=Y.+Laiauthor=Y.-a.+Biauthor=E.+Kimotoauthor=S.+Kempshallauthor=S.+C.+Tateauthor=A.+El-Kattanauthor=J.+B.+Houstonauthor=A.+Galetinauthor=K.+S.+Fenner&title=Mechanistic+pharmacokinetic+modeling+for+the+prediction+of+transporter-mediated+disposition+in+humans+from+sandwich+culture+human+hepatocyte+data&doi=10.1124%2Fdmd.111.042994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data</span></div><div class="casAuthors">Jones, Hannah M.; Barton, Hugh A.; Lai, Yurong; Bi, Yi-an; Kimoto, Emi; Kempshall, Sarah; Tate, Sonya C.; El-Kattan, Ayman; Houston, J. Brian; Galetin, Aleksandra; Fenner, Katherine S.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1007-1017</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">With efforts to reduce cytochrome P 450-mediated clearance (CL) during the early stages of drug discovery, transporter-mediated CL mechanisms are becoming more prevalent.  However, the prediction of plasma concn.-time profiles for such compds. using physiol. based pharmacokinetic (PBPK) modeling is far less established in comparison with that for compds. with passively mediated pharmacokinetics (PK).  In this study, we have assessed the predictability of human PK for seven org. anion-transporting polypeptide (OATP) substrates (pravastatin, cerivastatin, bosentan, fluvastatin, rosuvastatin, valsartan, and repaglinide) for which clin. i.v. data were available.  In vitro data generated from the sandwich culture human hepatocyte system were simultaneously fit to est. parameters describing both uptake and biliary efflux.  Use of scaled active uptake, passive distribution, and biliary efflux parameters as inputs into a PBPK model resulted in the overprediction of exposure for all seven drugs investigated, with the exception of pravastatin.  Therefore, fitting of in vivo data for each individual drug in the dataset was performed to establish empirical scaling factors to accurately capture their plasma concn.-time profiles.  Overall, active uptake and biliary efflux were under- and overpredicted, leading to av. empirical scaling factors of 58 and 0.061, resp.; passive diffusion required no scaling factor.  This study illustrates the mechanistic and model-driven application of in vitro uptake and efflux data for human PK prediction for OATP substrates.  A particular advantage is the ability to capture the multiphasic plasma concn.-time profiles for such compds. using only preclin. data.  A prediction strategy for novel OATP substrates is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTZLA7_SR2trVg90H21EOLACvtfcHk0lgdekKVIS1MKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1KnsrY%253D&md5=4dd3e5fb5fd400c979f160d89b39753f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.042994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.042994%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DBarton%26aufirst%3DH.%2BA.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DBi%26aufirst%3DY.-a.%26aulast%3DKimoto%26aufirst%3DE.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DTate%26aufirst%3DS.%2BC.%26aulast%3DEl-Kattan%26aufirst%3DA.%26aulast%3DHouston%26aufirst%3DJ.%2BB.%26aulast%3DGaletin%26aufirst%3DA.%26aulast%3DFenner%26aufirst%3DK.%2BS.%26atitle%3DMechanistic%2520pharmacokinetic%2520modeling%2520for%2520the%2520prediction%2520of%2520transporter-mediated%2520disposition%2520in%2520humans%2520from%2520sandwich%2520culture%2520human%2520hepatocyte%2520data%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D1007%26epage%3D1017%26doi%3D10.1124%2Fdmd.111.042994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span> <span> </span><span class="NLM_article-title">A “middle-out” approach to human pharmacokinetic predictions for OATP substrates using physiologically-based pharmacokinetic modeling</span>. <i>J. Pharmacokinet. Pharmacodyn.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">209</span>, <span class="refDoi"> DOI: 10.1007/s10928-014-9357-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1007%2Fs10928-014-9357-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=24718648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmt1GnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=197-209&author=R.+Liauthor=H.+A.+Bartonauthor=P.+D.+Yatesauthor=A.+Ghoshauthor=A.+C.+Wolfordauthor=K.+A.+Riccardiauthor=T.+S.+Maurer&title=A+%E2%80%9Cmiddle-out%E2%80%9D+approach+to+human+pharmacokinetic+predictions+for+OATP+substrates+using+physiologically-based+pharmacokinetic+modeling&doi=10.1007%2Fs10928-014-9357-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A "middle-out" approach to human pharmacokinetic predictions for OATP substrates using physiologically-based pharmacokinetic modeling</span></div><div class="casAuthors">Li, Rui; Barton, Hugh A.; Yates, Phillip D.; Ghosh, Avijit; Wolford, Angela C.; Riccardi, Keith A.; Maurer, Tristan S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacokinetics and Pharmacodynamics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">197-209</span>CODEN:
                <span class="NLM_cas:coden">JPPOAH</span>;
        ISSN:<span class="NLM_cas:issn">1567-567X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Physiol. based pharmacokinetic (PBPK) models provide a framework useful for generating credible human pharmacokinetic predictions from data available at the earliest, preclin. stages of pharmaceutical research.  With this approach, the pharmacokinetic implications of in vitro data are contextualized via scaling according to independent physiol. information.  However, in many cases these models also require model-based estn. of addnl. empirical scaling factors (SFs) in order to accurately recapitulate known human pharmacokinetic behavior.  While this practice clearly improves data characterization, the introduction of empirically derived SFs may belie the extrapolative power commonly attributed to PBPK.  This is particularly true when such SFs are compd. dependent and/or when there are issues with regard to identifiability.  As such, when empirically-derived SFs are necessary, a crit. evaluation of parameter estn. and model structure are prudent.  In this study, we applied a global optimization method to support model-based estn. of a single set of empirical SFs from i.v. clin. data on seven OATP substrates within the context of a previously published PBPK model as well as a revised PBPK model.  The revised model with exptl. measured unbound fraction in liver, permeability between liver compartments, and permeability limited distribution to selected tissues improved data characterization.  We utilized large-sample approxn. and resampling approaches to est. confidence intervals for the revised model in support of forward predictions that reflect the derived uncertainty.  This work illustrates an objective approach to estg. empirically-derived SFs, systematically refining PBPK model performance and conveying the assocd. confidence in subsequent forward predictions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdIDSVCuxE67Vg90H21EOLACvtfcHk0lgkZwPswfsFig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmt1GnsLk%253D&md5=f39119d03fb7ef39468b8dfa3e2f7800</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs10928-014-9357-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10928-014-9357-1%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DR.%26aulast%3DBarton%26aufirst%3DH.%2BA.%26aulast%3DYates%26aufirst%3DP.%2BD.%26aulast%3DGhosh%26aufirst%3DA.%26aulast%3DWolford%26aufirst%3DA.%2BC.%26aulast%3DRiccardi%26aufirst%3DK.%2BA.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26atitle%3DA%2520%25E2%2580%259Cmiddle-out%25E2%2580%259D%2520approach%2520to%2520human%2520pharmacokinetic%2520predictions%2520for%2520OATP%2520substrates%2520using%2520physiologically-based%2520pharmacokinetic%2520modeling%26jtitle%3DJ.%2520Pharmacokinet.%2520Pharmacodyn.%26date%3D2014%26volume%3D41%26spage%3D197%26epage%3D209%26doi%3D10.1007%2Fs10928-014-9357-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camenisch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riede, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunze, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huwyler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, K.</span></span> <span> </span><span class="NLM_article-title">The extended clearance model and its use for the interpretation of hepatobiliary elimination data</span>. <i>ADMET DMPK</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.5599/admet.3.1.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.5599%2Fadmet.3.1.144" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=1-4&author=G.+Camenischauthor=J.+Riedeauthor=A.+Kunzeauthor=J.+Huwylerauthor=B.+Pollerauthor=K.+Umehara&title=The+extended+clearance+model+and+its+use+for+the+interpretation+of+hepatobiliary+elimination+data&doi=10.5599%2Fadmet.3.1.144"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.5599%2Fadmet.3.1.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5599%252Fadmet.3.1.144%26sid%3Dliteratum%253Aachs%26aulast%3DCamenisch%26aufirst%3DG.%26aulast%3DRiede%26aufirst%3DJ.%26aulast%3DKunze%26aufirst%3DA.%26aulast%3DHuwyler%26aufirst%3DJ.%26aulast%3DPoller%26aufirst%3DB.%26aulast%3DUmehara%26aufirst%3DK.%26atitle%3DThe%2520extended%2520clearance%2520model%2520and%2520its%2520use%2520for%2520the%2520interpretation%2520of%2520hepatobiliary%2520elimination%2520data%26jtitle%3DADMET%2520DMPK%26date%3D2015%26volume%3D3%26spage%3D1%26epage%3D4%26doi%3D10.5599%2Fadmet.3.1.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyn, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allerton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kattan, A. F.</span></span> <span> </span><span class="NLM_article-title">Predicting clearance mechanism in drug discovery: extended clearance classification system (ECCS)</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">3785</span>– <span class="NLM_lpage">3802</span>, <span class="refDoi"> DOI: 10.1007/s11095-015-1749-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1007%2Fs11095-015-1749-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=26155985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCjurfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=3785-3802&author=M.+V.+Varmaauthor=S.+J.+Steynauthor=C.+Allertonauthor=A.+F.+El-Kattan&title=Predicting+clearance+mechanism+in+drug+discovery%3A+extended+clearance+classification+system+%28ECCS%29&doi=10.1007%2Fs11095-015-1749-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS)</span></div><div class="casAuthors">Varma, Manthena V.; Steyn, Stefanus J.; Allerton, Charlotte; El-Kattan, Ayman F.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3785-3802</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Early prediction of clearance mechanisms allows for the rapid progression of drug discovery and development programs, and facilitates risk assessment of the pharmacokinetic variability assocd. with drug interactions and pharmacogenomics.  Here we propose a scientific framework - Extended Clearance Classification System (ECCS) - which can be used to predict the predominant clearance mechanism (rate-detg. process) based on physicochem. properties and passive membrane permeability.  Compds. are classified as: Class 1A - metab. as primary systemic clearance mechanism (high permeability acids/zwitterions with mol. wt. (MW) ≤400 Da), Class 1B - transporter-mediated hepatic uptake as primary systemic clearance mechanism (high permeability acids/zwitterions with MW >400 Da), Class 2 - metab. as primary clearance mechanism (high permeability bases/neutrals), Class 3A -renal clearance (low permeability acids/zwitterions with MW ≤400 Da), Class 3B - transporter mediated hepatic uptake or renal clearance (low permeability acids/zwitterions with MW >400 Da), and Class 4 - renal clearance (low permeability bases/neutrals).  The performance of the ECCS framework was validated using 307 compds. with single clearance mechanism contributing to ≥70% of systemic clearance.  The apparent permeability across clonal cell line of Madin - Darby canine kidney cells, selected for low endogenous efflux transporter expression, with a cut-off of 5 × 10-6 cm/s was used for permeability classification, and the ionization (at pH7) was assigned based on calcd. pKa.  The proposed scheme correctly predicted the rate-detg. clearance mechanism to be either metab., hepatic uptake or renal for ∼92% of total compds.  We discuss the general characteristics of each ECCS class, as well as compare and contrast the framework with the biopharmaceutics classification system (BCS) and the biopharmaceutics drug disposition classification system (BDDCS).  Collectively, the ECCS framework is valuable in early prediction of clearance mechanism and can aid in choosing the right preclin. tool kit and strategy for optimizing drug exposure and evaluating clin. risk of pharmacokinetic variability caused by drug interactions and pharmacogenomics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRANZrcZqpObVg90H21EOLACvtfcHk0lgkZwPswfsFig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCjurfP&md5=836ba49f4fe66ceacfec6390e56bc792</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs11095-015-1749-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-015-1749-4%26sid%3Dliteratum%253Aachs%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DAllerton%26aufirst%3DC.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26atitle%3DPredicting%2520clearance%2520mechanism%2520in%2520drug%2520discovery%253A%2520extended%2520clearance%2520classification%2520system%2520%2528ECCS%2529%26jtitle%3DPharm.%2520Res.%26date%3D2015%26volume%3D32%26spage%3D3785%26epage%3D3802%26doi%3D10.1007%2Fs11095-015-1749-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camenisch, G. P.</span></span> <span> </span><span class="NLM_article-title">Drug disposition classification systems in discovery and development: a comparative review of the BDDCS, ECCS and ECCCS concepts</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2583</span>– <span class="NLM_lpage">2593</span>, <span class="refDoi"> DOI: 10.1007/s11095-016-2001-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1007%2Fs11095-016-2001-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=2583-2593&author=G.+P.+Camenisch&title=Drug+disposition+classification+systems+in+discovery+and+development%3A+a+comparative+review+of+the+BDDCS%2C+ECCS+and+ECCCS+concepts&doi=10.1007%2Fs11095-016-2001-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs11095-016-2001-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-016-2001-6%26sid%3Dliteratum%253Aachs%26aulast%3DCamenisch%26aufirst%3DG.%2BP.%26atitle%3DDrug%2520disposition%2520classification%2520systems%2520in%2520discovery%2520and%2520development%253A%2520a%2520comparative%2520review%2520of%2520the%2520BDDCS%252C%2520ECCS%2520and%2520ECCCS%2520concepts%26jtitle%3DPharm.%2520Res.%26date%3D2016%26volume%3D33%26spage%3D2583%26epage%3D2593%26doi%3D10.1007%2Fs11095-016-2001-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mordenti, J.</span></span> <span> </span><span class="NLM_article-title">Man versus beast: pharmacokinetic scaling in mammals</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">1028</span>– <span class="NLM_lpage">1040</span>, <span class="refDoi"> DOI: 10.1002/jps.2600751104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1002%2Fjps.2600751104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1986&pages=1028-1040&author=J.+Mordenti&title=Man+versus+beast%3A+pharmacokinetic+scaling+in+mammals&doi=10.1002%2Fjps.2600751104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600751104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600751104%26sid%3Dliteratum%253Aachs%26aulast%3DMordenti%26aufirst%3DJ.%26atitle%3DMan%2520versus%2520beast%253A%2520pharmacokinetic%2520scaling%2520in%2520mammals%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1986%26volume%3D75%26spage%3D1028%26epage%3D1040%26doi%3D10.1002%2Fjps.2600751104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boxenbaum, H.</span></span> <span> </span><span class="NLM_article-title">Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics</span>. <i>J. Pharmacokinet. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1007/BF01062336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1007%2FBF01062336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=7120049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADyaL38Xlt1Sjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1982&pages=201-227&author=H.+Boxenbaum&title=Interspecies+scaling%2C+allometry%2C+physiological+time%2C+and+the+ground+plan+of+pharmacokinetics&doi=10.1007%2FBF01062336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics</span></div><div class="casAuthors">Boxenbaum, Harold</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacokinetics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-27</span>CODEN:
                <span class="NLM_cas:coden">JPBPBJ</span>;
        ISSN:<span class="NLM_cas:issn">0090-466X</span>.
    </div><div class="casAbstract">Interspecies variation in pharmacokinetics is considered and treated as a property and consequence of body size (allometry).  Consequently, it is possible to ref. (scale) pharmacokinetic parameters to the organism's individual anatomy, biochem., and/or physiol. in such a manner that differences between species are nullified.  Thus, in the mouse, rat, dog, monkey, and human, methotrexate (I)  [59-05-2] plasma clearance always equals 133% of creatinine clearance and as such becomes invariant.  Pharmacokinetic time (a variable in terms of chronol. time) is shown to be a form of physiol. time in which a pharmacokinetic event becomes the independent variable, e.g., disposition half-life.  A relationship between pharmacokinetic time and body size is demonstrated.  Man's lesser quant. ability to metabolize many drugs may be correlated with his enhanced longevity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSl0rgKrgvErVg90H21EOLACvtfcHk0liHZ7_RbVjfqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xlt1Sjtbo%253D&md5=55fcc13c71bd4170866d95edf79f408c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2FBF01062336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01062336%26sid%3Dliteratum%253Aachs%26aulast%3DBoxenbaum%26aufirst%3DH.%26atitle%3DInterspecies%2520scaling%252C%2520allometry%252C%2520physiological%2520time%252C%2520and%2520the%2520ground%2520plan%2520of%2520pharmacokinetics%26jtitle%3DJ.%2520Pharmacokinet.%2520Biopharm.%26date%3D1982%26volume%3D10%26spage%3D201%26epage%3D227%26doi%3D10.1007%2FBF01062336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boxenbaum, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronfeld, R.</span></span> <span> </span><span class="NLM_article-title">Interspecies pharmacokinetic scaling and the Dedrick plots</span>. <i>Am. J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>245</i></span>,  <span class="NLM_fpage">R768</span>– <span class="NLM_lpage">R775</span>, <span class="refDoi"> DOI: 10.1152/ajpregu.1983.245.6.R768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1152%2Fajpregu.1983.245.6.R768" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=1983&pages=R768-R775&author=H.+Boxenbaumauthor=R.+Ronfeld&title=Interspecies+pharmacokinetic+scaling+and+the+Dedrick+plots&doi=10.1152%2Fajpregu.1983.245.6.R768"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.1983.245.6.R768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.1983.245.6.R768%26sid%3Dliteratum%253Aachs%26aulast%3DBoxenbaum%26aufirst%3DH.%26aulast%3DRonfeld%26aufirst%3DR.%26atitle%3DInterspecies%2520pharmacokinetic%2520scaling%2520and%2520the%2520Dedrick%2520plots%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1983%26volume%3D245%26spage%3DR768%26epage%3DR775%26doi%3D10.1152%2Fajpregu.1983.245.6.R768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahmood, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, R.</span></span> <span> </span><span class="NLM_article-title">A comparative study of allometric scaling with plasma concentrations predicted by species-invariant time methods</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1099-081X(199904)20:3<137::AID-BDD165>3.0.CO;2-I</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1002%2F%28SICI%291099-081X%28199904%2920%3A3%3C137%3A%3AAID-BDD165%3E3.0.CO%3B2-I" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10211866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADyaK1MXit1Kqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=137-144&author=I.+Mahmoodauthor=R.+Yuan&title=A+comparative+study+of+allometric+scaling+with+plasma+concentrations+predicted+by+species-invariant+time+methods&doi=10.1002%2F%28SICI%291099-081X%28199904%2920%3A3%3C137%3A%3AAID-BDD165%3E3.0.CO%3B2-I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative study of allometric scaling with plasma concentrations predicted by species-invariant time methods</span></div><div class="casAuthors">Mahmood, Iftekhar; Yuan, Rae</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">137-144</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The objective of this study is to compare the empirical allometric approaches with species invariant time methods using equiv. time, kallynochron, apolysichron, and dienetichrons.  Pharmacokinetic parameters (clearance, vol. of distribution, and elimination half-life) of ethosuximide, cyclosporine and ciprofloxacin were scaled-up from animal data obtained from the literature.  Two methods were utilized to generate plots for the prediction of clearance in humans: (i) clearance vs. body wt. (simple allometric equation); and (ii) the product of clearance and max. life-span potential (MLP) vs. body wt.  Plasma concns. of each of the drugs were predicted using elementary and complex Dedrick plots, equiv. time with an exponent of 0.25 and equiv. time with the exponent obtained from the plot of body wt. and half-life.  Plasma concns. of cyclosporine and ciprofloxacin were also predicted by MLP normalization (dienetichrons).  Almost similar results in the pharmacokinetic parameters of the tested drugs were obtained by the allometric approach and by the species invariant time methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_hVoKqPpen7Vg90H21EOLACvtfcHk0lhljr4fSW_ILA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXit1Kqt7c%253D&md5=680dd9aa145d9ee77e0c0c83ed2cf290</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291099-081X%28199904%2920%3A3%3C137%3A%3AAID-BDD165%3E3.0.CO%3B2-I&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291099-081X%2528199904%252920%253A3%253C137%253A%253AAID-BDD165%253E3.0.CO%253B2-I%26sid%3Dliteratum%253Aachs%26aulast%3DMahmood%26aufirst%3DI.%26aulast%3DYuan%26aufirst%3DR.%26atitle%3DA%2520comparative%2520study%2520of%2520allometric%2520scaling%2520with%2520plasma%2520concentrations%2520predicted%2520by%2520species-invariant%2520time%2520methods%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D1999%26volume%3D20%26spage%3D137%26epage%3D144%26doi%3D10.1002%2F%28SICI%291099-081X%28199904%2920%3A3%3C137%3A%3AAID-BDD165%3E3.0.CO%3B2-I" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosea, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collard, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, R. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakar, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span> <span> </span><span class="NLM_article-title">Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">533</span>, <span class="refDoi"> DOI: 10.1177/0091270009333209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1177%2F0091270009333209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=19299532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFWmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=513-533&author=N.+A.+Hoseaauthor=W.+T.+Collardauthor=S.+Coleauthor=T.+S.+Maurerauthor=R.+X.+Fangauthor=H.+Jonesauthor=S.+M.+Kakarauthor=Y.+Nakaiauthor=B.+J.+Smithauthor=R.+Websterauthor=K.+Beaumont&title=Prediction+of+human+pharmacokinetics+from+preclinical+information%3A+comparative+accuracy+of+quantitative+prediction+approaches&doi=10.1177%2F0091270009333209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches</span></div><div class="casAuthors">Hosea, Natilie A.; Collard, Wendy T.; Cole, Susan; Maurer, Tristan S.; Fang, Rick X.; Jones, Hannah; Kakar, Shefali M.; Nakai, Yasuhiro; Smith, Bill J.; Webster, Rob; Beaumont, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">513-533</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Quant. prediction of human pharmacokinetics is crit. in assessing the viability of drug candidates and in detg. first-in-human dosing.  Numerous prediction methodologies, incorporating both in vitro and preclin. in vivo data, have been developed in recent years, each with advantages and disadvantages.  However, the lack of a comprehensive data set, both preclin. and clin., has limited efforts to evaluate the optimal strategy (or strategies) that results in quant. predictions of human pharmacokinetics.  To address this issue, the authors conducted a retrospective anal. using 50 proprietary compds. for which in vitro, preclin. pharmacokinetic data and oral single-dose human pharmacokinetic data were available.  Five predictive strategies, involving either allometry or use of unbound intrinsic clearance from microsomes or hepatocytes, were then compared for their ability to predict human oral clearance, half-life through predictions of systemic clearance, vol. of distribution, and bioavailability.  Use of a single-species scaling approach with rat, dog, or monkey was as accurate as or more accurate than using multiple-species allometry.  For those compds. cleared almost exclusively by P 450-mediated pathways, scaling from human liver microsomes was as predictive as single-species scaling of clearance based on data from rat, dog, or monkey.  These data suggest that use of predictive methods involving either single-species in vivo data or in vitro human liver microsomes can quant. predict human in vivo pharmacokinetics and suggest the possibility of streamlining the predictive methodol. through use of a single species or use only of human in vitro microsomal prepns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg67HcwS4O4LVg90H21EOLACvtfcHk0lhljr4fSW_ILA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFWmu74%253D&md5=a0941d53fe43392f8fb1562ee546705e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1177%2F0091270009333209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270009333209%26sid%3Dliteratum%253Aachs%26aulast%3DHosea%26aufirst%3DN.%2BA.%26aulast%3DCollard%26aufirst%3DW.%2BT.%26aulast%3DCole%26aufirst%3DS.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DFang%26aufirst%3DR.%2BX.%26aulast%3DJones%26aufirst%3DH.%26aulast%3DKakar%26aufirst%3DS.%2BM.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DBeaumont%26aufirst%3DK.%26atitle%3DPrediction%2520of%2520human%2520pharmacokinetics%2520from%2520preclinical%2520information%253A%2520comparative%2520accuracy%2520of%2520quantitative%2520prediction%2520approaches%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2009%26volume%3D49%26spage%3D513%26epage%3D533%26doi%3D10.1177%2F0091270009333209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahmood, I.</span></span> <span> </span><span class="NLM_article-title">Allometric issues in drug development</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">1101</span>– <span class="NLM_lpage">1106</span>, <span class="refDoi"> DOI: 10.1021/js9902163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1021%2Fjs9902163" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=1101-1106&author=I.+Mahmood&title=Allometric+issues+in+drug+development&doi=10.1021%2Fjs9902163"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjs9902163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjs9902163%26sid%3Dliteratum%253Aachs%26aulast%3DMahmood%26aufirst%3DI.%26atitle%3DAllometric%2520issues%2520in%2520drug%2520development%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D1101%26epage%3D1106%26doi%3D10.1021%2Fjs9902163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayersohn, M.</span></span> <span> </span><span class="NLM_article-title">A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">1783</span>– <span class="NLM_lpage">1799</span>, <span class="refDoi"> DOI: 10.1002/jps.20481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1002%2Fjps.20481" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=1783-1799&author=H.+Tangauthor=M.+Mayersohn&title=A+global+examination+of+allometric+scaling+for+predicting+human+drug+clearance+and+the+prediction+of+large+vertical+allometry&doi=10.1002%2Fjps.20481"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fjps.20481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20481%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DH.%26aulast%3DMayersohn%26aufirst%3DM.%26atitle%3DA%2520global%2520examination%2520of%2520allometric%2520scaling%2520for%2520predicting%2520human%2520drug%2520clearance%2520and%2520the%2520prediction%2520of%2520large%2520vertical%2520allometry%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2006%26volume%3D95%26spage%3D1783%26epage%3D1799%26doi%3D10.1002%2Fjps.20481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, M. R.</span></span> <span> </span><span class="NLM_article-title">Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">972</span>– <span class="NLM_lpage">987</span>, <span class="refDoi"> DOI: 10.3109/00498254.2011.598582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.3109%2F00498254.2011.598582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=21892879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12jsbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=972-987&author=Y.+Huhauthor=D.+E.+Smithauthor=M.+R.+Feng&title=Interspecies+scaling+and+prediction+of+human+clearance%3A+comparison+of+small-+and+macro-molecule+drugs&doi=10.3109%2F00498254.2011.598582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs</span></div><div class="casAuthors">Huh, Yeamin; Smith, David E.; Feng, Meihau Rose</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">972-987</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Human clearance prediction for small- and macro-mol. drugs was evaluated and compared using various scaling methods and statistical anal.  Human clearance is generally well predicted using single or multiple species simple allometry for macro- and small-mol. drugs excreted renally.  The prediction error is higher for hepatically eliminated small-mols. using single or multiple species simple allometry scaling, and it appears that the prediction error is mainly assocd. with drugs with low hepatic extn. ratio (Eh).  The error in human clearance prediction for hepatically eliminated small-mols. was reduced using scaling methods with a correction of max. life span (MLP) or brain wt. (BRW).  Human clearance of both small- and macro-mol. drugs is well predicted using the monkey liver blood flow method.  Predictions using liver blood flow from other species did not work as well, esp. for the small-mol. drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdswCme7lV_LVg90H21EOLACvtfcHk0ljN7GnYCwSOug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12jsbnK&md5=07269e0ae5f9ac33735a91546b89eced</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3109%2F00498254.2011.598582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2011.598582%26sid%3Dliteratum%253Aachs%26aulast%3DHuh%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DD.%2BE.%26aulast%3DFeng%26aufirst%3DM.%2BR.%26atitle%3DInterspecies%2520scaling%2520and%2520prediction%2520of%2520human%2520clearance%253A%2520comparison%2520of%2520small-%2520and%2520macro-molecule%2520drugs%26jtitle%3DXenobiotica%26date%3D2011%26volume%3D41%26spage%3D972%26epage%3D987%26doi%3D10.3109%2F00498254.2011.598582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallegos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uttamsingh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miwa, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balani, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, L.-S.</span></span> <span> </span><span class="NLM_article-title">Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1600</span>– <span class="NLM_lpage">1605</span>, <span class="refDoi"> DOI: 10.1124/dmd.106.010793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1124%2Fdmd.106.010793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=16790553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1SksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1600-1605&author=C.+Luauthor=P.+Liauthor=R.+Gallegosauthor=V.+Uttamsinghauthor=C.+Q.+Xiaauthor=G.+T.+Miwaauthor=S.+K.+Balaniauthor=L.-S.+Gan&title=Comparison+of+intrinsic+clearance+in+liver+microsomes+and+hepatocytes+from+rats+and+humans%3A+evaluation+of+free+fraction+and+uptake+in+hepatocytes&doi=10.1124%2Fdmd.106.010793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes</span></div><div class="casAuthors">Lu, Chuang; Li, Ping; Gallegos, Richard; Uttamsingh, Vinita; Xia, Cindy Q.; Miwa, Gerald T.; Balani, Suresh K.; Gan, Liang-Shang</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1600-1605</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Apparent intrinsic clearance (CLint,app) of 7-ethoxycoumarin, phenacetin, propranolol, and midazolam was measured using rat and human liver microsomes and freshly isolated and cryopreserved hepatocytes to det. factors responsible for differences in rates of metab. in these systems.  The cryopreserved and freshly isolated hepatocytes generally provided similar results, although there was greater variability using the latter system.  The CLint,app values in hepatocytes are obsd. to be lower than that in microsomes, and this difference becomes greater for compds. with high CLint,app.  This could partly be attributed to the differences in the free fraction (fu).  The fu in hepatocyte incubations (fu,hep-inc) was influenced not only by the free fraction of compds. in the incubation buffer (fu,buffer) but also by the rate consts. of uptake (kup) and metab. (kmet).  This report provides a new derivation for fu,hep-inc, which can be expressed as fu,hep-inc = [kup/(kmet + kup)]/[1 + (Chep/Cbuffer) × (Vhep/Vbuffer)], where the Chep, Cbuffer, Vhep, and Vbuffer represent the concns. of a compd. in hepatocytes and buffer and vols. of hepatocytes and buffer, resp.  For midazolam, the fu,hep-inc was calcd., and the max. metab. rate in hepatocytes was shown to be limited by the uptake rate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkV9lSFxDFT7Vg90H21EOLACvtfcHk0ljN7GnYCwSOug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1SksLk%253D&md5=3d3ff22990742b26dc24c84a6aab720e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1124%2Fdmd.106.010793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.106.010793%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DGallegos%26aufirst%3DR.%26aulast%3DUttamsingh%26aufirst%3DV.%26aulast%3DXia%26aufirst%3DC.%2BQ.%26aulast%3DMiwa%26aufirst%3DG.%2BT.%26aulast%3DBalani%26aufirst%3DS.%2BK.%26aulast%3DGan%26aufirst%3DL.-S.%26atitle%3DComparison%2520of%2520intrinsic%2520clearance%2520in%2520liver%2520microsomes%2520and%2520hepatocytes%2520from%2520rats%2520and%2520humans%253A%2520evaluation%2520of%2520free%2520fraction%2520and%2520uptake%2520in%2520hepatocytes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D1600%26epage%3D1605%26doi%3D10.1124%2Fdmd.106.010793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naritomi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terashita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagayama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, Y.</span></span> <span> </span><span class="NLM_article-title">Utility of hepatocytes in predicting drug metabolism: Comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">580</span>– <span class="NLM_lpage">588</span>, <span class="refDoi"> DOI: 10.1124/dmd.31.5.580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1124%2Fdmd.31.5.580" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=580-588&author=Y.+Naritomiauthor=S.+Terashitaauthor=A.+Kagayamaauthor=Y.+Sugiyama&title=Utility+of+hepatocytes+in+predicting+drug+metabolism%3A+Comparison+of+hepatic+intrinsic+clearance+in+rats+and+humans+in+vivo+and+in+vitro&doi=10.1124%2Fdmd.31.5.580"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1124%2Fdmd.31.5.580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.31.5.580%26sid%3Dliteratum%253Aachs%26aulast%3DNaritomi%26aufirst%3DY.%26aulast%3DTerashita%26aufirst%3DS.%26aulast%3DKagayama%26aufirst%3DA.%26aulast%3DSugiyama%26aufirst%3DY.%26atitle%3DUtility%2520of%2520hepatocytes%2520in%2520predicting%2520drug%2520metabolism%253A%2520Comparison%2520of%2520hepatic%2520intrinsic%2520clearance%2520in%2520rats%2520and%2520humans%2520in%2520vivo%2520and%2520in%2520vitro%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2003%26volume%3D31%26spage%3D580%26epage%3D588%26doi%3D10.1124%2Fdmd.31.5.580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiou, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, F. H.</span></span> <span> </span><span class="NLM_article-title">Correlation of unbound plasma clearances of fifteen extensively metabolized drugs between humans and rats</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">668</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1023/A:1015935206569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1023%2FA%3A1015935206569" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1988&pages=668-672&author=W.+L.+Chiouauthor=F.+H.+Hsu&title=Correlation+of+unbound+plasma+clearances+of+fifteen+extensively+metabolized+drugs+between+humans+and+rats&doi=10.1023%2FA%3A1015935206569"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015935206569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015935206569%26sid%3Dliteratum%253Aachs%26aulast%3DChiou%26aufirst%3DW.%2BL.%26aulast%3DHsu%26aufirst%3DF.%2BH.%26atitle%3DCorrelation%2520of%2520unbound%2520plasma%2520clearances%2520of%2520fifteen%2520extensively%2520metabolized%2520drugs%2520between%2520humans%2520and%2520rats%26jtitle%3DPharm.%2520Res.%26date%3D1988%26volume%3D5%26spage%3D668%26epage%3D672%26doi%3D10.1023%2FA%3A1015935206569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bleasby, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evers, R.</span></span> <span> </span><span class="NLM_article-title">Species differences in drug transporters and implications for translating preclinical findings to humans</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1517/17425255.2013.741589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1517%2F17425255.2013.741589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=23256482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivFehtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=237-252&author=X.+Chuauthor=K.+Bleasbyauthor=R.+Evers&title=Species+differences+in+drug+transporters+and+implications+for+translating+preclinical+findings+to+humans&doi=10.1517%2F17425255.2013.741589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Species differences in drug transporters and implications for translating preclinical findings to humans</span></div><div class="casAuthors">Chu, Xiaoyan; Bleasby, Kelly; Evers, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-252</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Drug transporters play an important role in the absorption, distribution, and excretion (ADE) of many drugs.  In the last several years it has become increasingly clear that there are significant differences between rodents, dog, monkey, and human in the substrate specificity, tissue distribution, and relative abundance of transporters.  These differences complicate cross-species extrapolations, which is important when attempting to predict human pharmacokinetics (PK) of drug candidates and assess risk for drug-drug interactions (DDIs).Areas covered: This article provides an overview of species differences for the major transporters involved in drug disposition.  Specifically, the article looks at a no. of efflux and uptake transporters including multidrug resistance protein MDR1 P-glycoprotein (Pgp), breast cancer resistance protein (BCRP), multidrug resistance proteins (MRPs), members of the multidrug resistance and toxic extrusion protein (MATE) family, as well as members of org. anion transporting polypeptides (OATPs), org. anion transporters (OATs), and org. cation transporters (OCTs).Expert opinion: Quant. knowledge of species differences of transporters, esp. at the protein and functional level is still limited.  The current challenge is to extrapolate and integrate data from both preclin. species and humans to quant. predict the impact of transporters on drug absorption, disposition, and drug-drug interactions.  Increased understanding of species differences in transporter expression and functional activity is needed in order to translate findings from preclin. species to humans.  Ultimately, high quality in vitro and in vivo data will aid in the establishment of physiol. based pharmacokinetic (PBPK) models, which will improve the capability to predict PK characteristics of drug candidates in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsqBJmdYPjvLVg90H21EOLACvtfcHk0lgXVtfaU8SVOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivFehtLs%253D&md5=7f5ef0877516beada4264257777ca963</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1517%2F17425255.2013.741589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2013.741589%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DX.%26aulast%3DBleasby%26aufirst%3DK.%26aulast%3DEvers%26aufirst%3DR.%26atitle%3DSpecies%2520differences%2520in%2520drug%2520transporters%2520and%2520implications%2520for%2520translating%2520preclinical%2520findings%2520to%2520humans%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2013%26volume%3D9%26spage%3D237%26epage%3D252%26doi%3D10.1517%2F17425255.2013.741589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosgrove, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruston, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFaul, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colclough, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, B.</span></span> <span> </span><span class="NLM_article-title">Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6672</span>– <span class="NLM_lpage">6682</span>, <span class="refDoi"> DOI: 10.1021/jm0605233</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0605233" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtV2gtLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6672-6682&author=A.+G.+Leachauthor=H.+D.+Jonesauthor=D.+A.+Cosgroveauthor=P.+W.+Kennyauthor=L.+Rustonauthor=P.+MacFaulauthor=J.+M.+Woodauthor=N.+Colcloughauthor=B.+Law&title=Matched+molecular+pairs+as+a+guide+in+the+optimization+of+pharmaceutical+properties%3B+a+study+of+aqueous+solubility%2C+plasma+protein+binding+and+oral+exposure&doi=10.1021%2Fjm0605233"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pairs as a Guide in the Optimization of Pharmaceutical Properties; a Study of Aqueous Solubility, Plasma Protein Binding and Oral Exposure</span></div><div class="casAuthors">Leach, Andrew G.; Jones, Huw D.; Cosgrove, David A.; Kenny, Peter W.; Ruston, Linette; MacFaul, Philip; Wood, J. Matthew; Colclough, Nicola; Law, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6672-6682</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By identifying every pair of mols. that differ only by a particular, well-defined, structural transformation in a database of measured properties and computing the corresponding change in property, we obtain an overview of the effect that structural change has upon the property and set an expectation for what will happen when that transformation is applied elsewhere.  The mean change indicates the expected magnitude of the change in the property and the no. of cases in which the property increases give the probability that the structural transformation will cause the property to increase.  Outliers indicate potential ways of avoiding the general trend.  Comparing to changes in lipophilicity highlights structural transformations that have unusual effects, some of which can be explained by conformational changes.  In this paper, we focus upon the effects on aq. soly., plasma protein binding and oral exposure of adding substituents to arom. rings and methylating heteroatoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcyrloR79Oq7Vg90H21EOLACvtfcHk0lgXVtfaU8SVOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtV2gtLnO&md5=2c143b424aee3ddb6c34616aff699ee0</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm0605233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0605233%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DJones%26aufirst%3DH.%2BD.%26aulast%3DCosgrove%26aufirst%3DD.%2BA.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DRuston%26aufirst%3DL.%26aulast%3DMacFaul%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DColclough%26aufirst%3DN.%26aulast%3DLaw%26aufirst%3DB.%26atitle%3DMatched%2520molecular%2520pairs%2520as%2520a%2520guide%2520in%2520the%2520optimization%2520of%2520pharmaceutical%2520properties%253B%2520a%2520study%2520of%2520aqueous%2520solubility%252C%2520plasma%2520protein%2520binding%2520and%2520oral%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6672%26epage%3D6682%26doi%3D10.1021%2Fjm0605233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boros, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garvey, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golden, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazen, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koble, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurose, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mote, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshinaga, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antiviral activity of 7-benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV integrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2754</span>– <span class="NLM_lpage">2761</span>, <span class="refDoi"> DOI: 10.1021/jm801404b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801404b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2754-2761&author=E.+E.+Borosauthor=C.+E.+Edwardsauthor=S.+A.+Fosterauthor=M.+Fujiauthor=T.+Fujiwaraauthor=E.+P.+Garveyauthor=P.+L.+Goldenauthor=R.+J.+Hazenauthor=J.+L.+Jeffreyauthor=B.+A.+Johnsauthor=T.+Kawasujiauthor=R.+Kiyamaauthor=C.+S.+Kobleauthor=N.+Kuroseauthor=W.+H.+Millerauthor=A.+L.+Moteauthor=H.+Muraiauthor=A.+Satoauthor=J.+B.+Thompsonauthor=M.+C.+Woodwardauthor=T.+Yoshinaga&title=Synthesis+and+antiviral+activity+of+7-benzyl-4-hydroxy-1%2C5-naphthyridin-2%281H%29-one+HIV+integrase+inhibitors&doi=10.1021%2Fjm801404b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm801404b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801404b%26sid%3Dliteratum%253Aachs%26aulast%3DBoros%26aufirst%3DE.%2BE.%26aulast%3DEdwards%26aufirst%3DC.%2BE.%26aulast%3DFoster%26aufirst%3DS.%2BA.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DFujiwara%26aufirst%3DT.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DGolden%26aufirst%3DP.%2BL.%26aulast%3DHazen%26aufirst%3DR.%2BJ.%26aulast%3DJeffrey%26aufirst%3DJ.%2BL.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DKoble%26aufirst%3DC.%2BS.%26aulast%3DKurose%26aufirst%3DN.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26aulast%3DMote%26aufirst%3DA.%2BL.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DThompson%26aufirst%3DJ.%2BB.%26aulast%3DWoodward%26aufirst%3DM.%2BC.%26aulast%3DYoshinaga%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520antiviral%2520activity%2520of%25207-benzyl-4-hydroxy-1%252C5-naphthyridin-2%25281H%2529-one%2520HIV%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2754%26epage%3D2761%26doi%3D10.1021%2Fjm801404b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McKerrecher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caulkett, P. W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donald, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenwick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grange, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayner, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, R. P.</span></span> <span> </span><span class="NLM_article-title">Design of a potent, soluble glucokinase activator with excellent in vivo efficacy</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2705</span>– <span class="NLM_lpage">2709</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.02.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1016%2Fj.bmcl.2006.02.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2705-2709&author=D.+McKerrecherauthor=J.+V.+Allenauthor=P.+W.+R.+Caulkettauthor=C.+S.+Donaldauthor=M.+L.+Fenwickauthor=E.+Grangeauthor=K.+M.+Johnsonauthor=C.+Johnstoneauthor=C.+D.+Jonesauthor=K.+G.+Pikeauthor=J.+W.+Raynerauthor=R.+P.+Walker&title=Design+of+a+potent%2C+soluble+glucokinase+activator+with+excellent+in+vivo+efficacy&doi=10.1016%2Fj.bmcl.2006.02.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.02.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.02.022%26sid%3Dliteratum%253Aachs%26aulast%3DMcKerrecher%26aufirst%3DD.%26aulast%3DAllen%26aufirst%3DJ.%2BV.%26aulast%3DCaulkett%26aufirst%3DP.%2BW.%2BR.%26aulast%3DDonald%26aufirst%3DC.%2BS.%26aulast%3DFenwick%26aufirst%3DM.%2BL.%26aulast%3DGrange%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DK.%2BM.%26aulast%3DJohnstone%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DC.%2BD.%26aulast%3DPike%26aufirst%3DK.%2BG.%26aulast%3DRayner%26aufirst%3DJ.%2BW.%26aulast%3DWalker%26aufirst%3DR.%2BP.%26atitle%3DDesign%2520of%2520a%2520potent%252C%2520soluble%2520glucokinase%2520activator%2520with%2520excellent%2520in%2520vivo%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2705%26epage%3D2709%26doi%3D10.1016%2Fj.bmcl.2006.02.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hop, C. E. C. A.</span></span> <span> </span><span class="NLM_article-title">Rational use of plasma protein and tissue binding data in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8238</span>– <span class="NLM_lpage">8248</span>, <span class="refDoi"> DOI: 10.1021/jm5007935</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5007935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8238-8248&author=X.+Liuauthor=M.+Wrightauthor=C.+E.+C.+A.+Hop&title=Rational+use+of+plasma+protein+and+tissue+binding+data+in+drug+design&doi=10.1021%2Fjm5007935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Use of Plasma Protein and Tissue Binding Data in Drug Design</span></div><div class="casAuthors">Liu, Xingrong; Wright, Matthew; Hop, Cornelis E. C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8238-8248</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is a commonly accepted assumption that only unbound drug mols. are available to interact with their targets.  Therefore, one of the objectives in drug design is to optimize the compd. structure to increase in vivo unbound drug concn.  In this review, theor. analyses and exptl. observations are presented to illustrate that low plasma protein binding does not necessarily lead to high in vivo unbound plasma concn.  Similarly, low brain tissue binding does not lead to high in vivo unbound brain tissue concn.  Instead, low intrinsic clearance leads to high in vivo unbound plasma concn., and low efflux transport activity at the blood-brain barrier leads to high unbound brain concn.  Plasma protein and brain tissue binding are very important parameters in understanding pharmacokinetics, pharmacodynamics, and toxicities of drugs, but these parameters should not be targeted for optimization in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKiYUz9ljIDrVg90H21EOLACvtfcHk0ligc1h3tSmCgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M&md5=53ffbdb88ddf500a90a0eee14b0e641f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm5007935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5007935%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWright%26aufirst%3DM.%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26atitle%3DRational%2520use%2520of%2520plasma%2520protein%2520and%2520tissue%2520binding%2520data%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8238%26epage%3D8248%26doi%3D10.1021%2Fjm5007935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoener, B.-A.</span></span> <span> </span><span class="NLM_article-title">Changes in plasma protein binding have little clinical relevance</span>. <i>Clin. Pharmacol. Ther. (N. Y., NY, U. S.)</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1067/mcp.2002.121829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1067%2Fmcp.2002.121829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=11907485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtFChtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2002&pages=115-121&author=L.+Z.+Benetauthor=B.-A.+Hoener&title=Changes+in+plasma+protein+binding+have+little+clinical+relevance&doi=10.1067%2Fmcp.2002.121829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Changes in plasma protein binding have little clinical relevance</span></div><div class="casAuthors">Benet, Leslie Z.; Hoener, Betty-Ann</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">115-121</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Mosby, Inc.</span>)
        </div><div class="casAbstract">A review, discussing the clin. relevance of changes in plasma protein binding with regard to pharmacokinetics and pharmacodynamics of drugs with different therapeutic indexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnVXegu4HarLVg90H21EOLACvtfcHk0ligc1h3tSmCgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtFChtbc%253D&md5=2d475c624354013bf2f2a7b9135dffe0</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1067%2Fmcp.2002.121829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmcp.2002.121829%26sid%3Dliteratum%253Aachs%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26aulast%3DHoener%26aufirst%3DB.-A.%26atitle%3DChanges%2520in%2520plasma%2520protein%2520binding%2520have%2520little%2520clinical%2520relevance%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%2520%2528N.%2520Y.%252C%2520NY%252C%2520U.%2520S.%2529%26date%3D2002%26volume%3D71%26spage%3D115%26epage%3D121%26doi%3D10.1067%2Fmcp.2002.121829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremaine, L. M.</span></span> <span> </span><span class="NLM_article-title">A novel relay method for determining low-clearance values</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1860</span>– <span class="NLM_lpage">1865</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.046425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1124%2Fdmd.112.046425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=22645091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlShur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1860-1865&author=L.+Diauthor=P.+Trapaauthor=R.+S.+Obachauthor=K.+Atkinsonauthor=Y.-A.+Biauthor=A.+C.+Wolfordauthor=B.+Tanauthor=T.+S.+McDonaldauthor=Y.+Laiauthor=L.+M.+Tremaine&title=A+novel+relay+method+for+determining+low-clearance+values&doi=10.1124%2Fdmd.112.046425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A novel relay method for determining low-clearance values</span></div><div class="casAuthors">Di, Li; Trapa, Patrick; Obach, R. Scott; Atkinson, Karen; Bi, Yi-An; Wolford, Angela C.; Tan, Beijing; McDonald, Thomas S.; Lai, Yurong; Tremaine, Larry M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1860-1865</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A novel relay method has been developed using cryopreserved human hepatocytes to measure intrinsic clearance of low-clearance compds.  The relay method involved transferring the supernatant from hepatocyte incubations to freshly thawed hepatocytes at the end of the 4-h incubation to prolong the exposure time to active enzymes in hepatocytes.  An accumulative incubation time of 20 h or longer in hepatocytes can be achieved using the method.  The relay method was validated using seven com. drugs (diazepam, disopyramide, theophylline, timolol, tolbutamide, S-warfarin, and zolmitriptan) that were metabolized by various cytochrome P450s with low human in vivo intrinsic clearance at approx. 2 to 15 mL · min-1 · kg-1.  The results showed that the relay method produced excellent predictions of human in vivo clearance.  The difference between in vitro and in vivo intrinsic clearance was within 2-fold for most compds., which is similar to the std. prediction accuracy for moderate to high clearance compds. using hepatocytes.  The relay method is a straightforward, relatively low cost, and easy-to-use new tool to address the challenges of low clearance in drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz1LvwK-CqOLVg90H21EOLACvtfcHk0ligc1h3tSmCgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlShur7O&md5=faab456749ff398ad63d11eff6412fbc</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.046425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.046425%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DTrapa%26aufirst%3DP.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DBi%26aufirst%3DY.-A.%26aulast%3DWolford%26aufirst%3DA.%2BC.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DMcDonald%26aufirst%3DT.%2BS.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DTremaine%26aufirst%3DL.%2BM.%26atitle%3DA%2520novel%2520relay%2520method%2520for%2520determining%2520low-clearance%2520values%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D1860%26epage%3D1865%26doi%3D10.1124%2Fdmd.112.046425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">In vitro-in vivo correlation for low-clearance compounds using hepatocyte relay method</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2018</span>– <span class="NLM_lpage">2023</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.053322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1124%2Fdmd.113.053322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=23857891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=2018-2023&author=L.+Diauthor=K.+Atkinsonauthor=C.+C.+Orozcoauthor=C.+Funkauthor=H.+Zhangauthor=T.+S.+McDonaldauthor=B.+Tanauthor=J.+Linauthor=C.+Changauthor=R.+S.+Obach&title=In+vitro-in+vivo+correlation+for+low-clearance+compounds+using+hepatocyte+relay+method&doi=10.1124%2Fdmd.113.053322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro-in vivo correlation for low-clearance compounds using hepatocyte relay method</span></div><div class="casAuthors">Di, Li; Atkinson, Karen; Orozco, Christine C.; Funk, Carrie; Zhang, Hui; McDonald, Thomas S.; Tan, Beijing; Lin, Jian; Chang, Cheng; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2018-2023</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In vitro-in vivo correlation (IVIVC) of intrinsic clearance in preclin. species of rat and dog was established using the hepatocyte relay method to support high-confidence prediction of human pharmacokinetics for low-clearance compds.  Good IVIVC of intrinsic clearance was obsd. for most of the compds., with predicted values within 2-fold of the obsd. values.  The exceptions involved transporter-mediated uptake clearance or metabolizing enzymes with extensive extrahepatic contribution.  This is the first assay available to address low clearance challenges in preclin. species for IVIVC in drug discovery.  It extends the utility of the hepatocyte relay method in addressing low clearance issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaNjsAHv2AFLVg90H21EOLACvtfcHk0lg4etprQxV_ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtbvP&md5=89b3f33fdc8fc1c73ab593dc44612659</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.053322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.053322%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DOrozco%26aufirst%3DC.%2BC.%26aulast%3DFunk%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMcDonald%26aufirst%3DT.%2BS.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DIn%2520vitro-in%2520vivo%2520correlation%2520for%2520low-clearance%2520compounds%2520using%2520hepatocyte%2520relay%2520method%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D2018%26epage%3D2023%26doi%3D10.1124%2Fdmd.113.053322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Novel cytochrome P450 reaction phenotyping for low-clearance compounds using the hepatocyte relay method</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1124/dmd.115.067876</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1124%2Fdmd.115.067876" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=460-465&author=X.+Yangauthor=K.+Atkinsonauthor=L.+Di&title=Novel+cytochrome+P450+reaction+phenotyping+for+low-clearance+compounds+using+the+hepatocyte+relay+method&doi=10.1124%2Fdmd.115.067876"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.067876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.067876%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DNovel%2520cytochrome%2520P450%2520reaction%2520phenotyping%2520for%2520low-clearance%2520compounds%2520using%2520the%2520hepatocyte%2520relay%2520method%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26spage%3D460%26epage%3D465%26doi%3D10.1124%2Fdmd.115.067876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 32 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yunseo Hwang, Jie Ying Teoh, Sou Hyun Kim, Juhui Kim, Suhwan Jeon, Hyo-Cheol Kim, Young-Suk Jung, Hyeonjin Kim, Jin Woo Choi, <span class="NLM_string-name hlFld-ContribAuthor">Dongwon Yoo</span>. </span><span class="cited-content_cbyCitation_article-title">Simple Host–Guest Assembly for High-Resolution Magnetic Resonance Imaging of Microvasculature. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2021,</strong> <em>13 </em>
                                    (24)
                                     , 27945-27954. <a href="https://doi.org/10.1021/acsami.1c06509" title="DOI URL">https://doi.org/10.1021/acsami.1c06509</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.1c06509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.1c06509%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DSimple%252BHost%2525E2%252580%252593Guest%252BAssembly%252Bfor%252BHigh-Resolution%252BMagnetic%252BResonance%252BImaging%252Bof%252BMicrovasculature%26aulast%3DHwang%26aufirst%3DYunseo%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D09042021%26date%3D01062021%26date%3D10062021%26volume%3D13%26issue%3D24%26spage%3D27945%26epage%3D27954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael J. Palmer, Xiaoyi Deng, Shawn Watts, Goran Krilov, Aleksey Gerasyuto, Sreekanth Kokkonda, Farah El Mazouni, John White, Karen L. White, Josefine Striepen, Jade Bath, Kyra A. Schindler, Tomas Yeo, David M. Shackleford, Sachel Mok, Ioanna Deni, Aloysus Lawong, Ann Huang, Gong Chen, Wen Wang, Jaya Jayaseelan, Kasiram Katneni, Rahul Patil, Jessica Saunders, Shatrughan P. Shahi, Rajesh Chittimalla, Iñigo Angulo-Barturen, María Belén Jiménez-Díaz, Sergio Wittlin, Patrick K. Tumwebaze, Philip J. Rosenthal, Roland A. Cooper, Anna Caroline Campos Aguiar, Rafael V. C. Guido, Dhelio B. Pereira, Nimisha Mittal, Elizabeth A. Winzeler, Diana R. Tomchick, Benoît Laleu, Jeremy N. Burrows, Pradipsinh K. Rathod, David A. Fidock, Susan A. Charman, <span class="NLM_string-name hlFld-ContribAuthor">Margaret A. Phillips</span>. </span><span class="cited-content_cbyCitation_article-title">Potent Antimalarials with Development Potential Identified by Structure-Guided Computational Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 6085-6136. <a href="https://doi.org/10.1021/acs.jmedchem.1c00173" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00173</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00173%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%252BAntimalarials%252Bwith%252BDevelopment%252BPotential%252BIdentified%252Bby%252BStructure-Guided%252BComputational%252BOptimization%252Bof%252Ba%252BPyrrole-Based%252BDihydroorotate%252BDehydrogenase%252BInhibitor%252BSeries%26aulast%3DPalmer%26aufirst%3DMichael%2BJ.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D30012021%26date%3D20042021%26volume%3D64%26issue%3D9%26spage%3D6085%26epage%3D6136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jonathan G. Schlegel, Mariam Tahoun, Alexander Seidinger, Jan H. Voss, Markus Kuschak, Stefan Kehraus, Marion Schneider, Michaela Matthey, Bernd K. Fleischmann, Gabriele M. König, Daniela Wenzel, <span class="NLM_string-name hlFld-ContribAuthor">Christa E. Müller</span>. </span><span class="cited-content_cbyCitation_article-title">Macrocyclic Gq Protein Inhibitors FR900359 and/or YM-254890–Fit for Translation?. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2021,</strong> <em>4 </em>
                                    (2)
                                     , 888-897. <a href="https://doi.org/10.1021/acsptsci.1c00021" title="DOI URL">https://doi.org/10.1021/acsptsci.1c00021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.1c00021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.1c00021%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DMacrocyclic%252BGq%252BProtein%252BInhibitors%252BFR900359%252Band%25252For%252BYM-254890%2525E2%252580%252593Fit%252Bfor%252BTranslation%25253F%26aulast%3DSchlegel%26aufirst%3DJonathan%2BG.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D14012021%26date%3D19022021%26volume%3D4%26issue%3D2%26spage%3D888%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jasleen K. Sodhi, <span class="NLM_string-name hlFld-ContribAuthor">Leslie Z. Benet</span>. </span><span class="cited-content_cbyCitation_article-title">Successful and Unsuccessful Prediction of Human Hepatic Clearance for Lead Optimization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (7)
                                     , 3546-3559. <a href="https://doi.org/10.1021/acs.jmedchem.0c01930" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01930</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01930%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSuccessful%252Band%252BUnsuccessful%252BPrediction%252Bof%252BHuman%252BHepatic%252BClearance%252Bfor%252BLead%252BOptimization%26aulast%3DSodhi%26aufirst%3DJasleen%2BK.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D07112020%26date%3D25032021%26volume%3D64%26issue%3D7%26spage%3D3546%26epage%3D3559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ans Punt, Nicole Pinckaers, Ad Peijnenburg, <span class="NLM_string-name hlFld-ContribAuthor">Jochem Louisse</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Web-Based Toolbox to Support Quantitative In-Vitro-to-In-Vivo Extrapolations (QIVIVE) within Nonanimal Testing Strategies. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2021,</strong> <em>34 </em>
                                    (2)
                                     , 460-472. <a href="https://doi.org/10.1021/acs.chemrestox.0c00307" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.0c00307</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.0c00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.0c00307%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DDevelopment%252Bof%252Ba%252BWeb-Based%252BToolbox%252Bto%252BSupport%252BQuantitative%252BIn-Vitro-to-In-Vivo%252BExtrapolations%252B%252528QIVIVE%252529%252Bwithin%252BNonanimal%252BTesting%252BStrategies%26aulast%3DPunt%26aufirst%3DAns%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D30072020%26date%3D31122020%26volume%3D34%26issue%3D2%26spage%3D460%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wooseok Han, Yu Ding, Zheng Chen, John L. Langowski, Cornelia Bellamacina, Alice Rico, Gisele A. Nishiguchi, Jiong Lan, Gordana Atallah, Mika Lindvall, Song Lin, Richard Zang, Paul Feucht, Tatiana Zavorotinskaya, Yumin Dai, Pablo Garcia, <span class="NLM_string-name hlFld-ContribAuthor">Matthew T. Burger</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structure–Activity Relationship of Tetra-Substituted Cyclohexyl Diol Inhibitors of Proviral Insertion of Moloney Virus (PIM) Kinases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14885-14904. <a href="https://doi.org/10.1021/acs.jmedchem.0c01279" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01279%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252Bof%252BTetra-Substituted%252BCyclohexyl%252BDiol%252BInhibitors%252Bof%252BProviral%252BInsertion%252Bof%252BMoloney%252BVirus%252B%252528PIM%252529%252BKinases%26aulast%3DHan%26aufirst%3DWooseok%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11082020%26date%3D01122020%26volume%3D63%26issue%3D23%26spage%3D14885%26epage%3D14904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Randy R. Miller, Maria Madeira, Harold B. Wood, Wayne M. Geissler, Conrad E. Raab, <span class="NLM_string-name hlFld-ContribAuthor">Iain J. Martin</span>. </span><span class="cited-content_cbyCitation_article-title">Integrating the Impact of Lipophilicity on Potency and Pharmacokinetic Parameters Enables the Use of Diverse Chemical Space during Small Molecule Drug Optimization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12156-12170. <a href="https://doi.org/10.1021/acs.jmedchem.9b01813" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01813</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01813%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIntegrating%252Bthe%252BImpact%252Bof%252BLipophilicity%252Bon%252BPotency%252Band%252BPharmacokinetic%252BParameters%252BEnables%252Bthe%252BUse%252Bof%252BDiverse%252BChemical%252BSpace%252Bduring%252BSmall%252BMolecule%252BDrug%252BOptimization%26aulast%3DMiller%26aufirst%3DRandy%2BR.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D01112019%26date%3D07072020%26volume%3D63%26issue%3D21%26spage%3D12156%26epage%3D12170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Julia Shanu-Wilson, Liam Evans, Stephen Wrigley, Jonathan Steele, James Atherton, <span class="NLM_string-name hlFld-ContribAuthor">Jason Boer</span>. </span><span class="cited-content_cbyCitation_article-title">Biotransformation: Impact and Application of Metabolism in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (11)
                                     , 2087-2107. <a href="https://doi.org/10.1021/acsmedchemlett.0c00202" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00202%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBiotransformation%25253A%252BImpact%252Band%252BApplication%252Bof%252BMetabolism%252Bin%252BDrug%252BDiscovery%26aulast%3DShanu-Wilson%26aufirst%3DJulia%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21042020%26date%3D13082020%26date%3D28082020%26volume%3D11%26issue%3D11%26spage%3D2087%26epage%3D2107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mateusz Adam Krzyscik, Małgorzata Zakrzewska, <span class="NLM_string-name hlFld-ContribAuthor">Jacek Otlewski</span>. </span><span class="cited-content_cbyCitation_article-title">Site-Specific, Stoichiometric-Controlled, PEGylated Conjugates of Fibroblast Growth Factor 2 (FGF2) with Hydrophilic Auristatin Y for Highly Selective Killing of Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1 (FGFR1). </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2020,</strong> <em>17 </em>
                                    (7)
                                     , 2734-2748. <a href="https://doi.org/10.1021/acs.molpharmaceut.0c00419" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.0c00419</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.0c00419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.0c00419%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DSite-Specific%25252C%252BStoichiometric-Controlled%25252C%252BPEGylated%252BConjugates%252Bof%252BFibroblast%252BGrowth%252BFactor%252B2%252B%252528FGF2%252529%252Bwith%252BHydrophilic%252BAuristatin%252BY%252Bfor%252BHighly%252BSelective%252BKilling%252Bof%252BCancer%252BCells%252BOverproducing%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252B1%252B%252528FGFR1%252529%26aulast%3DKrzyscik%26aufirst%3DMateusz%2BAdam%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D18042020%26date%3D05062020%26date%3D05062020%26date%3D16062020%26date%3D05062020%26volume%3D17%26issue%3D7%26spage%3D2734%26epage%3D2748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tristan S. Maurer, Dennis Smith, Kevin Beaumont, <span class="NLM_string-name hlFld-ContribAuthor">Li Di</span>. </span><span class="cited-content_cbyCitation_article-title">Dose Predictions for Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (12)
                                     , 6423-6435. <a href="https://doi.org/10.1021/acs.jmedchem.9b01365" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01365</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01365%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDose%252BPredictions%252Bfor%252BDrug%252BDesign%26aulast%3DMaurer%26aufirst%3DTristan%2BS.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D18082019%26date%3D22012020%26date%3D08012020%26volume%3D63%26issue%3D12%26spage%3D6423%26epage%3D6435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ya-Li Luo, Rui-Xue Rong, Jin-Mei Li, Xiao Chen, Shan-Shan Wang, Xiao-Liu Li, <span class="NLM_string-name hlFld-ContribAuthor">Ke-Rang Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Effective Renal Clearance and Photothermal Therapy of a Cyclodextrin-Modified Quaterrylene Derivative. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Bio Materials</span><span> <strong>2020,</strong> <em>3 </em>
                                    (5)
                                     , 3390-3400. <a href="https://doi.org/10.1021/acsabm.0c00311" title="DOI URL">https://doi.org/10.1021/acsabm.0c00311</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsabm.0c00311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsabm.0c00311%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Bio%2520Materials%26atitle%3DEffective%252BRenal%252BClearance%252Band%252BPhotothermal%252BTherapy%252Bof%252Ba%252BCyclodextrin-Modified%252BQuaterrylene%252BDerivative%26aulast%3DLuo%26aufirst%3DYa-Li%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19032020%26date%3D25042020%26date%3D06052020%26date%3D26042020%26volume%3D3%26issue%3D5%26spage%3D3390%26epage%3D3400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Frederick W. Goldberg, M. Raymond V. Finlay, Attilla K. T. Ting, David Beattie, Gillian M. Lamont, Charlene Fallan, Gail L. Wrigley, Marianne Schimpl, Martin R. Howard, Beth Williamson, Mercedes Vazquez-Chantada, Derek G. Barratt, Barry R. Davies, Elaine B. Cadogan, Antonio Ramos-Montoya, <span class="NLM_string-name hlFld-ContribAuthor">Emma Dean</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (7)
                                     , 3461-3471. <a href="https://doi.org/10.1021/acs.jmedchem.9b01684" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01684</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01684%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252B7-Methyl-2-%25255B%2525287-methyl%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-a%25255Dpyridin-6-yl%252529amino%25255D-9-%252528tetrahydro-2H-pyran-4-yl%252529-7%25252C9-dihydro-8H-purin-8-one%252B%252528AZD7648%252529%25252C%252Ba%252BPotent%252Band%252BSelective%252BDNA-Dependent%252BProtein%252BKinase%252B%252528DNA-PK%252529%252BInhibitor%26aulast%3DGoldberg%26aufirst%3DFrederick%2BW.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D11102019%26date%3D15012020%26date%3D18122019%26volume%3D63%26issue%3D7%26spage%3D3461%26epage%3D3471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Annica Wetzel, <span class="NLM_string-name hlFld-ContribAuthor">Alan M. Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Electrically Driven N(sp2)–C(sp2/3) Bond Cleavage of Sulfonamides. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2020,</strong> <em>8 </em>
                                    (8)
                                     , 3487-3493. <a href="https://doi.org/10.1021/acssuschemeng.0c00387" title="DOI URL">https://doi.org/10.1021/acssuschemeng.0c00387</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssuschemeng.0c00387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssuschemeng.0c00387%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DElectrically%252BDriven%252BN%252528sp2%252529%2525E2%252580%252593C%252528sp2%25252F3%252529%252BBond%252BCleavage%252Bof%252BSulfonamides%26aulast%3DWetzel%26aufirst%3DAnnica%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15012020%26date%3D07022020%26date%3D17022020%26date%3D10022020%26volume%3D8%26issue%3D8%26spage%3D3487%26epage%3D3493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Carl A. Brooks, Linda S. Barton, David J. Behm, Edward J. Brnardic, Melissa H. Costell, Dennis A. Holt, Larry J. Jolivette, Jay M. Matthews, John J. McAtee, Brent W. McCleland, Jaclyn R. Patterson, Joseph E. Pero, Ralph A. Rivero, Theresa J. Roethke, Robert M. Sanchez, Raynold Shenje, Lamont R. Terrell, <span class="NLM_string-name hlFld-ContribAuthor">Brian G. Lawhorn</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of GSK3527497: A Candidate for the Inhibition of Transient Receptor Potential Vanilloid-4 (TRPV4). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 9270-9280. <a href="https://doi.org/10.1021/acs.jmedchem.9b01247" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01247</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01247%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BGSK3527497%25253A%252BA%252BCandidate%252Bfor%252Bthe%252BInhibition%252Bof%252BTransient%252BReceptor%252BPotential%252BVanilloid-4%252B%252528TRPV4%252529%26aulast%3DBrooks%26aufirst%3DCarl%2BA.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D31072019%26date%3D09102019%26date%3D18092019%26volume%3D62%26issue%3D20%26spage%3D9270%26epage%3D9280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">X.D. Divya  Dexlin</span>, <span class="hlFld-ContribAuthor ">J.D. Deephlin  Tarika</span>, <span class="hlFld-ContribAuthor ">S. Madhan  Kumar</span>, <span class="hlFld-ContribAuthor ">A.  Mariappan</span>, <span class="hlFld-ContribAuthor ">T. Joselin  Beaula</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and DFT computations on structural, electronic and vibrational spectra, RDG analysis and molecular docking of novel Anti COVID-19 molecule 3, 5 Dimethyl Pyrazolium 3, 5 Dichloro Salicylate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1246 </em>, 131165. <a href="https://doi.org/10.1016/j.molstruc.2021.131165" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.131165</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.131165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.131165%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%252Band%252BDFT%252Bcomputations%252Bon%252Bstructural%25252C%252Belectronic%252Band%252Bvibrational%252Bspectra%25252C%252BRDG%252Banalysis%252Band%252Bmolecular%252Bdocking%252Bof%252Bnovel%252BAnti%252BCOVID-19%252Bmolecule%252B3%25252C%252B5%252BDimethyl%252BPyrazolium%252B3%25252C%252B5%252BDichloro%252BSalicylate%26aulast%3DDexlin%26aufirst%3DX.D.%2BDivya%26date%3D2021%26volume%3D1246%26spage%3D131165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soumeya  Abed</span>, <span class="hlFld-ContribAuthor ">Rebecca  Turner</span>, <span class="hlFld-ContribAuthor ">Nickolas  Serniuck</span>, <span class="hlFld-ContribAuthor ">Victor  Tat</span>, <span class="hlFld-ContribAuthor ">Safaa  Naiel</span>, <span class="hlFld-ContribAuthor ">Aaron  Hayat</span>, <span class="hlFld-ContribAuthor ">Olivia  Mekhael</span>, <span class="hlFld-ContribAuthor ">Megan  Vierhout</span>, <span class="hlFld-ContribAuthor ">Kjetil  Ask</span>, <span class="hlFld-ContribAuthor ">Anthony F.  Rullo</span>. </span><span class="cited-content_cbyCitation_article-title">Cell-specific drug targeting in the lung. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2021,</strong> <em>190 </em>, 114577. <a href="https://doi.org/10.1016/j.bcp.2021.114577" title="DOI URL">https://doi.org/10.1016/j.bcp.2021.114577</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2021.114577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2021.114577%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DCell-specific%252Bdrug%252Btargeting%252Bin%252Bthe%252Blung%26aulast%3DAbed%26aufirst%3DSoumeya%26date%3D2021%26volume%3D190%26spage%3D114577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anu Shilpa  Krishnatry</span>, <span class="hlFld-ContribAuthor ">Alexander  Voelkner</span>, <span class="hlFld-ContribAuthor ">Arindam  Dhar</span>, <span class="hlFld-ContribAuthor ">Marita  Prohn</span>, <span class="hlFld-ContribAuthor ">Geraldine  Ferron‐Brady</span>. </span><span class="cited-content_cbyCitation_article-title">Population pharmacokinetic modeling of molibresib and its active metabolites in patients with solid tumors: A semimechanistic autoinduction model. </span><span class="cited-content_cbyCitation_journal-name">CPT: Pharmacometrics & Systems Pharmacology</span><span> <strong>2021,</strong> <em>10 </em>
                                    (7)
                                     , 709-722. <a href="https://doi.org/10.1002/psp4.12639" title="DOI URL">https://doi.org/10.1002/psp4.12639</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/psp4.12639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpsp4.12639%26sid%3Dliteratum%253Aachs%26jtitle%3DCPT%253A%2520Pharmacometrics%2520%2526%2520Systems%2520Pharmacology%26atitle%3DPopulation%252Bpharmacokinetic%252Bmodeling%252Bof%252Bmolibresib%252Band%252Bits%252Bactive%252Bmetabolites%252Bin%252Bpatients%252Bwith%252Bsolid%252Btumors%25253A%252BA%252Bsemimechanistic%252Bautoinduction%252Bmodel%26aulast%3DKrishnatry%26aufirst%3DAnu%2BShilpa%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D7%26spage%3D709%26epage%3D722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmad Dzulfikri  Nurhan</span>, <span class="hlFld-ContribAuthor ">Maria Apriliani  Gani</span>, <span class="hlFld-ContribAuthor ">Aniek Setiya  Budiatin</span>, <span class="hlFld-ContribAuthor ">Siswandono  Siswodihardjo</span>, <span class="hlFld-ContribAuthor ">Junaidi  Khotib</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular docking studies of
              Nigella sativa
              L and
              Curcuma xanthorrhiza Roxb
              secondary metabolites against histamine
              N
              -methyltransferase with their ADMET prediction. </span><span class="cited-content_cbyCitation_journal-name">Journal of Basic and Clinical Physiology and Pharmacology</span><span> <strong>2021,</strong> <em>32 </em>
                                    (4)
                                     , 795-802. <a href="https://doi.org/10.1515/jbcpp-2020-0425" title="DOI URL">https://doi.org/10.1515/jbcpp-2020-0425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/jbcpp-2020-0425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fjbcpp-2020-0425%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Basic%2520and%2520Clinical%2520Physiology%2520and%2520Pharmacology%26atitle%3DMolecular%252Bdocking%252Bstudies%252Bof%252BNigella%252Bsativa%252BL%252Band%252BCurcuma%252Bxanthorrhiza%252BRoxb%252Bsecondary%252Bmetabolites%252Bagainst%252Bhistamine%252BN%252B-methyltransferase%252Bwith%252Btheir%252BADMET%252Bprediction%26aulast%3DNurhan%26aufirst%3DAhmad%2BDzulfikri%26date%3D2021%26date%3D2021%26volume%3D32%26issue%3D4%26spage%3D795%26epage%3D802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Subhashini  Bharathala</span>, <span class="hlFld-ContribAuthor ">Lakshmi Kanth  Kotarkonda</span>, <span class="hlFld-ContribAuthor ">Vijay Pal  Singh</span>, <span class="hlFld-ContribAuthor ">Rajni  Singh</span>, <span class="hlFld-ContribAuthor ">Pankaj  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">In silico and experimental studies of bovine serum albumin-encapsulated carbenoxolone nanoparticles with reduced cytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">Colloids and Surfaces B: Biointerfaces</span><span> <strong>2021,</strong> <em>202 </em>, 111670. <a href="https://doi.org/10.1016/j.colsurfb.2021.111670" title="DOI URL">https://doi.org/10.1016/j.colsurfb.2021.111670</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.colsurfb.2021.111670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.colsurfb.2021.111670%26sid%3Dliteratum%253Aachs%26jtitle%3DColloids%2520and%2520Surfaces%2520B%253A%2520Biointerfaces%26atitle%3DIn%252Bsilico%252Band%252Bexperimental%252Bstudies%252Bof%252Bbovine%252Bserum%252Balbumin-encapsulated%252Bcarbenoxolone%252Bnanoparticles%252Bwith%252Breduced%252Bcytotoxicity%26aulast%3DBharathala%26aufirst%3DSubhashini%26date%3D2021%26volume%3D202%26spage%3D111670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edward H.  Kerns</span>, <span class="hlFld-ContribAuthor ">Xun  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Di</span>. </span><span class="cited-content_cbyCitation_article-title">ADMET
              In
              Vitro
              Profiling – Utility and Applications in Lead Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-31. <a href="https://doi.org/10.1002/0471266949.bmc118.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc118.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc118.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc118.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DADMET%252BIn%252BVitro%252BProfiling%252B%2525E2%252580%252593%252BUtility%252Band%252BApplications%252Bin%252BLead%252BDiscovery%26aulast%3DKerns%26aufirst%3DEdward%2BH.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D31%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shabbir  Muhammad</span>, <span class="hlFld-ContribAuthor ">Sayyeda Hira  Hassan</span>, <span class="hlFld-ContribAuthor ">Abdullah G.  Al-Sehemi</span>, <span class="hlFld-ContribAuthor ">Hafiz Abdullah  Shakir</span>, <span class="hlFld-ContribAuthor ">Muhammad  Khan</span>, <span class="hlFld-ContribAuthor ">Muhammad  Irfan</span>, <span class="hlFld-ContribAuthor ">Javed  Iqbal</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the new potential antiviral constituents of Moringa oliefera for SARS-COV-2 pathogenesis: An in silico molecular docking and dynamic studies. </span><span class="cited-content_cbyCitation_journal-name">Chemical Physics Letters</span><span> <strong>2021,</strong> <em>767 </em>, 138379. <a href="https://doi.org/10.1016/j.cplett.2021.138379" title="DOI URL">https://doi.org/10.1016/j.cplett.2021.138379</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cplett.2021.138379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cplett.2021.138379%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Physics%2520Letters%26atitle%3DExploring%252Bthe%252Bnew%252Bpotential%252Bantiviral%252Bconstituents%252Bof%252BMoringa%252Boliefera%252Bfor%252BSARS-COV-2%252Bpathogenesis%25253A%252BAn%252Bin%252Bsilico%252Bmolecular%252Bdocking%252Band%252Bdynamic%252Bstudies%26aulast%3DMuhammad%26aufirst%3DShabbir%26date%3D2021%26volume%3D767%26spage%3D138379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher  Keefer</span>, <span class="hlFld-ContribAuthor ">George  Chang</span>, <span class="hlFld-ContribAuthor ">Anthony  Carlo</span>, <span class="hlFld-ContribAuthor ">Jonathan J.  Novak</span>, <span class="hlFld-ContribAuthor ">Michael  Banker</span>, <span class="hlFld-ContribAuthor ">Jackie  Carey</span>, <span class="hlFld-ContribAuthor ">Julie  Cianfrogna</span>, <span class="hlFld-ContribAuthor ">Heather  Eng</span>, <span class="hlFld-ContribAuthor ">Caitlin  Jagla</span>, <span class="hlFld-ContribAuthor ">Nathaniel  Johnson</span>, <span class="hlFld-ContribAuthor ">Rhys  Jones</span>, <span class="hlFld-ContribAuthor ">Samantha  Jordan</span>, <span class="hlFld-ContribAuthor ">Sarah  Lazzaro</span>, <span class="hlFld-ContribAuthor ">JianHua  Liu</span>, <span class="hlFld-ContribAuthor ">R.  Scott Obach</span>, <span class="hlFld-ContribAuthor ">Keith  Riccardi</span>, <span class="hlFld-ContribAuthor ">David  Tess</span>, <span class="hlFld-ContribAuthor ">John  Umland</span>, <span class="hlFld-ContribAuthor ">Jillian  Racich</span>, <span class="hlFld-ContribAuthor ">Manthena  Varma</span>, <span class="hlFld-ContribAuthor ">Ravi  Visswanathan</span>, <span class="hlFld-ContribAuthor ">Li  Di</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic insights on clearance and inhibition discordance between liver microsomes and hepatocytes when clearance in liver microsomes is higher than in hepatocytes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2020,</strong> <em>155 </em>, 105541. <a href="https://doi.org/10.1016/j.ejps.2020.105541" title="DOI URL">https://doi.org/10.1016/j.ejps.2020.105541</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2020.105541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2020.105541%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DMechanistic%252Binsights%252Bon%252Bclearance%252Band%252Binhibition%252Bdiscordance%252Bbetween%252Bliver%252Bmicrosomes%252Band%252Bhepatocytes%252Bwhen%252Bclearance%252Bin%252Bliver%252Bmicrosomes%252Bis%252Bhigher%252Bthan%252Bin%252Bhepatocytes%26aulast%3DKeefer%26aufirst%3DChristopher%26date%3D2020%26volume%3D155%26spage%3D105541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susan A.  Charman</span>, <span class="hlFld-ContribAuthor ">Alice  Andreu</span>, <span class="hlFld-ContribAuthor ">Helena  Barker</span>, <span class="hlFld-ContribAuthor ">Scott  Blundell</span>, <span class="hlFld-ContribAuthor ">Anna  Campbell</span>, <span class="hlFld-ContribAuthor ">Michael  Campbell</span>, <span class="hlFld-ContribAuthor ">Gong  Chen</span>, <span class="hlFld-ContribAuthor ">Francis C. K.  Chiu</span>, <span class="hlFld-ContribAuthor ">Elly  Crighton</span>, <span class="hlFld-ContribAuthor ">Kasiram  Katneni</span>, <span class="hlFld-ContribAuthor ">Julia  Morizzi</span>, <span class="hlFld-ContribAuthor ">Rahul  Patil</span>, <span class="hlFld-ContribAuthor ">Thao  Pham</span>, <span class="hlFld-ContribAuthor ">Eileen  Ryan</span>, <span class="hlFld-ContribAuthor ">Jessica  Saunders</span>, <span class="hlFld-ContribAuthor ">David M.  Shackleford</span>, <span class="hlFld-ContribAuthor ">Karen L.  White</span>, <span class="hlFld-ContribAuthor ">Lisa  Almond</span>, <span class="hlFld-ContribAuthor ">Maurice  Dickins</span>, <span class="hlFld-ContribAuthor ">Dennis A.  Smith</span>, <span class="hlFld-ContribAuthor ">Joerg J.  Moehrle</span>, <span class="hlFld-ContribAuthor ">Jeremy N.  Burrows</span>, <span class="hlFld-ContribAuthor ">Nada  Abla</span>. </span><span class="cited-content_cbyCitation_article-title">An in vitro toolbox to accelerate anti-malarial drug discovery and development. </span><span class="cited-content_cbyCitation_journal-name">Malaria Journal</span><span> <strong>2020,</strong> <em>19 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12936-019-3075-5" title="DOI URL">https://doi.org/10.1186/s12936-019-3075-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12936-019-3075-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12936-019-3075-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMalaria%2520Journal%26atitle%3DAn%252Bin%252Bvitro%252Btoolbox%252Bto%252Baccelerate%252Banti-malarial%252Bdrug%252Bdiscovery%252Band%252Bdevelopment%26aulast%3DCharman%26aufirst%3DSusan%2BA.%26date%3D2020%26date%3D2020%26volume%3D19%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhanhui  Li</span>, <span class="hlFld-ContribAuthor ">Xu  Wang</span>, <span class="hlFld-ContribAuthor ">Yu  Lin</span>, <span class="hlFld-ContribAuthor ">Yujie  Wang</span>, <span class="hlFld-ContribAuthor ">Shuwei  Wu</span>, <span class="hlFld-ContribAuthor ">Kaijiang  Xia</span>, <span class="hlFld-ContribAuthor ">Chen  Xu</span>, <span class="hlFld-ContribAuthor ">Haikuo  Ma</span>, <span class="hlFld-ContribAuthor ">Jiyue  Zheng</span>, <span class="hlFld-ContribAuthor ">Lusong  Luo</span>, <span class="hlFld-ContribAuthor ">Fang  Zhu</span>, <span class="hlFld-ContribAuthor ">Sudan  He</span>, <span class="hlFld-ContribAuthor ">Xiaohu  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of pyrrolidine based CXCR4 antagonists with in vivo anti-tumor metastatic activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>205 </em>, 112537. <a href="https://doi.org/10.1016/j.ejmech.2020.112537" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112537</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112537%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252Bpyrrolidine%252Bbased%252BCXCR4%252Bantagonists%252Bwith%252Bin%2525C2%2525A0vivo%252Banti-tumor%252Bmetastatic%252Bactivity%26aulast%3DLi%26aufirst%3DZhanhui%26date%3D2020%26volume%3D205%26spage%3D112537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antony  Okumu</span>, <span class="hlFld-ContribAuthor ">Yanran  Lu</span>, <span class="hlFld-ContribAuthor ">Sheri  Dellos-Nolan</span>, <span class="hlFld-ContribAuthor ">Jonathan L.  Papa</span>, <span class="hlFld-ContribAuthor ">Bryan  Koci</span>, <span class="hlFld-ContribAuthor ">Nicholas T.  Cockroft</span>, <span class="hlFld-ContribAuthor ">Judith  Gallucci</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Wozniak</span>, <span class="hlFld-ContribAuthor ">Jack C.  Yalowich</span>, <span class="hlFld-ContribAuthor ">Mark J.  Mitton-Fry</span>. </span><span class="cited-content_cbyCitation_article-title">Novel bacterial topoisomerase inhibitors derived from isomannide. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>199 </em>, 112324. <a href="https://doi.org/10.1016/j.ejmech.2020.112324" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112324</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112324%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bbacterial%252Btopoisomerase%252Binhibitors%252Bderived%252Bfrom%252Bisomannide%26aulast%3DOkumu%26aufirst%3DAntony%26date%3D2020%26volume%3D199%26spage%3D112324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Beth  Williamson</span>, <span class="hlFld-ContribAuthor ">Nicola  Colclough</span>, <span class="hlFld-ContribAuthor ">Adrian John  Fretland</span>, <span class="hlFld-ContribAuthor ">Barry Christopher  Jones</span>, <span class="hlFld-ContribAuthor ">Rhys Dafydd Owen  Jones</span>, <span class="hlFld-ContribAuthor ">Dermot Francis  McGinnity</span>. </span><span class="cited-content_cbyCitation_article-title">Further Considerations Towards an Effective and Efficient Oncology Drug Discovery DMPK Strategy. </span><span class="cited-content_cbyCitation_journal-name">Current Drug Metabolism</span><span> <strong>2020,</strong> <em>21 </em>
                                    (2)
                                     , 145-162. <a href="https://doi.org/10.2174/1389200221666200312104837" title="DOI URL">https://doi.org/10.2174/1389200221666200312104837</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389200221666200312104837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389200221666200312104837%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Drug%2520Metabolism%26atitle%3DFurther%252BConsiderations%252BTowards%252Ban%252BEffective%252Band%252BEfficient%252BOncology%252BDrug%252BDiscovery%252BDMPK%252BStrategy%26aulast%3DWilliamson%26aufirst%3DBeth%26date%3D2020%26volume%3D21%26issue%3D2%26spage%3D145%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayoung  Pyo</span>, <span class="hlFld-ContribAuthor ">Dong-Yeon  Kim</span>, <span class="hlFld-ContribAuthor ">Heejung  Kim</span>, <span class="hlFld-ContribAuthor ">Daejin  Lim</span>, <span class="hlFld-ContribAuthor ">Seong Young  Kwon</span>, <span class="hlFld-ContribAuthor ">Sae-Ryung  Kang</span>, <span class="hlFld-ContribAuthor ">Hyung-Seok  Kim</span>, <span class="hlFld-ContribAuthor ">Hee-Seung  Bom</span>, <span class="hlFld-ContribAuthor ">Jung-Joon  Min</span>. </span><span class="cited-content_cbyCitation_article-title">Ultrasensitive detection of malignant melanoma using PET molecular imaging probes. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2020,</strong> <em>117 </em>
                                    (23)
                                     , 12991-12999. <a href="https://doi.org/10.1073/pnas.1922313117" title="DOI URL">https://doi.org/10.1073/pnas.1922313117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1922313117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1922313117%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DUltrasensitive%252Bdetection%252Bof%252Bmalignant%252Bmelanoma%252Busing%252BPET%252Bmolecular%252Bimaging%252Bprobes%26aulast%3DPyo%26aufirst%3DAyoung%26date%3D2020%26date%3D2020%26volume%3D117%26issue%3D23%26spage%3D12991%26epage%3D12999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kimiyuki  Shibuya</span>, <span class="hlFld-ContribAuthor ">Toru  Miura</span>, <span class="hlFld-ContribAuthor ">Tadaaki  Ohgiya</span>, <span class="hlFld-ContribAuthor ">Kozo  Omichi</span>, <span class="hlFld-ContribAuthor ">Yoshihiko  Tsunenari</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses and pharmacokinetic evaluations of four metabolites of 2-(4-(2-((1H-benzo[d]imidazol-2-yl)thio)ethyl)piperazin-1-yl)-N-(6-methyl-2,4-bis-(methylthio)pyridin-3-yl)acetamide hydrochloride [K-604], an acyl-CoA:cholesterol O-acyltransferase-1 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (11)
                                     , 115457. <a href="https://doi.org/10.1016/j.bmc.2020.115457" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115457%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSyntheses%252Band%252Bpharmacokinetic%252Bevaluations%252Bof%252Bfour%252Bmetabolites%252Bof%252B2-%2525284-%2525282-%252528%2525281H-benzo%25255Bd%25255Dimidazol-2-yl%252529thio%252529ethyl%252529piperazin-1-yl%252529-N-%2525286-methyl-2%25252C4-bis-%252528methylthio%252529pyridin-3-yl%252529acetamide%252Bhydrochloride%252B%25255BK-604%25255D%25252C%252Ban%252Bacyl-CoA%25253Acholesterol%252BO-acyltransferase-1%252Binhibitor%26aulast%3DShibuya%26aufirst%3DKimiyuki%26date%3D2020%26volume%3D28%26issue%3D11%26spage%3D115457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kuanglei  Wang</span>, <span class="hlFld-ContribAuthor ">Hongxi  Zhu</span>, <span class="hlFld-ContribAuthor ">Hongqian  Zhao</span>, <span class="hlFld-ContribAuthor ">Kun  Zhang</span>, <span class="hlFld-ContribAuthor ">Yongshou  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">Application of carbamyl in structural optimization. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>98 </em>, 103757. <a href="https://doi.org/10.1016/j.bioorg.2020.103757" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103757</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103757%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DApplication%252Bof%252Bcarbamyl%252Bin%252Bstructural%252Boptimization%26aulast%3DWang%26aufirst%3DKuanglei%26date%3D2020%26volume%3D98%26spage%3D103757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lorena  Baboci</span>, <span class="hlFld-ContribAuthor ">Sara  Capolla</span>, <span class="hlFld-ContribAuthor ">Federica  Di Cintio</span>, <span class="hlFld-ContribAuthor ">Federico  Colombo</span>, <span class="hlFld-ContribAuthor ">Prisca  Mauro</span>, <span class="hlFld-ContribAuthor ">Michele  Dal Bo</span>, <span class="hlFld-ContribAuthor ">Monica  Argenziano</span>, <span class="hlFld-ContribAuthor ">Roberta  Cavalli</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Toffoli</span>, <span class="hlFld-ContribAuthor ">Paolo  Macor</span>. </span><span class="cited-content_cbyCitation_article-title">The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target. </span><span class="cited-content_cbyCitation_journal-name">Journal of Oncology</span><span> <strong>2020,</strong> <em>2020 </em>, 1-15. <a href="https://doi.org/10.1155/2020/4638192" title="DOI URL">https://doi.org/10.1155/2020/4638192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2020/4638192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2020%2F4638192%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Oncology%26atitle%3DThe%252BDual%252BRole%252Bof%252Bthe%252BLiver%252Bin%252BNanomedicine%252Bas%252Ban%252BActor%252Bin%252Bthe%252BElimination%252Bof%252BNanostructures%252Bor%252Ba%252BTherapeutic%252BTarget%26aulast%3DBaboci%26aufirst%3DLorena%26date%3D2020%26volume%3D2020%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel S.  Nielsen</span>, <span class="hlFld-ContribAuthor ">Rink-Jan  Lohman</span>, <span class="hlFld-ContribAuthor ">Huy N.  Hoang</span>, <span class="hlFld-ContribAuthor ">David P.  Fairlie</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Hill</span>. </span><span class="cited-content_cbyCitation_article-title">High Cell Permeability Does Not Predict Oral Bioavailability for Analogues of Cyclic Heptapeptide Sanguinamide A. </span><span class="cited-content_cbyCitation_journal-name">Australian Journal of Chemistry</span><span> <strong>2020,</strong> <em>73 </em>
                                    (4)
                                     , 344. <a href="https://doi.org/10.1071/CH19479" title="DOI URL">https://doi.org/10.1071/CH19479</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1071/CH19479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1071%2FCH19479%26sid%3Dliteratum%253Aachs%26jtitle%3DAustralian%2520Journal%2520of%2520Chemistry%26atitle%3DHigh%252BCell%252BPermeability%252BDoes%252BNot%252BPredict%252BOral%252BBioavailability%252Bfor%252BAnalogues%252Bof%252BCyclic%252BHeptapeptide%252BSanguinamide%252BA%26aulast%3DNielsen%26aufirst%3DDaniel%2BS.%26date%3D2020%26volume%3D73%26issue%3D4%26spage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad H.  Rahman</span>, <span class="hlFld-ContribAuthor ">Mandeep K.  Bal</span>, <span class="hlFld-ContribAuthor ">Alan M.  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism‐Inspired Electrosynthesis. </span><span class="cited-content_cbyCitation_journal-name">ChemElectroChem</span><span> <strong>2019,</strong> <em>6 </em>
                                    (16)
                                     , 4093-4104. <a href="https://doi.org/10.1002/celc.201900117" title="DOI URL">https://doi.org/10.1002/celc.201900117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/celc.201900117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcelc.201900117%26sid%3Dliteratum%253Aachs%26jtitle%3DChemElectroChem%26atitle%3DMetabolism%2525E2%252580%252590Inspired%252BElectrosynthesis%26aulast%3DRahman%26aufirst%3DMuhammad%2BH.%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D16%26spage%3D4093%26epage%3D4104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_0010.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Typical iv plasma concentration versus time curve for a compound in human.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Simple model of clearance for an organ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic of the hepatobiliary system.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Preparation of hepatic subcellular fractions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vitro metabolism experiment following parent depletion in linear and log scales.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Scaling human liver microsomal and hepatocyte CL<sub>int,app</sub> to human blood CL<sub>b</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Permeability controls the effects of transporter efflux or influx.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/medium/jm-2018-01263h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Basics of an allometric scaling experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01263/20190308/images/large/jm-2018-01263h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01263&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 52 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span>; <span class="NLM_string-name">Allerton, C.</span>; <span class="NLM_string-name">Kalgutkar, A. S.</span>; <span class="NLM_string-name">van de Waterbeemd, H.</span>; <span class="NLM_string-name">Walker, D. K.</span></span> <i>Pharmacokinetics and Metabolism in Drug Design</i>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1002%2F9783527645763" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=D.+A.+Smith&author=C.+Allerton&author=A.+S.+Kalgutkar&author=H.+van+de+Waterbeemd&author=D.+K.+Walker&title=Pharmacokinetics+and+Metabolism+in+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2F9783527645763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527645763%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26btitle%3DPharmacokinetics%2520and%2520Metabolism%2520in%2520Drug%2520Design%26pub%3DWiley-VCH%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span>; <span class="NLM_string-name">Kerns, E.
H.</span></span> <i>Drug-like Properties: Concepts, Structure Design, and Methods</i>; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">London, U.K.</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=L.+Di&author=E.%0AH.+Kerns&title=Drug-like+Properties%3A+Concepts%2C+Structure+Design%2C+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26btitle%3DDrug-like%2520Properties%253A%2520Concepts%252C%2520Structure%2520Design%252C%2520and%2520Methods%26pub%3DElsevier%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khojasteh, S. C.</span>; <span class="NLM_string-name">Wong, H.</span>; <span class="NLM_string-name">Hop, C.
E. C. A.</span></span> <i>Drug Metabolism and Pharmacokinetics Quick Guide</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1007%2F978-1-4419-5629-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+C.+Khojasteh&author=H.+Wong&author=C.%0AE.+C.+A.+Hop&title=Drug+Metabolism+and+Pharmacokinetics+Quick+Guide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-5629-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4419-5629-3%26sid%3Dliteratum%253Aachs%26aulast%3DKhojasteh%26aufirst%3DS.%2BC.%26btitle%3DDrug%2520Metabolism%2520and%2520Pharmacokinetics%2520Quick%2520Guide%26pub%3DSpringer%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Volume of distribution in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5691</span>– <span class="NLM_lpage">5698</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00201</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00201" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFSlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5691-5698&author=D.+A.+Smithauthor=K.+Beaumontauthor=T.+S.+Maurerauthor=L.+Di&title=Volume+of+distribution+in+drug+design&doi=10.1021%2Facs.jmedchem.5b00201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Volume of Distribution in Drug Design</span></div><div class="casAuthors">Smith, Dennis A.; Beaumont, Kevin; Maurer, Tristan S.; Di, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5691-5698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Vol. of distribution is one of the most important pharmacokinetic properties of a drug candidate.  It is a major determinant of half-life and dosing frequency of a drug.  For a similar log P, a basic mol. will tend to exhibit higher vol. of distribution than a neutral mol.  Acids often exhibit low vols. of distribution.  Although a design strategy against vol. of distribution can be advantageous in achieving desirable dosing regimen, it must be well-directed in order to avoid detrimental effects to other important properties.  Strategies to increase vol. of distribution include adding lipophilicity and introducing basic functional groups in a way that does not increase metabolic clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP7QwgPahf4bVg90H21EOLACvtfcHk0lgbEgBGhwLJYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFSlsb0%253D&md5=2c7289b3602a8edef2d9ef0e6a82e483</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00201%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DVolume%2520of%2520distribution%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5691%26epage%3D5698%26doi%3D10.1021%2Facs.jmedchem.5b00201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Relevance of half-life in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4273</span>– <span class="NLM_lpage">4282</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00969</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00969" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslOnsrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4273-4282&author=D.+A.+Smithauthor=K.+Beaumontauthor=T.+S.+Maurerauthor=L.+Di&title=Relevance+of+half-life+in+drug+design&doi=10.1021%2Facs.jmedchem.7b00969"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Relevance of Half-Life in Drug Design</span></div><div class="casAuthors">Smith, Dennis A.; Beaumont, Kevin; Maurer, Tristan S.; Di, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4273-4282</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Drug half-life has important implications for dosing regimen and peak-to-trough ratio at the steady state.  A half-life of 12-48 h is generally ideal for once daily dosing of oral drugs.  If the half-life is too short, it may require more frequent dosing in order to maintain desired exposures and avoid unnecessarily high peak concns.  This may pose challenges to achieving optimal efficacy, safety, and patient compliance.  If the half-life is too long, the time over which accumulation and subsequent elimination occur may be prolonged.  This may pose problems with managing adverse effects and the design of efficient clin. trials.  Half-life is a key parameter for optimization in research and development.  Structural modification to affect clearance, and to a lesser extent vol. of distribution, is the preferred means of modulating half-life.  An effective approach to half-life optimization requires an understanding of the many pitfalls assocd. with its estn. and interpretation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7kT9hNLRzb7Vg90H21EOLACvtfcHk0ljSfX5scbfLSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslOnsrnN&md5=ff748cbebc765f4fa3c3d7b3831f51c8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00969%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DRelevance%2520of%2520half-life%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4273%26epage%3D4282%26doi%3D10.1021%2Facs.jmedchem.7b00969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, S.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics and metabolism of a sulphamide NK2 antagonist in rat, dog and human</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">642</span>, <span class="refDoi"> DOI: 10.1080/004982500406453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1080%2F004982500406453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10923864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFCltL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2000&pages=627-642&author=K.+Beaumontauthor=A.+Harperauthor=D.+A.+Smithauthor=S.+Abel&title=Pharmacokinetics+and+metabolism+of+a+sulphamide+NK2+antagonist+in+rat%2C+dog+and+human&doi=10.1080%2F004982500406453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and metabolism of a sulphamide NK2 antagonist in rat, dog and human</span></div><div class="casAuthors">Beaumont, K.; Harper, A.; Smith, D. A.; Abel, S.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">627-642</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">1. UK-224,671 is a sulfamide-contg. NK2 antagonist with moderate lipophilicity and basicity.  2. The physicochem. properties of UK-224,671 are reflected in its pharmacokinetics following i.v. administration.  The compd. partitioned extensively into red blood cells in all species examd. and the blood clearance was moderate to low with respect to liver blood flow and distribution into tissues was extensive.  3. UK-224,671 exhibited species differences in oral bioavailability.  In dog, the compd. exhibited moderate bioavailability (55%), whereas in rat and man oral bioavailability was < 10%.  4. In rat and dog, the major excreted form after i.v. administration was unchanged UK-224,671 in both urine and feces.  In addn., of three metabolites obsd., the most abundant was the N-descyclopropylmethyl (UK-280,045).  5. The profile of radioactivity in rat following oral administration of [14C]-UK-224,671 was not consistent with a 10% absorbed compd. with 40% of the dose present as metabolites.  This suggests that the low bioavailability of UK-224,671 in rat is due to a combination of moderate intestinal permeability and extensive first-pass metab. by the gut and does not result from poor gastrointestinal absorption per se.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpns74iTwf5PbVg90H21EOLACvtfcHk0ljSfX5scbfLSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFCltL4%253D&md5=5d6a03b5b2b7060be7e6c4c6fb0f1af0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1080%2F004982500406453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F004982500406453%26sid%3Dliteratum%253Aachs%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DHarper%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DAbel%26aufirst%3DS.%26atitle%3DPharmacokinetics%2520and%2520metabolism%2520of%2520a%2520sulphamide%2520NK2%2520antagonist%2520in%2520rat%252C%2520dog%2520and%2520human%26jtitle%3DXenobiotica%26date%3D2000%26volume%3D30%26spage%3D627%26epage%3D642%26doi%3D10.1080%2F004982500406453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northam, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alway, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, O. S.</span></span> <span> </span><span class="NLM_article-title">Blood levels of drug at the equilibrium state after multiple dosing</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>207</i></span>,  <span class="NLM_fpage">1301</span>– <span class="NLM_lpage">1302</span>, <span class="refDoi"> DOI: 10.1038/2071301a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1038%2F2071301a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=5884654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A280%3ADyaF287ksVSntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=1965&pages=1301-1302&author=J.+G.+Wagnerauthor=J.+I.+Northamauthor=C.+D.+Alwayauthor=O.+S.+Carpenter&title=Blood+levels+of+drug+at+the+equilibrium+state+after+multiple+dosing&doi=10.1038%2F2071301a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Blood levels of drug at the equilibrium state after multiple dosing</span></div><div class="casAuthors">Wagner J G; Northam J I; Alway C D; Carpenter O S</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">5003</span>),
    <span class="NLM_cas:pages">1301-2</span>
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkXM4pbz4uL8uCWE5mhx1RfW6udTcc2ea3SThUZgXpQ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF287ksVSntQ%253D%253D&md5=de878fcb3ee5b632be74a12d50dfcfa7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F2071301a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F2071301a0%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DJ.%2BG.%26aulast%3DNortham%26aufirst%3DJ.%2BI.%26aulast%3DAlway%26aufirst%3DC.%2BD.%26aulast%3DCarpenter%26aufirst%3DO.%2BS.%26atitle%3DBlood%2520levels%2520of%2520drug%2520at%2520the%2520equilibrium%2520state%2520after%2520multiple%2520dosing%26jtitle%3DNature%26date%3D1965%26volume%3D207%26spage%3D1301%26epage%3D1302%26doi%3D10.1038%2F2071301a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, M.</span></span> <span> </span><span class="NLM_article-title">Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance</span>. <i>J. Pharmacokinet. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">653</span>, <span class="refDoi"> DOI: 10.1007/BF01059688</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1007%2FBF01059688" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=599411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADyaE1cXhtFGjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1977&pages=625-653&author=K.+S.+Pangauthor=M.+Rowland&title=Hepatic+clearance+of+drugs.+I.+Theoretical+considerations+of+a+%E2%80%9Cwell-stirred%E2%80%9D+model+and+a+%E2%80%9Cparallel+tube%E2%80%9D+model.+Influence+of+hepatic+blood+flow%2C+plasma+and+blood+cell+binding%2C+and+the+hepatocellular+enzymatic+activity+on+hepatic+drug+clearance&doi=10.1007%2FBF01059688"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic clearance of drugs.  I.  Theoretical considerations of a "well-stirred" model and a "parallel tube" model.  Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance</span></div><div class="casAuthors">Pang, K. Sandy; Rowland, Malcolm</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacokinetics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">625-53</span>CODEN:
                <span class="NLM_cas:coden">JPBPBJ</span>;
        ISSN:<span class="NLM_cas:issn">0090-466X</span>.
    </div><div class="casAbstract">Two commonly used models of hepatic drug clearance were examd.  The well-stirred model (model I) views the liver as a well-stirred compartment with concn. of drug in the liver in equil. with that in the emergent blood.  The parallel tube model (model II) regards the liver as a series of parallel tubes with enzymes distributed evenly around the tubes and the concn. of drug declining along the length of the tube.  Both models were examd. under steady-state considerations in the absence of diffusional limitations (i.e., cell membranes not limiting the movement of drug mols.).  Equations involving the determinants of hepatic drug clearance (hepatic blood flow, fraction of drug in blood unbound, and the hepatocellular enzymic activity) and various pharmacokinetic parameters were derived.  Similarities and differences between the models were explored.  Although both models predict similar hepatic drug clearances under a variety of conditions, marked differences between them become apparent in their predictions of the influence of changes in the determinants of drug clearance on various pharmacokinetic parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDpZaENZqfCbVg90H21EOLACvtfcHk0lgCUQCZHa1eKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhtFGjtLs%253D&md5=6a9e9bf46d9ce3571d8da77495cc9e19</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2FBF01059688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01059688%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DK.%2BS.%26aulast%3DRowland%26aufirst%3DM.%26atitle%3DHepatic%2520clearance%2520of%2520drugs.%2520I.%2520Theoretical%2520considerations%2520of%2520a%2520%25E2%2580%259Cwell-stirred%25E2%2580%259D%2520model%2520and%2520a%2520%25E2%2580%259Cparallel%2520tube%25E2%2580%259D%2520model.%2520Influence%2520of%2520hepatic%2520blood%2520flow%252C%2520plasma%2520and%2520blood%2520cell%2520binding%252C%2520and%2520the%2520hepatocellular%2520enzymatic%2520activity%2520on%2520hepatic%2520drug%2520clearance%26jtitle%3DJ.%2520Pharmacokinet.%2520Biopharm.%26date%3D1977%26volume%3D5%26spage%3D625%26epage%3D653%26doi%3D10.1007%2FBF01059688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, G. G.</span></span> <span> </span><span class="NLM_article-title">Clearance concepts in pharmacokinetics</span>. <i>J. Pharmacokinet. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1007/BF01059626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1007%2FBF01059626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=4764426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A280%3ADyaE2c%252FmtVKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1973&pages=123-136&author=M.+Rowlandauthor=L.+Z.+Benetauthor=G.+G.+Graham&title=Clearance+concepts+in+pharmacokinetics&doi=10.1007%2FBF01059626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Clearance concepts in pharmacokinetics</span></div><div class="casAuthors">Rowland M; Benet L Z; Graham G G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacokinetics and biopharmaceutics</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-36</span>
        ISSN:<span class="NLM_cas:issn">0090-466X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSz4Zcsmz7GkKe0F5ixvZgXfW6udTcc2ea3SThUZgXpQ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE2c%252FmtVKisw%253D%253D&md5=bf6ffefba3dd092a61fb55bca443973a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2FBF01059626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01059626%26sid%3Dliteratum%253Aachs%26aulast%3DRowland%26aufirst%3DM.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26aulast%3DGraham%26aufirst%3DG.%2BG.%26atitle%3DClearance%2520concepts%2520in%2520pharmacokinetics%26jtitle%3DJ.%2520Pharmacokinet.%2520Biopharm.%26date%3D1973%26volume%3D1%26spage%3D123%26epage%3D136%26doi%3D10.1007%2FBF01059626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shand, D. G.</span></span> <span> </span><span class="NLM_article-title">Commentary: a physiological approach to hepatic drug clearance</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1002/cpt1975184377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1002%2Fcpt1975184377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1164821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A280%3ADyaE28%252FitFemsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1975&pages=377-390&author=G.+R.+Wilkinsonauthor=D.+G.+Shand&title=Commentary%3A+a+physiological+approach+to+hepatic+drug+clearance&doi=10.1002%2Fcpt1975184377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Commentary: a physiological approach to hepatic drug clearance</span></div><div class="casAuthors">Wilkinson G R; Shand D G</div><div class="citationInfo"><span class="NLM_cas:title">Clinical pharmacology and therapeutics</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">377-90</span>
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">A physiological approach has been developed recognizing that hepatic blood flow, the activity of the overall elimination process (intrinsic clearance), drug binding in the blood, and the anatomical arrangement of the hepatic circulation are the major biological determinants of hepatic drug clearance.  This approach permits quantitative prediction of both the unbound and total drug concentration/time relationships in the blood after intravenous and oral administration, and any changes that may occur as a result of alterations in the above biological parameters.  These considerations have led to a classification of drug metabolism based on the hepatic extraction ratio.  The proposed classification allows prediction and interpretation of the effects of individual variations in drug-metabolizing activity, route of administration, pharmacokinetic interactions, and disease states on hepatic drug elimination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3aFnQ1cqrfp0d-O_J5C0AfW6udTcc2eax1Ya7q8BCs7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE28%252FitFemsA%253D%253D&md5=3ff5e564e044c18f22f48ba0af48259c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fcpt1975184377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpt1975184377%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DG.%2BR.%26aulast%3DShand%26aufirst%3DD.%2BG.%26atitle%3DCommentary%253A%2520a%2520physiological%2520approach%2520to%2520hepatic%2520drug%2520clearance%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1975%26volume%3D18%26spage%3D377%26epage%3D390%26doi%3D10.1002%2Fcpt1975184377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, Y.</span></span> <span> </span><span class="NLM_article-title">Prediction of hepatic clearance in human from in vitro data for successful drug development</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">262</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1208/s12248-009-9103-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1208%2Fs12248-009-9103-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=19408130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWqs7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=262-276&author=M.+Chibaauthor=Y.+Ishiiauthor=Y.+Sugiyama&title=Prediction+of+hepatic+clearance+in+human+from+in+vitro+data+for+successful+drug+development&doi=10.1208%2Fs12248-009-9103-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of hepatic clearance in human from in vitro data for successful drug development</span></div><div class="casAuthors">Chiba, Masato; Ishii, Yasuyuki; Sugiyama, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">262-276</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The in vivo metabolic clearance in human has been successfully predicted by using in vitro data of metabolic stability in cryopreserved prepns. of human hepatocytes.  In the predictions by human hepatocytes, the systematic underpredictions of in vivo clearance have been commonly obsd. among different datasets.  The regression-based scaling factor for the in vitro-to-in vivo extrapolation has mitigated discrepancy between in vitro prediction and in vivo observation.  In addn. to the elimination by metabolic degrdn., the important roles of transporter-mediated hepatic uptake and canalicular excretion have been increasingly recognized as a rate-detg. step in the hepatic clearance.  It has been, therefore, proposed that the in vitro assessment should allow the evaluation of clearances for both transporter(s)-mediated uptake/excretion and metabolic degrdn.  This review first outlines the limited ability of subcellular fractions such as liver microsomes to predict hepatic clearance in vivo.  It highlights the advantages of cryopreserved human hepatocytes as one of the versatile in vitro systems for the prediction of in vivo metabolic clearance in human at the early development state.  The following section discusses the mechanisms underlying the systematic underprediction of in vivo intrinsic clearance by hepatocytes.  It leads to the proposal for the assessment of hepatic uptake clearance as one of the kinetically important determinants for accurate predictions of hepatic clearance in human.  The judicious combination of advanced technologies and understandings for the drug disposition allows us to rationally optimize new chem. entities to the drug candidate with higher probability of success during the clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC52lEOUdlKLVg90H21EOLACvtfcHk0liubglElrdUvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWqs7rI&md5=8c2b3366285c690ba1055d46f52f0b6b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1208%2Fs12248-009-9103-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-009-9103-6%26sid%3Dliteratum%253Aachs%26aulast%3DChiba%26aufirst%3DM.%26aulast%3DIshii%26aufirst%3DY.%26aulast%3DSugiyama%26aufirst%3DY.%26atitle%3DPrediction%2520of%2520hepatic%2520clearance%2520in%2520human%2520from%2520in%2520vitro%2520data%2520for%2520successful%2520drug%2520development%26jtitle%3DAAPS%2520J.%26date%3D2009%26volume%3D11%26spage%3D262%26epage%3D276%26doi%3D10.1208%2Fs12248-009-9103-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hallifax, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houston, J. B.</span></span> <span> </span><span class="NLM_article-title">Prediction of human metabolic clearance from in vitro systems: retrospective analysis and prospective view</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2150</span>– <span class="NLM_lpage">2161</span>, <span class="refDoi"> DOI: 10.1007/s11095-010-0218-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1007%2Fs11095-010-0218-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=20661765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt12rsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2010&pages=2150-2161&author=D.+Hallifaxauthor=J.+A.+Fosterauthor=J.+B.+Houston&title=Prediction+of+human+metabolic+clearance+from+in+vitro+systems%3A+retrospective+analysis+and+prospective+view&doi=10.1007%2Fs11095-010-0218-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of Human Metabolic Clearance from In Vitro Systems: Retrospective Analysis and Prospective View</span></div><div class="casAuthors">Hallifax, David; Foster, Joanne A.; Houston, J. Brian</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2150-2161</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: To provide a definitive assessment of prediction of in vivo CLint from human liver in vitro systems for assessment of typical underprediction.  Methods: A database of published predictions of clearance from human hepatocytes and liver microsomes was compiled, including only i.v. CLb.  The influence of liver model (well-stirred (WS) or parallel tube (PT)), plasma protein binding and clearance level on the relationship between in vitro and in vivo CLint was examd.  Results: Av. prediction bias was about 5- and 4-fold for microsomes and hepatocytes, resp.  Reduced bias using the PT model, in preference to the popular WS model, was only marginal across a wide range of clearance with a consequential minor impact on prediction.  Increasing underprediction with decreasing fub, or increasing CLint, was found only for hepatocytes, suggesting fundamental in vitro artifacts rather than failure to model potentially unequilibrated binding during rapid extn.  Conclusions: In contrast to microsomes, hepatocytes give a disproportionate prediction with increasing clearance suggesting limitations either at the active site, such as cofactor exhaustion, or with intracellular concn. equil., such as rate-limiting cell permeability.  A simple log linear empirical relationship can be used to correct hepatocyte predictions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2OFAIV4xbqrVg90H21EOLACvtfcHk0lhQ-SFaRU3mhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt12rsLs%253D&md5=eacc0536e048fee3cab292ae2b52f608</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs11095-010-0218-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-010-0218-3%26sid%3Dliteratum%253Aachs%26aulast%3DHallifax%26aufirst%3DD.%26aulast%3DFoster%26aufirst%3DJ.%2BA.%26aulast%3DHouston%26aufirst%3DJ.%2BB.%26atitle%3DPrediction%2520of%2520human%2520metabolic%2520clearance%2520from%2520in%2520vitro%2520systems%253A%2520retrospective%2520analysis%2520and%2520prospective%2520view%26jtitle%3DPharm.%2520Res.%26date%3D2010%26volume%3D27%26spage%3D2150%26epage%3D2161%26doi%3D10.1007%2Fs11095-010-0218-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span> <span> </span><span class="NLM_article-title">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1038/nrd3287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1038%2Fnrd3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=21119731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=929-939&author=D.+A.+Smithauthor=L.+Diauthor=E.+H.+Kerns&title=The+effect+of+plasma+protein+binding+on+in+vivo+efficacy%3A+misconceptions+in+drug+discovery&doi=10.1038%2Fnrd3287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span></div><div class="casAuthors">Smith, Dennis A.; Di, Li; Kerns, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">929-939</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Data from in vitro plasma protein binding expts. that det. the fraction of protein-bound drug are frequently used in drug discovery to guide structure design and to prioritize compds. for in vivo studies.  However, we consider that these practices are usually misleading, because in vivo efficacy is detd. by the free (unbound) drug concn. surrounding the therapeutic target, not by the free drug fraction.  These practices yield no enhancement of the in vivo free drug concn.  So, decisions based on free drug fraction could result in the wrong compds. being advanced through drug discovery programs.  This Perspective provides guidance on the application of plasma protein binding information in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOa3ippodhGbVg90H21EOLACvtfcHk0lhQ-SFaRU3mhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI&md5=a45d00f68ab44580fa38a6acef49493a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3287%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26atitle%3DThe%2520effect%2520of%2520plasma%2520protein%2520binding%2520on%2520in%2520vivo%2520efficacy%253A%2520misconceptions%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D929%26epage%3D939%26doi%3D10.1038%2Fnrd3287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Houston, J.
B.</span></span> <span> </span><span class="NLM_article-title">Relevance of in vitro kinetic parameters to in vivo metabolism of xenobiotics</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.1016/0887-2333(94)90002-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1016%2F0887-2333%2894%2990002-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1994&pages=507-512&author=J.%0AB.+Houston&title=Relevance+of+in+vitro+kinetic+parameters+to+in+vivo+metabolism+of+xenobiotics&doi=10.1016%2F0887-2333%2894%2990002-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2F0887-2333%2894%2990002-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0887-2333%252894%252990002-7%26sid%3Dliteratum%253Aachs%26aulast%3DHouston%26aufirst%3DJ.%2BB.%26atitle%3DRelevance%2520of%2520in%2520vitro%2520kinetic%2520parameters%2520to%2520in%2520vivo%2520metabolism%2520of%2520xenobiotics%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D1994%26volume%3D8%26spage%3D507%26epage%3D512%26doi%3D10.1016%2F0887-2333%2894%2990002-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10534321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1350-1359&author=R.+S.+Obach&title=Prediction+of+human+clearance+of+twenty-nine+drugs+from+hepatic+microsomal+intrinsic+clearance+data%3A+an+examination+of+in+vitro+half-life+approach+and+nonspecific+binding+to+microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1350-1359</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Twenty-nine drugs of disparate structures and physicochem. properties were used in an examn. of the capability of human liver microsomal lability data ("in vitro T1/2" approach) to be useful in the prediction of human clearance.  Addnl., the potential importance of nonspecific binding to microsomes in the in vitro incubation milieu for the accurate prediction of human clearance was investigated.  The compds. examd. demonstrated a wide range of microsomal metabolic labilities with scaled intrinsic clearance values ranging from less than 0.5 mL/min/kg to 189 mL/min/kg.  Microsomal binding was detd. at microsomal protein concns. used in the lability incubations.  For the 29 compds. studied, unbound fractions in microsomes ranged from 0.11 to 1.0.  Generally, basic compds. demonstrated the greatest extent of binding and neutral and acidic compds. the least extent of binding.  In the projection of human clearance values, basic and neutral compds. were well predicted when all binding considerations (blood and microsome) were disregarded, however, including both binding considerations also yielded reasonable predictions.  Including only blood binding yielded very poor projections of human clearance for these two types of compds.  However, for acidic compds., disregarding all binding considerations yielded poor predictions of human clearance.  It was generally most difficult to accurately predict clearance for this class of compds.; however the accuracy was best when all binding considerations were included.  Overall, inclusion of both blood and microsome binding values gave the best agreement between in vivo clearance values and clearance values projected from in vitro intrinsic clearance data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWp2hUTOxyubVg90H21EOLACvtfcHk0liQU4759E1Q-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D&md5=7804cd4dfb131caac45aff9b7a1df901</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPrediction%2520of%2520human%2520clearance%2520of%2520twenty-nine%2520drugs%2520from%2520hepatic%2520microsomal%2520intrinsic%2520clearance%2520data%253A%2520an%2520examination%2520of%2520in%2520vitro%2520half-life%2520approach%2520and%2520nonspecific%2520binding%2520to%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landis, J.</span></span> <span> </span><span class="NLM_article-title">Opinion: can the pharmaceutical industry reduce attrition rates?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">711</span>– <span class="NLM_lpage">716</span>, <span class="refDoi"> DOI: 10.1038/nrd1470</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1038%2Fnrd1470" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=711-716&author=I.+Kolaauthor=J.+Landis&title=Opinion%3A+can+the+pharmaceutical+industry+reduce+attrition+rates%3F&doi=10.1038%2Fnrd1470"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnrd1470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1470%26sid%3Dliteratum%253Aachs%26aulast%3DKola%26aufirst%3DI.%26aulast%3DLandis%26aufirst%3DJ.%26atitle%3DOpinion%253A%2520can%2520the%2520pharmaceutical%2520industry%2520reduce%2520attrition%2520rates%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D711%26epage%3D716%26doi%3D10.1038%2Fnrd1470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0liQU4759E1Q-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
de Waterbeemd, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, B. C.</span></span> <span> </span><span class="NLM_article-title">Lipophilicity in PK design: methyl, ethyl, futile</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1023/A:1008192010023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1023%2FA%3A1008192010023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=11289080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitlWjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=273-286&author=H.+Van%0Ade+Waterbeemdauthor=D.+A.+Smithauthor=B.+C.+Jones&title=Lipophilicity+in+PK+design%3A+methyl%2C+ethyl%2C+futile&doi=10.1023%2FA%3A1008192010023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in PK design: methyl, ethyl, futile</span></div><div class="casAuthors">Van de Waterbeemd, Han; Smith, Dennis A.; Jones, Barry C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-286</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review with 39 refs.  Lipophilicity, often expressed as distribution coeffs. (log D) in octanol/water, is an important physicochem. parameter influencing processes such as oral absorption, brain uptake and various pharmacokinetic (PK) properties.  Increasing log D values increases oral absorption, plasma protein binding and vol. of distribution.  However, more lipophilic compds. also become more vulnerable to P 450 metab., leading to higher clearance.  Mol. size and hydrogen bonding capacity are two other properties often considered as important for membrane permeation and pharmacokinetics.  Interrelationships among these physicochem. properties are discussed.  Increasing size (mol. wt.) often gives higher potency, but inevitably also leads to either higher lipophilicity, and hence poorer dissoln./soly., or to more hydrogen bonding capacity, which limits oral absorption.  Differences in optimal properties between gastrointestinal absorption and uptake into the brain are addressed.  Special attention is given to the desired lipophilicity of CNS drugs.  In examples using β-blockers, Ca channel antagonists and peptidic renin inhibitors we will demonstrate how potency and pharmacokinetic properties need to be balanced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohNJonr7f2hbVg90H21EOLACvtfcHk0li6jcGfSuFE0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitlWjtLo%253D&md5=04f94add93edc2b1a211bb53f676d908</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008192010023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008192010023%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bde%2BWaterbeemd%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DJones%26aufirst%3DB.%2BC.%26atitle%3DLipophilicity%2520in%2520PK%2520design%253A%2520methyl%252C%2520ethyl%252C%2520futile%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2001%26volume%3D15%26spage%3D273%26epage%3D286%26doi%3D10.1023%2FA%3A1008192010023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
de Waterbeemd, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. K.</span></span> <span> </span><span class="NLM_article-title">Property-based design: optimization of drug absorption and pharmacokinetics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1313</span>– <span class="NLM_lpage">1333</span>, <span class="refDoi"> DOI: 10.1021/jm000407e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000407e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BD3MXit1Whu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1313-1333&author=H.+van%0Ade+Waterbeemdauthor=D.+A.+Smithauthor=K.+Beaumontauthor=D.+K.+Walker&title=Property-based+design%3A+optimization+of+drug+absorption+and+pharmacokinetics&doi=10.1021%2Fjm000407e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Property-based design: optimization of drug absorption and pharmacokinetics</span></div><div class="casAuthors">van de Waterbeemd, Han; Smith, Dennis A.; Beaumont, Kevin; Walker, Don K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1313-1333</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 223 refs.  The authors discuss some aspects of the properties of biol. barriers.  In different sections the estn. of drug absorption via important barriers including gastrointestinal tract, blood-brain barrier, and skin are reviewed.  Various approaches for the measurement and computation of physicochem. and mol. properties currently used in the optimization of absorption as well as the use of physicochem. properties in the design of optimal pharmacokinetic profiles are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaQwsmoX0-mbVg90H21EOLACvtfcHk0li6jcGfSuFE0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXit1Whu7c%253D&md5=3183baedca70020f4ce27f306ba0997e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm000407e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000407e%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bde%2BWaterbeemd%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DWalker%26aufirst%3DD.%2BK.%26atitle%3DProperty-based%2520design%253A%2520optimization%2520of%2520drug%2520absorption%2520and%2520pharmacokinetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D1313%26epage%3D1333%26doi%3D10.1021%2Fjm000407e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Houston, J. B.</span></span> <span> </span><span class="NLM_article-title">Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1469</span>– <span class="NLM_lpage">1479</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(94)90520-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1016%2F0006-2952%2894%2990520-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=8185657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADyaK2cXkt1Kju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1994&pages=1469-1479&author=J.+B.+Houston&title=Utility+of+in+vitro+drug+metabolism+data+in+predicting+in+vivo+metabolic+clearance&doi=10.1016%2F0006-2952%2894%2990520-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance</span></div><div class="casAuthors">Houston, J. Brian</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1469-79</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A review with 54 refs.  The aim of the commentary is to present a strategy to achieve the prediction of in vivo clearance from in vitro data based on the current understanding of metabolite kinetics in vitro and in vivo.  Hepatic microsomes and hepatocyte suspension are the main in vitro system addressed.  The theor. basis of the strategy is outlined and its general applicability evaluated, using a data base of 25 drugs drawn from the literature.  Finally, the prospective value of the approach is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFHqQ8gCJ6lrVg90H21EOLACvtfcHk0li6jcGfSuFE0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkt1Kju7c%253D&md5=a6d0abdbd2f0b238a6a01ba63ee67739</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2894%2990520-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252894%252990520-7%26sid%3Dliteratum%253Aachs%26aulast%3DHouston%26aufirst%3DJ.%2BB.%26atitle%3DUtility%2520of%2520in%2520vitro%2520drug%2520metabolism%2520data%2520in%2520predicting%2520in%2520vivo%2520metabolic%2520clearance%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1994%26volume%3D47%26spage%3D1469%26epage%3D1479%26doi%3D10.1016%2F0006-2952%2894%2990520-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T.</span></span> <span> </span><span class="NLM_article-title">Physicochemical drug properties associated with in vivo toxicological outcomes: a review</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">921</span>– <span class="NLM_lpage">931</span>, <span class="refDoi"> DOI: 10.1517/17425250903042318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1517%2F17425250903042318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=19519283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVCjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=921-931&author=D.+A.+Priceauthor=J.+Blaggauthor=L.+Jonesauthor=N.+Greeneauthor=T.+Wager&title=Physicochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes%3A+a+review&doi=10.1517%2F17425250903042318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical drug properties associated with in vivo toxicological outcomes: a review</span></div><div class="casAuthors">Price, David A.; Blagg, Julian; Jones, Lyn; Greene, Nigel; Wager, Travis</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">921-931</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The genesis of any toxicol. or safety outcome is multifactorial and complex; for this reason, it can be difficult for drug discovery projects to factor the avoidance of toxicity outcomes into their target design.  A focus on readily measurable parameters from high-throughput in vitro assays (e.g., primary potency, clearance) is easier to handle and have become the mainstays of drug discovery projects.  However, the fundamental origins of adverse safety or toxicity findings can be considered as deriving from four parameters, all of which are in the control of the drug designer.  These can be described as primary pharmacol., off target pharmacol., the presence of a defined structural fragment that can be assocd. with adverse outcomes and the overall physicochem. properties of the mol. that may predispose it to adverse outcomes.  In the drug discovery community, there has been recognition for many years of the influence of physicochem. drug properties (in particular lipophilicity) on the toxicol. profile of compds., and recent research is now beginning to quantify that risk in a probabilistic sense.  This review focuses on the overall properties of classes of mols. that are assocd. with an increased probability of adverse outcomes in in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU8kwwUsaFIrVg90H21EOLACvtfcHk0lj5fkfnvrD3pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVCjtb0%253D&md5=bd1cca3634afda14de2f8aa115d7d55e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1517%2F17425250903042318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425250903042318%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DL.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DWager%26aufirst%3DT.%26atitle%3DPhysicochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%253A%2520a%2520review%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2009%26volume%3D5%26spage%3D921%26epage%3D931%26doi%3D10.1517%2F17425250903042318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keefer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckworth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">448</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.06.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1016%2Fj.ejmech.2012.06.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=22840492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslaqu77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2012&pages=441-448&author=L.+Diauthor=C.+Keeferauthor=D.+O.+Scottauthor=T.+J.+Strelevitzauthor=G.+Changauthor=Y.-A.+Biauthor=Y.+Laiauthor=J.+Duckworthauthor=K.+Fennerauthor=M.+D.+Troutmanauthor=R.+S.+Obach&title=Mechanistic+insights+from+comparing+intrinsic+clearance+values+between+human+liver+microsomes+and+hepatocytes+to+guide+drug+design&doi=10.1016%2Fj.ejmech.2012.06.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design</span></div><div class="casAuthors">Di, Li; Keefer, Christopher; Scott, Dennis O.; Strelevitz, Timothy J.; Chang, George; Bi, Yi-An; Lai, Yurong; Duckworth, Jonathon; Fenner, Katherine; Troutman, Matthew D.; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">441-448</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Metabolic stability of drug candidates are often detd. in both liver microsome and hepatocyte assays.  Comparison of intrinsic clearance values between the two assays provides addnl. information to guide drug design.  Intrinsic clearance values from human liver microsomes and hepatocytes were compared for a set of com. drugs with known metabolic pathways and transporter characteristics.  The results showed that for compds. that were predominately metabolized by CYP mediated mechanisms, the intrinsic clearance values from the two assays were comparable.  For compds. with non-CYP pathways, such as UGT and AO, intrinsic clearance was faster in hepatocytes than in microsomes.  Substrates of uptake or efflux transporters in this study did not have significant differences of intrinsic clearance between microsomes and hepatocytes, when uptake into the hepatocytes was not the rate-limiting step.  When hepatic uptake was rate limiting, intrinsic clearance in microsomes was faster than that in hepatocytes, which was more prevalent for compds. with rapid metab.  Low passive permeability can limit the exposure to drug mols. to the metabolizing enzymes in the hepatocytes in relationship to the rate of metab.  The faster the rate of metab., the higher permeability is needed for mol. to enter the cells and not becoming rate-limiting.  The findings are very useful for drug discovery programs to gain addnl. insights on mechanistic information to help drug design without added expts.  Follow-up studies can then be designed to address specific questions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpotepvZ_arBrVg90H21EOLACvtfcHk0lj5fkfnvrD3pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslaqu77M&md5=37b89dbe98fecdd067453ce49042d668</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.06.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.06.043%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKeefer%26aufirst%3DC.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DBi%26aufirst%3DY.-A.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DDuckworth%26aufirst%3DJ.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DMechanistic%2520insights%2520from%2520comparing%2520intrinsic%2520clearance%2520values%2520between%2520human%2520liver%2520microsomes%2520and%2520hepatocytes%2520to%2520guide%2520drug%2520design%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D57%26spage%3D441%26epage%3D448%26doi%3D10.1016%2Fj.ejmech.2012.06.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niosi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosa, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litchfield, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Novel method to predict in vivo liver-to-plasma Kpuu for OATP substrates using suspension hepatocytes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">576</span>– <span class="NLM_lpage">580</span>, <span class="refDoi"> DOI: 10.1124/dmd.116.074575</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1124%2Fdmd.116.074575" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=576-580&author=K.+Riccardiauthor=J.+Linauthor=Z.+Liauthor=M.+Niosiauthor=S.+Ryuauthor=W.+Huaauthor=K.+Atkinsonauthor=R.+E.+Kosaauthor=J.+Litchfieldauthor=L.+Di&title=Novel+method+to+predict+in+vivo+liver-to-plasma+Kpuu+for+OATP+substrates+using+suspension+hepatocytes&doi=10.1124%2Fdmd.116.074575"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fdmd.116.074575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.116.074575%26sid%3Dliteratum%253Aachs%26aulast%3DRiccardi%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DNiosi%26aufirst%3DM.%26aulast%3DRyu%26aufirst%3DS.%26aulast%3DHua%26aufirst%3DW.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DKosa%26aufirst%3DR.%2BE.%26aulast%3DLitchfield%26aufirst%3DJ.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DNovel%2520method%2520to%2520predict%2520in%2520vivo%2520liver-to-plasma%2520Kpuu%2520for%2520OATP%2520substrates%2520using%2520suspension%2520hepatocytes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2017%26volume%3D45%26spage%3D576%26epage%3D580%26doi%3D10.1124%2Fdmd.116.074575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y.-a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scialis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathialagan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keefer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vildhede, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremaine, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V. S.</span></span> <span> </span><span class="NLM_article-title">Reliable rate measurements for active and passive hepatic uptake using plated human hepatocytes</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.1208/s12248-017-0051-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1208%2Fs12248-017-0051-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=28188574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivFSqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=787-796&author=Y.-a.+Biauthor=R.+Scialisauthor=S.+Lazzaroauthor=S.+Mathialaganauthor=E.+Kimotoauthor=J.+Keeferauthor=H.+Zhangauthor=A.+M.+Vildhedeauthor=C.+Costalesauthor=A.+D.+Rodriguesauthor=L.+M.+Tremaineauthor=M.+V.+S.+Varma&title=Reliable+rate+measurements+for+active+and+passive+hepatic+uptake+using+plated+human+hepatocytes&doi=10.1208%2Fs12248-017-0051-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Reliable Rate Measurements for Active and Passive Hepatic Uptake Using Plated Human Hepatocytes</span></div><div class="casAuthors">Bi, Yi-an; Scialis, Renato; Lazzaro, Sarah; Mathialagan, Sumathy; Kimoto, Emi; Keefer, Julie; Zhang, Hui; Vildhede, Anna M.; Costales, Chester; Rodrigues, A. David; Tremaine, Larry M.; Varma, Manthena V. S.</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">787-796</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Transporter-mediated hepatic uptake is proven to be the rate-detg. step in the systemic clearance of several drugs.  Therefore, accurate measurement of active and passive uptake clearances in vitro is crit. to facilitate pharmacokinetics and drug-drug interaction predictions.  Here, we evaluated the plated human hepatocytes (PHH) and studied the effect of incubation temp. and inhibitor concn. on uptake measurements, in order to reliably est. hepatic uptake components.  Uptake rates measured using PHH, at 37°C without and with rifamycin SV, were comparable with those obtained from suspension hepatocytes and sandwich-cultured hepatocytes for a set of 10-13 compds.  Apparent permeability across monolayers of low-efflux Madin-Darby canine kidney cells was measured at 4, 10, and 37°C.  Of the 23 compds. evaluated, 13 compds. showed >2-fold redn. in passive permeability at 4°C compared to 37°C, inferring that low-temp. incubations may underestimate passive uptake.  Inhibition studies using transporter-transfected cells suggested that ∼20 μM rifamycin SV completely inhibited org. anion-transporting polypeptides (OATPs), while no significant inhibition was noted for other hepatic uptake transporters.  On the basis of inhibition profiles, the contribution of active vs. passive and OATP vs. non-OATP transport to the PHH uptake was discerned for various endogenous substrates and statins.  With the exception of fluvastatin, the statins studied were predominantly transported by OATPs in PHH and the non-OATP transporters, such as Na+-taurocholate co-transporting polypeptide, played a minimal role.  In conclusion, PHH is useful for uptake measurements, and rifamycin SV employed at different concns. can reliably est. active and passive uptake and characterize OATP-dependent active uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZp938mtplg7Vg90H21EOLACvtfcHk0lgUAvb-iEx72w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivFSqtbg%253D&md5=aafedb94cb981fcde209de3632a46e2d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1208%2Fs12248-017-0051-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-017-0051-2%26sid%3Dliteratum%253Aachs%26aulast%3DBi%26aufirst%3DY.-a.%26aulast%3DScialis%26aufirst%3DR.%26aulast%3DLazzaro%26aufirst%3DS.%26aulast%3DMathialagan%26aufirst%3DS.%26aulast%3DKimoto%26aufirst%3DE.%26aulast%3DKeefer%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DVildhede%26aufirst%3DA.%2BM.%26aulast%3DCostales%26aufirst%3DC.%26aulast%3DRodrigues%26aufirst%3DA.%2BD.%26aulast%3DTremaine%26aufirst%3DL.%2BM.%26aulast%3DVarma%26aufirst%3DM.%2BV.%2BS.%26atitle%3DReliable%2520rate%2520measurements%2520for%2520active%2520and%2520passive%2520hepatic%2520uptake%2520using%2520plated%2520human%2520hepatocytes%26jtitle%3DAAPS%2520J.%26date%3D2017%26volume%3D19%26spage%3D787%26epage%3D796%26doi%3D10.1208%2Fs12248-017-0051-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Claire, R. L.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, K. L. R.</span></span> <span> </span><span class="NLM_article-title">Prediction of altered bile acid disposition due to inhibition of multiple transporters: an integrated approach using sandwich- cultured hepatocytes, mechanistic modeling, and simulations</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">324</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.1124/jpet.116.231928</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1124%2Fjpet.116.231928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=27233294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCqtbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2016&pages=324-333&author=C.+Guoauthor=K.+Yangauthor=K.+R.+Brouwerauthor=R.+L.+St.+Claireauthor=K.+L.+R.+Brouwer&title=Prediction+of+altered+bile+acid+disposition+due+to+inhibition+of+multiple+transporters%3A+an+integrated+approach+using+sandwich-+cultured+hepatocytes%2C+mechanistic+modeling%2C+and+simulations&doi=10.1124%2Fjpet.116.231928"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of altered bile acid disposition due to inhibition of multiple transporters: an integrated approach using sandwich- cultured hepatocytes, mechanistic modeling, and simulations</span></div><div class="casAuthors">Guo, Cen; Yang, Kyunghee; Brouwer, Kenneth R.; St. Claire, Robert L., III; Brouwer, Kim L. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">324-333</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Transporter-mediated alterations in bile acid disposition may have significant toxicol. implications.  Current methods to predict interactions are limited by the interplay of multiple transporters, absence of protein in the exptl. system, and inaccurate ests. of inhibitor concns.  An integrated approach was developed to predict altered bile acid disposition due to inhibition of multiple transporters using the model bile acid taurocholate (TCA).  TCA pharmacokinetic parameters were estd. by mechanistic modeling using sandwich-cultured human hepatocyte data with protein in the medium.  Uptake, basolateral efflux, and biliary clearance ests. were 0.63, 0.034, and 0.074 mL/min/g liver, resp.  Cellular total TCA concns. (Ct,Cells) were selected as the model output based on sensitivity anal.  Monte Carlo simulations of TCA Ct,Cells in the presence of model inhibitors (telmisartan and bosentan) were performed using inhibition consts. for TCA transporters and inhibitor concns., including cellular total inhibitor concns. ([I]t,cell) or unbound concns., and cytosolic total or unbound concns.  For telmisartan, themodel prediction was accurate with an av. fold error (AFE) of 0.99-1.0 when unbound inhibitor concn. ([I]u) was used; accuracy dropped when total inhibitor concn. ([I]t) was used.  For bosentan, AFEwas 1.2-1.3 using either [I]u or [I]t.  This difference was evaluated by sensitivity anal. of the cellular unbound fraction of inhibitor (fu,cell,inhibitor), which revealed higher sensitivity of fu,cell,inhibitor for predicting TCA Ct,Cells when inhibitors exhibited larger ([I]t,cell/IC50) values.  In conclusion, this study demonstrated the applicability of a framework to predict hepatocellular bile acid concns. due to drug-mediated inhibition of transporters using mechanistic modeling and cytosolic or cellular unbound concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0MZBuSC-1X7Vg90H21EOLACvtfcHk0lg2Oe1Sjwndrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCqtbfN&md5=c69a2b924eed2b12a1b1677beb6879cb</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.231928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.231928%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DBrouwer%26aufirst%3DK.%2BR.%26aulast%3DSt.%2BClaire%26aufirst%3DR.%2BL.%26aulast%3DBrouwer%26aufirst%3DK.%2BL.%2BR.%26atitle%3DPrediction%2520of%2520altered%2520bile%2520acid%2520disposition%2520due%2520to%2520inhibition%2520of%2520multiple%2520transporters%253A%2520an%2520integrated%2520approach%2520using%2520sandwich-%2520cultured%2520hepatocytes%252C%2520mechanistic%2520modeling%252C%2520and%2520simulations%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D358%26spage%3D324%26epage%3D333%26doi%3D10.1124%2Fjpet.116.231928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsunaga, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imawaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamai, I.</span></span> <span> </span><span class="NLM_article-title">Sandwich-cultured hepatocytes for mechanistic understanding of hepatic disposition of parent drugs and metabolites by transporter-enzyme interplay</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">680</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1124/dmd.117.079236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1124%2Fdmd.117.079236" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=680-691&author=N.+Matsunagaauthor=Y.+Fukuchiauthor=H.+Imawakaauthor=I.+Tamai&title=Sandwich-cultured+hepatocytes+for+mechanistic+understanding+of+hepatic+disposition+of+parent+drugs+and+metabolites+by+transporter-enzyme+interplay&doi=10.1124%2Fdmd.117.079236"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fdmd.117.079236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.117.079236%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DN.%26aulast%3DFukuchi%26aufirst%3DY.%26aulast%3DImawaka%26aufirst%3DH.%26aulast%3DTamai%26aufirst%3DI.%26atitle%3DSandwich-cultured%2520hepatocytes%2520for%2520mechanistic%2520understanding%2520of%2520hepatic%2520disposition%2520of%2520parent%2520drugs%2520and%2520metabolites%2520by%2520transporter-enzyme%2520interplay%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2018%26volume%3D46%26spage%3D680%26epage%3D691%26doi%3D10.1124%2Fdmd.117.079236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosa, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremaine, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V. S.</span></span> <span> </span><span class="NLM_article-title">Hepatobiliary clearance prediction: species scaling from monkey, dog, and rat, and in vitro-in vivo extrapolation of sandwich-cultured human hepatocytes using 17 drugs</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">2795</span>– <span class="NLM_lpage">2804</span>, <span class="refDoi"> DOI: 10.1016/j.xphs.2017.04.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1016%2Fj.xphs.2017.04.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=28456723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslGnsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2017&pages=2795-2804&author=E.+Kimotoauthor=Y.-A.+Biauthor=R.+E.+Kosaauthor=L.+M.+Tremaineauthor=M.+V.+S.+Varma&title=Hepatobiliary+clearance+prediction%3A+species+scaling+from+monkey%2C+dog%2C+and+rat%2C+and+in+vitro-in+vivo+extrapolation+of+sandwich-cultured+human+hepatocytes+using+17+drugs&doi=10.1016%2Fj.xphs.2017.04.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatobiliary Clearance Prediction: Species Scaling From Monkey, Dog, and Rat, and In Vitro-In Vivo Extrapolation of Sandwich-Cultured Human Hepatocytes Using 17 Drugs</span></div><div class="casAuthors">Kimoto, Emi; Bi, Yi-An; Kosa, Rachel E.; Tremaine, Larry M.; Varma, Manthena V. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2795-2804</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Hepatobiliary elimination can be a major clearance pathway dictating the pharmacokinetics of drugs.  Here, we first compared the dose eliminated in bile in preclin. species (monkey, dog, and rat) with that in human and further evaluated single-species scaling (SSS) to predict human hepatobiliary clearance.  Six compds. dosed in bile duct-cannulated (BDC) monkeys showed biliary excretion comparable to human; and the SSS of hepatobiliary clearance with plasma fraction unbound correction yielded reasonable predictions (within 3-fold).  Although dog SSS also showed reasonable predictions, rat overpredicted hepatobiliary clearance for 13 of 24 compds.  Second, we evaluated the translatability of in vitro sandwich-cultured human hepatocytes (SCHHs) to predict human hepatobiliary clearance for 17 drugs.  For drugs with no significant active uptake in SCHH studies (i.e., with or without rifamycin SV), measured intrinsic biliary clearance was directly scalable with good predictability (abs. av. fold error [AAFE] = 1.6).  Drugs showing significant active uptake in SCHH, however, showed improved predictability when scaled based on extended clearance term (AAFE = 2.0), which incorporated sinusoidal uptake along with a global scaling factor for active uptake and the canalicular efflux clearance.  In conclusion, SCHH is a useful tool to predict human hepatobiliary clearance, whereas BDC monkey model may provide further confidence in the prospective predictions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnnfbBzDYp4rVg90H21EOLACvtfcHk0lg2Oe1Sjwndrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslGnsbc%253D&md5=7b059b55d39b86abafbb5791c16bc15f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.xphs.2017.04.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.xphs.2017.04.043%26sid%3Dliteratum%253Aachs%26aulast%3DKimoto%26aufirst%3DE.%26aulast%3DBi%26aufirst%3DY.-A.%26aulast%3DKosa%26aufirst%3DR.%2BE.%26aulast%3DTremaine%26aufirst%3DL.%2BM.%26aulast%3DVarma%26aufirst%3DM.%2BV.%2BS.%26atitle%3DHepatobiliary%2520clearance%2520prediction%253A%2520species%2520scaling%2520from%2520monkey%252C%2520dog%252C%2520and%2520rat%252C%2520and%2520in%2520vitro-in%2520vivo%2520extrapolation%2520of%2520sandwich-cultured%2520human%2520hepatocytes%2520using%252017%2520drugs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2017%26volume%3D106%26spage%3D2795%26epage%3D2804%26doi%3D10.1016%2Fj.xphs.2017.04.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y.-a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempshall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kattan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houston, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galetin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenner, K. S.</span></span> <span> </span><span class="NLM_article-title">Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1007</span>– <span class="NLM_lpage">1017</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.042994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1124%2Fdmd.111.042994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=22344703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1KnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1007-1017&author=H.+M.+Jonesauthor=H.+A.+Bartonauthor=Y.+Laiauthor=Y.-a.+Biauthor=E.+Kimotoauthor=S.+Kempshallauthor=S.+C.+Tateauthor=A.+El-Kattanauthor=J.+B.+Houstonauthor=A.+Galetinauthor=K.+S.+Fenner&title=Mechanistic+pharmacokinetic+modeling+for+the+prediction+of+transporter-mediated+disposition+in+humans+from+sandwich+culture+human+hepatocyte+data&doi=10.1124%2Fdmd.111.042994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data</span></div><div class="casAuthors">Jones, Hannah M.; Barton, Hugh A.; Lai, Yurong; Bi, Yi-an; Kimoto, Emi; Kempshall, Sarah; Tate, Sonya C.; El-Kattan, Ayman; Houston, J. Brian; Galetin, Aleksandra; Fenner, Katherine S.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1007-1017</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">With efforts to reduce cytochrome P 450-mediated clearance (CL) during the early stages of drug discovery, transporter-mediated CL mechanisms are becoming more prevalent.  However, the prediction of plasma concn.-time profiles for such compds. using physiol. based pharmacokinetic (PBPK) modeling is far less established in comparison with that for compds. with passively mediated pharmacokinetics (PK).  In this study, we have assessed the predictability of human PK for seven org. anion-transporting polypeptide (OATP) substrates (pravastatin, cerivastatin, bosentan, fluvastatin, rosuvastatin, valsartan, and repaglinide) for which clin. i.v. data were available.  In vitro data generated from the sandwich culture human hepatocyte system were simultaneously fit to est. parameters describing both uptake and biliary efflux.  Use of scaled active uptake, passive distribution, and biliary efflux parameters as inputs into a PBPK model resulted in the overprediction of exposure for all seven drugs investigated, with the exception of pravastatin.  Therefore, fitting of in vivo data for each individual drug in the dataset was performed to establish empirical scaling factors to accurately capture their plasma concn.-time profiles.  Overall, active uptake and biliary efflux were under- and overpredicted, leading to av. empirical scaling factors of 58 and 0.061, resp.; passive diffusion required no scaling factor.  This study illustrates the mechanistic and model-driven application of in vitro uptake and efflux data for human PK prediction for OATP substrates.  A particular advantage is the ability to capture the multiphasic plasma concn.-time profiles for such compds. using only preclin. data.  A prediction strategy for novel OATP substrates is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTZLA7_SR2trVg90H21EOLACvtfcHk0lhh-vLKcIHn0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1KnsrY%253D&md5=4dd3e5fb5fd400c979f160d89b39753f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.042994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.042994%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DBarton%26aufirst%3DH.%2BA.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DBi%26aufirst%3DY.-a.%26aulast%3DKimoto%26aufirst%3DE.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DTate%26aufirst%3DS.%2BC.%26aulast%3DEl-Kattan%26aufirst%3DA.%26aulast%3DHouston%26aufirst%3DJ.%2BB.%26aulast%3DGaletin%26aufirst%3DA.%26aulast%3DFenner%26aufirst%3DK.%2BS.%26atitle%3DMechanistic%2520pharmacokinetic%2520modeling%2520for%2520the%2520prediction%2520of%2520transporter-mediated%2520disposition%2520in%2520humans%2520from%2520sandwich%2520culture%2520human%2520hepatocyte%2520data%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D1007%26epage%3D1017%26doi%3D10.1124%2Fdmd.111.042994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span> <span> </span><span class="NLM_article-title">A “middle-out” approach to human pharmacokinetic predictions for OATP substrates using physiologically-based pharmacokinetic modeling</span>. <i>J. Pharmacokinet. Pharmacodyn.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">209</span>, <span class="refDoi"> DOI: 10.1007/s10928-014-9357-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1007%2Fs10928-014-9357-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=24718648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmt1GnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=197-209&author=R.+Liauthor=H.+A.+Bartonauthor=P.+D.+Yatesauthor=A.+Ghoshauthor=A.+C.+Wolfordauthor=K.+A.+Riccardiauthor=T.+S.+Maurer&title=A+%E2%80%9Cmiddle-out%E2%80%9D+approach+to+human+pharmacokinetic+predictions+for+OATP+substrates+using+physiologically-based+pharmacokinetic+modeling&doi=10.1007%2Fs10928-014-9357-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A "middle-out" approach to human pharmacokinetic predictions for OATP substrates using physiologically-based pharmacokinetic modeling</span></div><div class="casAuthors">Li, Rui; Barton, Hugh A.; Yates, Phillip D.; Ghosh, Avijit; Wolford, Angela C.; Riccardi, Keith A.; Maurer, Tristan S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacokinetics and Pharmacodynamics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">197-209</span>CODEN:
                <span class="NLM_cas:coden">JPPOAH</span>;
        ISSN:<span class="NLM_cas:issn">1567-567X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Physiol. based pharmacokinetic (PBPK) models provide a framework useful for generating credible human pharmacokinetic predictions from data available at the earliest, preclin. stages of pharmaceutical research.  With this approach, the pharmacokinetic implications of in vitro data are contextualized via scaling according to independent physiol. information.  However, in many cases these models also require model-based estn. of addnl. empirical scaling factors (SFs) in order to accurately recapitulate known human pharmacokinetic behavior.  While this practice clearly improves data characterization, the introduction of empirically derived SFs may belie the extrapolative power commonly attributed to PBPK.  This is particularly true when such SFs are compd. dependent and/or when there are issues with regard to identifiability.  As such, when empirically-derived SFs are necessary, a crit. evaluation of parameter estn. and model structure are prudent.  In this study, we applied a global optimization method to support model-based estn. of a single set of empirical SFs from i.v. clin. data on seven OATP substrates within the context of a previously published PBPK model as well as a revised PBPK model.  The revised model with exptl. measured unbound fraction in liver, permeability between liver compartments, and permeability limited distribution to selected tissues improved data characterization.  We utilized large-sample approxn. and resampling approaches to est. confidence intervals for the revised model in support of forward predictions that reflect the derived uncertainty.  This work illustrates an objective approach to estg. empirically-derived SFs, systematically refining PBPK model performance and conveying the assocd. confidence in subsequent forward predictions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdIDSVCuxE67Vg90H21EOLACvtfcHk0lhh-vLKcIHn0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmt1GnsLk%253D&md5=f39119d03fb7ef39468b8dfa3e2f7800</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs10928-014-9357-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10928-014-9357-1%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DR.%26aulast%3DBarton%26aufirst%3DH.%2BA.%26aulast%3DYates%26aufirst%3DP.%2BD.%26aulast%3DGhosh%26aufirst%3DA.%26aulast%3DWolford%26aufirst%3DA.%2BC.%26aulast%3DRiccardi%26aufirst%3DK.%2BA.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26atitle%3DA%2520%25E2%2580%259Cmiddle-out%25E2%2580%259D%2520approach%2520to%2520human%2520pharmacokinetic%2520predictions%2520for%2520OATP%2520substrates%2520using%2520physiologically-based%2520pharmacokinetic%2520modeling%26jtitle%3DJ.%2520Pharmacokinet.%2520Pharmacodyn.%26date%3D2014%26volume%3D41%26spage%3D197%26epage%3D209%26doi%3D10.1007%2Fs10928-014-9357-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camenisch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riede, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunze, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huwyler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, K.</span></span> <span> </span><span class="NLM_article-title">The extended clearance model and its use for the interpretation of hepatobiliary elimination data</span>. <i>ADMET DMPK</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.5599/admet.3.1.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.5599%2Fadmet.3.1.144" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=1-4&author=G.+Camenischauthor=J.+Riedeauthor=A.+Kunzeauthor=J.+Huwylerauthor=B.+Pollerauthor=K.+Umehara&title=The+extended+clearance+model+and+its+use+for+the+interpretation+of+hepatobiliary+elimination+data&doi=10.5599%2Fadmet.3.1.144"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.5599%2Fadmet.3.1.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5599%252Fadmet.3.1.144%26sid%3Dliteratum%253Aachs%26aulast%3DCamenisch%26aufirst%3DG.%26aulast%3DRiede%26aufirst%3DJ.%26aulast%3DKunze%26aufirst%3DA.%26aulast%3DHuwyler%26aufirst%3DJ.%26aulast%3DPoller%26aufirst%3DB.%26aulast%3DUmehara%26aufirst%3DK.%26atitle%3DThe%2520extended%2520clearance%2520model%2520and%2520its%2520use%2520for%2520the%2520interpretation%2520of%2520hepatobiliary%2520elimination%2520data%26jtitle%3DADMET%2520DMPK%26date%3D2015%26volume%3D3%26spage%3D1%26epage%3D4%26doi%3D10.5599%2Fadmet.3.1.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyn, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allerton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kattan, A. F.</span></span> <span> </span><span class="NLM_article-title">Predicting clearance mechanism in drug discovery: extended clearance classification system (ECCS)</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">3785</span>– <span class="NLM_lpage">3802</span>, <span class="refDoi"> DOI: 10.1007/s11095-015-1749-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1007%2Fs11095-015-1749-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=26155985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCjurfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=3785-3802&author=M.+V.+Varmaauthor=S.+J.+Steynauthor=C.+Allertonauthor=A.+F.+El-Kattan&title=Predicting+clearance+mechanism+in+drug+discovery%3A+extended+clearance+classification+system+%28ECCS%29&doi=10.1007%2Fs11095-015-1749-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS)</span></div><div class="casAuthors">Varma, Manthena V.; Steyn, Stefanus J.; Allerton, Charlotte; El-Kattan, Ayman F.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3785-3802</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Early prediction of clearance mechanisms allows for the rapid progression of drug discovery and development programs, and facilitates risk assessment of the pharmacokinetic variability assocd. with drug interactions and pharmacogenomics.  Here we propose a scientific framework - Extended Clearance Classification System (ECCS) - which can be used to predict the predominant clearance mechanism (rate-detg. process) based on physicochem. properties and passive membrane permeability.  Compds. are classified as: Class 1A - metab. as primary systemic clearance mechanism (high permeability acids/zwitterions with mol. wt. (MW) ≤400 Da), Class 1B - transporter-mediated hepatic uptake as primary systemic clearance mechanism (high permeability acids/zwitterions with MW >400 Da), Class 2 - metab. as primary clearance mechanism (high permeability bases/neutrals), Class 3A -renal clearance (low permeability acids/zwitterions with MW ≤400 Da), Class 3B - transporter mediated hepatic uptake or renal clearance (low permeability acids/zwitterions with MW >400 Da), and Class 4 - renal clearance (low permeability bases/neutrals).  The performance of the ECCS framework was validated using 307 compds. with single clearance mechanism contributing to ≥70% of systemic clearance.  The apparent permeability across clonal cell line of Madin - Darby canine kidney cells, selected for low endogenous efflux transporter expression, with a cut-off of 5 × 10-6 cm/s was used for permeability classification, and the ionization (at pH7) was assigned based on calcd. pKa.  The proposed scheme correctly predicted the rate-detg. clearance mechanism to be either metab., hepatic uptake or renal for ∼92% of total compds.  We discuss the general characteristics of each ECCS class, as well as compare and contrast the framework with the biopharmaceutics classification system (BCS) and the biopharmaceutics drug disposition classification system (BDDCS).  Collectively, the ECCS framework is valuable in early prediction of clearance mechanism and can aid in choosing the right preclin. tool kit and strategy for optimizing drug exposure and evaluating clin. risk of pharmacokinetic variability caused by drug interactions and pharmacogenomics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRANZrcZqpObVg90H21EOLACvtfcHk0lgdAyjTZOxg5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCjurfP&md5=836ba49f4fe66ceacfec6390e56bc792</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs11095-015-1749-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-015-1749-4%26sid%3Dliteratum%253Aachs%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DAllerton%26aufirst%3DC.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26atitle%3DPredicting%2520clearance%2520mechanism%2520in%2520drug%2520discovery%253A%2520extended%2520clearance%2520classification%2520system%2520%2528ECCS%2529%26jtitle%3DPharm.%2520Res.%26date%3D2015%26volume%3D32%26spage%3D3785%26epage%3D3802%26doi%3D10.1007%2Fs11095-015-1749-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camenisch, G. P.</span></span> <span> </span><span class="NLM_article-title">Drug disposition classification systems in discovery and development: a comparative review of the BDDCS, ECCS and ECCCS concepts</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2583</span>– <span class="NLM_lpage">2593</span>, <span class="refDoi"> DOI: 10.1007/s11095-016-2001-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1007%2Fs11095-016-2001-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=2583-2593&author=G.+P.+Camenisch&title=Drug+disposition+classification+systems+in+discovery+and+development%3A+a+comparative+review+of+the+BDDCS%2C+ECCS+and+ECCCS+concepts&doi=10.1007%2Fs11095-016-2001-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs11095-016-2001-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-016-2001-6%26sid%3Dliteratum%253Aachs%26aulast%3DCamenisch%26aufirst%3DG.%2BP.%26atitle%3DDrug%2520disposition%2520classification%2520systems%2520in%2520discovery%2520and%2520development%253A%2520a%2520comparative%2520review%2520of%2520the%2520BDDCS%252C%2520ECCS%2520and%2520ECCCS%2520concepts%26jtitle%3DPharm.%2520Res.%26date%3D2016%26volume%3D33%26spage%3D2583%26epage%3D2593%26doi%3D10.1007%2Fs11095-016-2001-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mordenti, J.</span></span> <span> </span><span class="NLM_article-title">Man versus beast: pharmacokinetic scaling in mammals</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">1028</span>– <span class="NLM_lpage">1040</span>, <span class="refDoi"> DOI: 10.1002/jps.2600751104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1002%2Fjps.2600751104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1986&pages=1028-1040&author=J.+Mordenti&title=Man+versus+beast%3A+pharmacokinetic+scaling+in+mammals&doi=10.1002%2Fjps.2600751104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600751104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600751104%26sid%3Dliteratum%253Aachs%26aulast%3DMordenti%26aufirst%3DJ.%26atitle%3DMan%2520versus%2520beast%253A%2520pharmacokinetic%2520scaling%2520in%2520mammals%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1986%26volume%3D75%26spage%3D1028%26epage%3D1040%26doi%3D10.1002%2Fjps.2600751104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boxenbaum, H.</span></span> <span> </span><span class="NLM_article-title">Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics</span>. <i>J. Pharmacokinet. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1007/BF01062336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1007%2FBF01062336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=7120049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADyaL38Xlt1Sjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1982&pages=201-227&author=H.+Boxenbaum&title=Interspecies+scaling%2C+allometry%2C+physiological+time%2C+and+the+ground+plan+of+pharmacokinetics&doi=10.1007%2FBF01062336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics</span></div><div class="casAuthors">Boxenbaum, Harold</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacokinetics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-27</span>CODEN:
                <span class="NLM_cas:coden">JPBPBJ</span>;
        ISSN:<span class="NLM_cas:issn">0090-466X</span>.
    </div><div class="casAbstract">Interspecies variation in pharmacokinetics is considered and treated as a property and consequence of body size (allometry).  Consequently, it is possible to ref. (scale) pharmacokinetic parameters to the organism's individual anatomy, biochem., and/or physiol. in such a manner that differences between species are nullified.  Thus, in the mouse, rat, dog, monkey, and human, methotrexate (I)  [59-05-2] plasma clearance always equals 133% of creatinine clearance and as such becomes invariant.  Pharmacokinetic time (a variable in terms of chronol. time) is shown to be a form of physiol. time in which a pharmacokinetic event becomes the independent variable, e.g., disposition half-life.  A relationship between pharmacokinetic time and body size is demonstrated.  Man's lesser quant. ability to metabolize many drugs may be correlated with his enhanced longevity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSl0rgKrgvErVg90H21EOLACvtfcHk0lgdAyjTZOxg5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xlt1Sjtbo%253D&md5=55fcc13c71bd4170866d95edf79f408c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2FBF01062336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01062336%26sid%3Dliteratum%253Aachs%26aulast%3DBoxenbaum%26aufirst%3DH.%26atitle%3DInterspecies%2520scaling%252C%2520allometry%252C%2520physiological%2520time%252C%2520and%2520the%2520ground%2520plan%2520of%2520pharmacokinetics%26jtitle%3DJ.%2520Pharmacokinet.%2520Biopharm.%26date%3D1982%26volume%3D10%26spage%3D201%26epage%3D227%26doi%3D10.1007%2FBF01062336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boxenbaum, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronfeld, R.</span></span> <span> </span><span class="NLM_article-title">Interspecies pharmacokinetic scaling and the Dedrick plots</span>. <i>Am. J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>245</i></span>,  <span class="NLM_fpage">R768</span>– <span class="NLM_lpage">R775</span>, <span class="refDoi"> DOI: 10.1152/ajpregu.1983.245.6.R768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1152%2Fajpregu.1983.245.6.R768" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=1983&pages=R768-R775&author=H.+Boxenbaumauthor=R.+Ronfeld&title=Interspecies+pharmacokinetic+scaling+and+the+Dedrick+plots&doi=10.1152%2Fajpregu.1983.245.6.R768"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.1983.245.6.R768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.1983.245.6.R768%26sid%3Dliteratum%253Aachs%26aulast%3DBoxenbaum%26aufirst%3DH.%26aulast%3DRonfeld%26aufirst%3DR.%26atitle%3DInterspecies%2520pharmacokinetic%2520scaling%2520and%2520the%2520Dedrick%2520plots%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1983%26volume%3D245%26spage%3DR768%26epage%3DR775%26doi%3D10.1152%2Fajpregu.1983.245.6.R768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahmood, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, R.</span></span> <span> </span><span class="NLM_article-title">A comparative study of allometric scaling with plasma concentrations predicted by species-invariant time methods</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1099-081X(199904)20:3<137::AID-BDD165>3.0.CO;2-I</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1002%2F%28SICI%291099-081X%28199904%2920%3A3%3C137%3A%3AAID-BDD165%3E3.0.CO%3B2-I" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10211866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADyaK1MXit1Kqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=137-144&author=I.+Mahmoodauthor=R.+Yuan&title=A+comparative+study+of+allometric+scaling+with+plasma+concentrations+predicted+by+species-invariant+time+methods&doi=10.1002%2F%28SICI%291099-081X%28199904%2920%3A3%3C137%3A%3AAID-BDD165%3E3.0.CO%3B2-I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative study of allometric scaling with plasma concentrations predicted by species-invariant time methods</span></div><div class="casAuthors">Mahmood, Iftekhar; Yuan, Rae</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">137-144</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The objective of this study is to compare the empirical allometric approaches with species invariant time methods using equiv. time, kallynochron, apolysichron, and dienetichrons.  Pharmacokinetic parameters (clearance, vol. of distribution, and elimination half-life) of ethosuximide, cyclosporine and ciprofloxacin were scaled-up from animal data obtained from the literature.  Two methods were utilized to generate plots for the prediction of clearance in humans: (i) clearance vs. body wt. (simple allometric equation); and (ii) the product of clearance and max. life-span potential (MLP) vs. body wt.  Plasma concns. of each of the drugs were predicted using elementary and complex Dedrick plots, equiv. time with an exponent of 0.25 and equiv. time with the exponent obtained from the plot of body wt. and half-life.  Plasma concns. of cyclosporine and ciprofloxacin were also predicted by MLP normalization (dienetichrons).  Almost similar results in the pharmacokinetic parameters of the tested drugs were obtained by the allometric approach and by the species invariant time methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_hVoKqPpen7Vg90H21EOLACvtfcHk0ljfCVyIsFj6MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXit1Kqt7c%253D&md5=680dd9aa145d9ee77e0c0c83ed2cf290</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291099-081X%28199904%2920%3A3%3C137%3A%3AAID-BDD165%3E3.0.CO%3B2-I&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291099-081X%2528199904%252920%253A3%253C137%253A%253AAID-BDD165%253E3.0.CO%253B2-I%26sid%3Dliteratum%253Aachs%26aulast%3DMahmood%26aufirst%3DI.%26aulast%3DYuan%26aufirst%3DR.%26atitle%3DA%2520comparative%2520study%2520of%2520allometric%2520scaling%2520with%2520plasma%2520concentrations%2520predicted%2520by%2520species-invariant%2520time%2520methods%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D1999%26volume%3D20%26spage%3D137%26epage%3D144%26doi%3D10.1002%2F%28SICI%291099-081X%28199904%2920%3A3%3C137%3A%3AAID-BDD165%3E3.0.CO%3B2-I" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosea, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collard, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, R. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakar, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span> <span> </span><span class="NLM_article-title">Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">533</span>, <span class="refDoi"> DOI: 10.1177/0091270009333209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1177%2F0091270009333209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=19299532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFWmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=513-533&author=N.+A.+Hoseaauthor=W.+T.+Collardauthor=S.+Coleauthor=T.+S.+Maurerauthor=R.+X.+Fangauthor=H.+Jonesauthor=S.+M.+Kakarauthor=Y.+Nakaiauthor=B.+J.+Smithauthor=R.+Websterauthor=K.+Beaumont&title=Prediction+of+human+pharmacokinetics+from+preclinical+information%3A+comparative+accuracy+of+quantitative+prediction+approaches&doi=10.1177%2F0091270009333209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches</span></div><div class="casAuthors">Hosea, Natilie A.; Collard, Wendy T.; Cole, Susan; Maurer, Tristan S.; Fang, Rick X.; Jones, Hannah; Kakar, Shefali M.; Nakai, Yasuhiro; Smith, Bill J.; Webster, Rob; Beaumont, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">513-533</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Quant. prediction of human pharmacokinetics is crit. in assessing the viability of drug candidates and in detg. first-in-human dosing.  Numerous prediction methodologies, incorporating both in vitro and preclin. in vivo data, have been developed in recent years, each with advantages and disadvantages.  However, the lack of a comprehensive data set, both preclin. and clin., has limited efforts to evaluate the optimal strategy (or strategies) that results in quant. predictions of human pharmacokinetics.  To address this issue, the authors conducted a retrospective anal. using 50 proprietary compds. for which in vitro, preclin. pharmacokinetic data and oral single-dose human pharmacokinetic data were available.  Five predictive strategies, involving either allometry or use of unbound intrinsic clearance from microsomes or hepatocytes, were then compared for their ability to predict human oral clearance, half-life through predictions of systemic clearance, vol. of distribution, and bioavailability.  Use of a single-species scaling approach with rat, dog, or monkey was as accurate as or more accurate than using multiple-species allometry.  For those compds. cleared almost exclusively by P 450-mediated pathways, scaling from human liver microsomes was as predictive as single-species scaling of clearance based on data from rat, dog, or monkey.  These data suggest that use of predictive methods involving either single-species in vivo data or in vitro human liver microsomes can quant. predict human in vivo pharmacokinetics and suggest the possibility of streamlining the predictive methodol. through use of a single species or use only of human in vitro microsomal prepns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg67HcwS4O4LVg90H21EOLACvtfcHk0ljfCVyIsFj6MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFWmu74%253D&md5=a0941d53fe43392f8fb1562ee546705e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1177%2F0091270009333209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270009333209%26sid%3Dliteratum%253Aachs%26aulast%3DHosea%26aufirst%3DN.%2BA.%26aulast%3DCollard%26aufirst%3DW.%2BT.%26aulast%3DCole%26aufirst%3DS.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DFang%26aufirst%3DR.%2BX.%26aulast%3DJones%26aufirst%3DH.%26aulast%3DKakar%26aufirst%3DS.%2BM.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DBeaumont%26aufirst%3DK.%26atitle%3DPrediction%2520of%2520human%2520pharmacokinetics%2520from%2520preclinical%2520information%253A%2520comparative%2520accuracy%2520of%2520quantitative%2520prediction%2520approaches%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2009%26volume%3D49%26spage%3D513%26epage%3D533%26doi%3D10.1177%2F0091270009333209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahmood, I.</span></span> <span> </span><span class="NLM_article-title">Allometric issues in drug development</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">1101</span>– <span class="NLM_lpage">1106</span>, <span class="refDoi"> DOI: 10.1021/js9902163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1021%2Fjs9902163" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=1101-1106&author=I.+Mahmood&title=Allometric+issues+in+drug+development&doi=10.1021%2Fjs9902163"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjs9902163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjs9902163%26sid%3Dliteratum%253Aachs%26aulast%3DMahmood%26aufirst%3DI.%26atitle%3DAllometric%2520issues%2520in%2520drug%2520development%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D1101%26epage%3D1106%26doi%3D10.1021%2Fjs9902163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayersohn, M.</span></span> <span> </span><span class="NLM_article-title">A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">1783</span>– <span class="NLM_lpage">1799</span>, <span class="refDoi"> DOI: 10.1002/jps.20481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1002%2Fjps.20481" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=1783-1799&author=H.+Tangauthor=M.+Mayersohn&title=A+global+examination+of+allometric+scaling+for+predicting+human+drug+clearance+and+the+prediction+of+large+vertical+allometry&doi=10.1002%2Fjps.20481"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fjps.20481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20481%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DH.%26aulast%3DMayersohn%26aufirst%3DM.%26atitle%3DA%2520global%2520examination%2520of%2520allometric%2520scaling%2520for%2520predicting%2520human%2520drug%2520clearance%2520and%2520the%2520prediction%2520of%2520large%2520vertical%2520allometry%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2006%26volume%3D95%26spage%3D1783%26epage%3D1799%26doi%3D10.1002%2Fjps.20481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, M. R.</span></span> <span> </span><span class="NLM_article-title">Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">972</span>– <span class="NLM_lpage">987</span>, <span class="refDoi"> DOI: 10.3109/00498254.2011.598582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.3109%2F00498254.2011.598582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=21892879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12jsbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=972-987&author=Y.+Huhauthor=D.+E.+Smithauthor=M.+R.+Feng&title=Interspecies+scaling+and+prediction+of+human+clearance%3A+comparison+of+small-+and+macro-molecule+drugs&doi=10.3109%2F00498254.2011.598582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs</span></div><div class="casAuthors">Huh, Yeamin; Smith, David E.; Feng, Meihau Rose</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">972-987</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Human clearance prediction for small- and macro-mol. drugs was evaluated and compared using various scaling methods and statistical anal.  Human clearance is generally well predicted using single or multiple species simple allometry for macro- and small-mol. drugs excreted renally.  The prediction error is higher for hepatically eliminated small-mols. using single or multiple species simple allometry scaling, and it appears that the prediction error is mainly assocd. with drugs with low hepatic extn. ratio (Eh).  The error in human clearance prediction for hepatically eliminated small-mols. was reduced using scaling methods with a correction of max. life span (MLP) or brain wt. (BRW).  Human clearance of both small- and macro-mol. drugs is well predicted using the monkey liver blood flow method.  Predictions using liver blood flow from other species did not work as well, esp. for the small-mol. drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdswCme7lV_LVg90H21EOLACvtfcHk0lj6UeZKYG28cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12jsbnK&md5=07269e0ae5f9ac33735a91546b89eced</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3109%2F00498254.2011.598582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2011.598582%26sid%3Dliteratum%253Aachs%26aulast%3DHuh%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DD.%2BE.%26aulast%3DFeng%26aufirst%3DM.%2BR.%26atitle%3DInterspecies%2520scaling%2520and%2520prediction%2520of%2520human%2520clearance%253A%2520comparison%2520of%2520small-%2520and%2520macro-molecule%2520drugs%26jtitle%3DXenobiotica%26date%3D2011%26volume%3D41%26spage%3D972%26epage%3D987%26doi%3D10.3109%2F00498254.2011.598582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallegos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uttamsingh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miwa, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balani, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, L.-S.</span></span> <span> </span><span class="NLM_article-title">Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1600</span>– <span class="NLM_lpage">1605</span>, <span class="refDoi"> DOI: 10.1124/dmd.106.010793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1124%2Fdmd.106.010793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=16790553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1SksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1600-1605&author=C.+Luauthor=P.+Liauthor=R.+Gallegosauthor=V.+Uttamsinghauthor=C.+Q.+Xiaauthor=G.+T.+Miwaauthor=S.+K.+Balaniauthor=L.-S.+Gan&title=Comparison+of+intrinsic+clearance+in+liver+microsomes+and+hepatocytes+from+rats+and+humans%3A+evaluation+of+free+fraction+and+uptake+in+hepatocytes&doi=10.1124%2Fdmd.106.010793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes</span></div><div class="casAuthors">Lu, Chuang; Li, Ping; Gallegos, Richard; Uttamsingh, Vinita; Xia, Cindy Q.; Miwa, Gerald T.; Balani, Suresh K.; Gan, Liang-Shang</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1600-1605</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Apparent intrinsic clearance (CLint,app) of 7-ethoxycoumarin, phenacetin, propranolol, and midazolam was measured using rat and human liver microsomes and freshly isolated and cryopreserved hepatocytes to det. factors responsible for differences in rates of metab. in these systems.  The cryopreserved and freshly isolated hepatocytes generally provided similar results, although there was greater variability using the latter system.  The CLint,app values in hepatocytes are obsd. to be lower than that in microsomes, and this difference becomes greater for compds. with high CLint,app.  This could partly be attributed to the differences in the free fraction (fu).  The fu in hepatocyte incubations (fu,hep-inc) was influenced not only by the free fraction of compds. in the incubation buffer (fu,buffer) but also by the rate consts. of uptake (kup) and metab. (kmet).  This report provides a new derivation for fu,hep-inc, which can be expressed as fu,hep-inc = [kup/(kmet + kup)]/[1 + (Chep/Cbuffer) × (Vhep/Vbuffer)], where the Chep, Cbuffer, Vhep, and Vbuffer represent the concns. of a compd. in hepatocytes and buffer and vols. of hepatocytes and buffer, resp.  For midazolam, the fu,hep-inc was calcd., and the max. metab. rate in hepatocytes was shown to be limited by the uptake rate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkV9lSFxDFT7Vg90H21EOLACvtfcHk0lj6UeZKYG28cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1SksLk%253D&md5=3d3ff22990742b26dc24c84a6aab720e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1124%2Fdmd.106.010793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.106.010793%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DGallegos%26aufirst%3DR.%26aulast%3DUttamsingh%26aufirst%3DV.%26aulast%3DXia%26aufirst%3DC.%2BQ.%26aulast%3DMiwa%26aufirst%3DG.%2BT.%26aulast%3DBalani%26aufirst%3DS.%2BK.%26aulast%3DGan%26aufirst%3DL.-S.%26atitle%3DComparison%2520of%2520intrinsic%2520clearance%2520in%2520liver%2520microsomes%2520and%2520hepatocytes%2520from%2520rats%2520and%2520humans%253A%2520evaluation%2520of%2520free%2520fraction%2520and%2520uptake%2520in%2520hepatocytes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D1600%26epage%3D1605%26doi%3D10.1124%2Fdmd.106.010793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naritomi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terashita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagayama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, Y.</span></span> <span> </span><span class="NLM_article-title">Utility of hepatocytes in predicting drug metabolism: Comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">580</span>– <span class="NLM_lpage">588</span>, <span class="refDoi"> DOI: 10.1124/dmd.31.5.580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1124%2Fdmd.31.5.580" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=580-588&author=Y.+Naritomiauthor=S.+Terashitaauthor=A.+Kagayamaauthor=Y.+Sugiyama&title=Utility+of+hepatocytes+in+predicting+drug+metabolism%3A+Comparison+of+hepatic+intrinsic+clearance+in+rats+and+humans+in+vivo+and+in+vitro&doi=10.1124%2Fdmd.31.5.580"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1124%2Fdmd.31.5.580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.31.5.580%26sid%3Dliteratum%253Aachs%26aulast%3DNaritomi%26aufirst%3DY.%26aulast%3DTerashita%26aufirst%3DS.%26aulast%3DKagayama%26aufirst%3DA.%26aulast%3DSugiyama%26aufirst%3DY.%26atitle%3DUtility%2520of%2520hepatocytes%2520in%2520predicting%2520drug%2520metabolism%253A%2520Comparison%2520of%2520hepatic%2520intrinsic%2520clearance%2520in%2520rats%2520and%2520humans%2520in%2520vivo%2520and%2520in%2520vitro%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2003%26volume%3D31%26spage%3D580%26epage%3D588%26doi%3D10.1124%2Fdmd.31.5.580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiou, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, F. H.</span></span> <span> </span><span class="NLM_article-title">Correlation of unbound plasma clearances of fifteen extensively metabolized drugs between humans and rats</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">668</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1023/A:1015935206569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1023%2FA%3A1015935206569" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1988&pages=668-672&author=W.+L.+Chiouauthor=F.+H.+Hsu&title=Correlation+of+unbound+plasma+clearances+of+fifteen+extensively+metabolized+drugs+between+humans+and+rats&doi=10.1023%2FA%3A1015935206569"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015935206569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015935206569%26sid%3Dliteratum%253Aachs%26aulast%3DChiou%26aufirst%3DW.%2BL.%26aulast%3DHsu%26aufirst%3DF.%2BH.%26atitle%3DCorrelation%2520of%2520unbound%2520plasma%2520clearances%2520of%2520fifteen%2520extensively%2520metabolized%2520drugs%2520between%2520humans%2520and%2520rats%26jtitle%3DPharm.%2520Res.%26date%3D1988%26volume%3D5%26spage%3D668%26epage%3D672%26doi%3D10.1023%2FA%3A1015935206569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bleasby, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evers, R.</span></span> <span> </span><span class="NLM_article-title">Species differences in drug transporters and implications for translating preclinical findings to humans</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1517/17425255.2013.741589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1517%2F17425255.2013.741589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=23256482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivFehtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=237-252&author=X.+Chuauthor=K.+Bleasbyauthor=R.+Evers&title=Species+differences+in+drug+transporters+and+implications+for+translating+preclinical+findings+to+humans&doi=10.1517%2F17425255.2013.741589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Species differences in drug transporters and implications for translating preclinical findings to humans</span></div><div class="casAuthors">Chu, Xiaoyan; Bleasby, Kelly; Evers, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-252</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Drug transporters play an important role in the absorption, distribution, and excretion (ADE) of many drugs.  In the last several years it has become increasingly clear that there are significant differences between rodents, dog, monkey, and human in the substrate specificity, tissue distribution, and relative abundance of transporters.  These differences complicate cross-species extrapolations, which is important when attempting to predict human pharmacokinetics (PK) of drug candidates and assess risk for drug-drug interactions (DDIs).Areas covered: This article provides an overview of species differences for the major transporters involved in drug disposition.  Specifically, the article looks at a no. of efflux and uptake transporters including multidrug resistance protein MDR1 P-glycoprotein (Pgp), breast cancer resistance protein (BCRP), multidrug resistance proteins (MRPs), members of the multidrug resistance and toxic extrusion protein (MATE) family, as well as members of org. anion transporting polypeptides (OATPs), org. anion transporters (OATs), and org. cation transporters (OCTs).Expert opinion: Quant. knowledge of species differences of transporters, esp. at the protein and functional level is still limited.  The current challenge is to extrapolate and integrate data from both preclin. species and humans to quant. predict the impact of transporters on drug absorption, disposition, and drug-drug interactions.  Increased understanding of species differences in transporter expression and functional activity is needed in order to translate findings from preclin. species to humans.  Ultimately, high quality in vitro and in vivo data will aid in the establishment of physiol. based pharmacokinetic (PBPK) models, which will improve the capability to predict PK characteristics of drug candidates in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsqBJmdYPjvLVg90H21EOLACvtfcHk0liK41WYdhLSFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivFehtLs%253D&md5=7f5ef0877516beada4264257777ca963</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1517%2F17425255.2013.741589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2013.741589%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DX.%26aulast%3DBleasby%26aufirst%3DK.%26aulast%3DEvers%26aufirst%3DR.%26atitle%3DSpecies%2520differences%2520in%2520drug%2520transporters%2520and%2520implications%2520for%2520translating%2520preclinical%2520findings%2520to%2520humans%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2013%26volume%3D9%26spage%3D237%26epage%3D252%26doi%3D10.1517%2F17425255.2013.741589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosgrove, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruston, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFaul, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colclough, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, B.</span></span> <span> </span><span class="NLM_article-title">Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6672</span>– <span class="NLM_lpage">6682</span>, <span class="refDoi"> DOI: 10.1021/jm0605233</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0605233" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtV2gtLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6672-6682&author=A.+G.+Leachauthor=H.+D.+Jonesauthor=D.+A.+Cosgroveauthor=P.+W.+Kennyauthor=L.+Rustonauthor=P.+MacFaulauthor=J.+M.+Woodauthor=N.+Colcloughauthor=B.+Law&title=Matched+molecular+pairs+as+a+guide+in+the+optimization+of+pharmaceutical+properties%3B+a+study+of+aqueous+solubility%2C+plasma+protein+binding+and+oral+exposure&doi=10.1021%2Fjm0605233"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pairs as a Guide in the Optimization of Pharmaceutical Properties; a Study of Aqueous Solubility, Plasma Protein Binding and Oral Exposure</span></div><div class="casAuthors">Leach, Andrew G.; Jones, Huw D.; Cosgrove, David A.; Kenny, Peter W.; Ruston, Linette; MacFaul, Philip; Wood, J. Matthew; Colclough, Nicola; Law, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6672-6682</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By identifying every pair of mols. that differ only by a particular, well-defined, structural transformation in a database of measured properties and computing the corresponding change in property, we obtain an overview of the effect that structural change has upon the property and set an expectation for what will happen when that transformation is applied elsewhere.  The mean change indicates the expected magnitude of the change in the property and the no. of cases in which the property increases give the probability that the structural transformation will cause the property to increase.  Outliers indicate potential ways of avoiding the general trend.  Comparing to changes in lipophilicity highlights structural transformations that have unusual effects, some of which can be explained by conformational changes.  In this paper, we focus upon the effects on aq. soly., plasma protein binding and oral exposure of adding substituents to arom. rings and methylating heteroatoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcyrloR79Oq7Vg90H21EOLACvtfcHk0lj6THQJl94PhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtV2gtLnO&md5=2c143b424aee3ddb6c34616aff699ee0</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm0605233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0605233%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DJones%26aufirst%3DH.%2BD.%26aulast%3DCosgrove%26aufirst%3DD.%2BA.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DRuston%26aufirst%3DL.%26aulast%3DMacFaul%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DColclough%26aufirst%3DN.%26aulast%3DLaw%26aufirst%3DB.%26atitle%3DMatched%2520molecular%2520pairs%2520as%2520a%2520guide%2520in%2520the%2520optimization%2520of%2520pharmaceutical%2520properties%253B%2520a%2520study%2520of%2520aqueous%2520solubility%252C%2520plasma%2520protein%2520binding%2520and%2520oral%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6672%26epage%3D6682%26doi%3D10.1021%2Fjm0605233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boros, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garvey, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golden, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazen, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koble, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurose, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mote, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshinaga, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antiviral activity of 7-benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV integrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2754</span>– <span class="NLM_lpage">2761</span>, <span class="refDoi"> DOI: 10.1021/jm801404b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801404b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2754-2761&author=E.+E.+Borosauthor=C.+E.+Edwardsauthor=S.+A.+Fosterauthor=M.+Fujiauthor=T.+Fujiwaraauthor=E.+P.+Garveyauthor=P.+L.+Goldenauthor=R.+J.+Hazenauthor=J.+L.+Jeffreyauthor=B.+A.+Johnsauthor=T.+Kawasujiauthor=R.+Kiyamaauthor=C.+S.+Kobleauthor=N.+Kuroseauthor=W.+H.+Millerauthor=A.+L.+Moteauthor=H.+Muraiauthor=A.+Satoauthor=J.+B.+Thompsonauthor=M.+C.+Woodwardauthor=T.+Yoshinaga&title=Synthesis+and+antiviral+activity+of+7-benzyl-4-hydroxy-1%2C5-naphthyridin-2%281H%29-one+HIV+integrase+inhibitors&doi=10.1021%2Fjm801404b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm801404b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801404b%26sid%3Dliteratum%253Aachs%26aulast%3DBoros%26aufirst%3DE.%2BE.%26aulast%3DEdwards%26aufirst%3DC.%2BE.%26aulast%3DFoster%26aufirst%3DS.%2BA.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DFujiwara%26aufirst%3DT.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DGolden%26aufirst%3DP.%2BL.%26aulast%3DHazen%26aufirst%3DR.%2BJ.%26aulast%3DJeffrey%26aufirst%3DJ.%2BL.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DKoble%26aufirst%3DC.%2BS.%26aulast%3DKurose%26aufirst%3DN.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26aulast%3DMote%26aufirst%3DA.%2BL.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DThompson%26aufirst%3DJ.%2BB.%26aulast%3DWoodward%26aufirst%3DM.%2BC.%26aulast%3DYoshinaga%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520antiviral%2520activity%2520of%25207-benzyl-4-hydroxy-1%252C5-naphthyridin-2%25281H%2529-one%2520HIV%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2754%26epage%3D2761%26doi%3D10.1021%2Fjm801404b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McKerrecher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caulkett, P. W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donald, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenwick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grange, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayner, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, R. P.</span></span> <span> </span><span class="NLM_article-title">Design of a potent, soluble glucokinase activator with excellent in vivo efficacy</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2705</span>– <span class="NLM_lpage">2709</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.02.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1016%2Fj.bmcl.2006.02.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2705-2709&author=D.+McKerrecherauthor=J.+V.+Allenauthor=P.+W.+R.+Caulkettauthor=C.+S.+Donaldauthor=M.+L.+Fenwickauthor=E.+Grangeauthor=K.+M.+Johnsonauthor=C.+Johnstoneauthor=C.+D.+Jonesauthor=K.+G.+Pikeauthor=J.+W.+Raynerauthor=R.+P.+Walker&title=Design+of+a+potent%2C+soluble+glucokinase+activator+with+excellent+in+vivo+efficacy&doi=10.1016%2Fj.bmcl.2006.02.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.02.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.02.022%26sid%3Dliteratum%253Aachs%26aulast%3DMcKerrecher%26aufirst%3DD.%26aulast%3DAllen%26aufirst%3DJ.%2BV.%26aulast%3DCaulkett%26aufirst%3DP.%2BW.%2BR.%26aulast%3DDonald%26aufirst%3DC.%2BS.%26aulast%3DFenwick%26aufirst%3DM.%2BL.%26aulast%3DGrange%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DK.%2BM.%26aulast%3DJohnstone%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DC.%2BD.%26aulast%3DPike%26aufirst%3DK.%2BG.%26aulast%3DRayner%26aufirst%3DJ.%2BW.%26aulast%3DWalker%26aufirst%3DR.%2BP.%26atitle%3DDesign%2520of%2520a%2520potent%252C%2520soluble%2520glucokinase%2520activator%2520with%2520excellent%2520in%2520vivo%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2705%26epage%3D2709%26doi%3D10.1016%2Fj.bmcl.2006.02.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hop, C. E. C. A.</span></span> <span> </span><span class="NLM_article-title">Rational use of plasma protein and tissue binding data in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8238</span>– <span class="NLM_lpage">8248</span>, <span class="refDoi"> DOI: 10.1021/jm5007935</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5007935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8238-8248&author=X.+Liuauthor=M.+Wrightauthor=C.+E.+C.+A.+Hop&title=Rational+use+of+plasma+protein+and+tissue+binding+data+in+drug+design&doi=10.1021%2Fjm5007935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Use of Plasma Protein and Tissue Binding Data in Drug Design</span></div><div class="casAuthors">Liu, Xingrong; Wright, Matthew; Hop, Cornelis E. C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8238-8248</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is a commonly accepted assumption that only unbound drug mols. are available to interact with their targets.  Therefore, one of the objectives in drug design is to optimize the compd. structure to increase in vivo unbound drug concn.  In this review, theor. analyses and exptl. observations are presented to illustrate that low plasma protein binding does not necessarily lead to high in vivo unbound plasma concn.  Similarly, low brain tissue binding does not lead to high in vivo unbound brain tissue concn.  Instead, low intrinsic clearance leads to high in vivo unbound plasma concn., and low efflux transport activity at the blood-brain barrier leads to high unbound brain concn.  Plasma protein and brain tissue binding are very important parameters in understanding pharmacokinetics, pharmacodynamics, and toxicities of drugs, but these parameters should not be targeted for optimization in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKiYUz9ljIDrVg90H21EOLACvtfcHk0ljlJ1VwmiHkFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M&md5=53ffbdb88ddf500a90a0eee14b0e641f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm5007935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5007935%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWright%26aufirst%3DM.%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26atitle%3DRational%2520use%2520of%2520plasma%2520protein%2520and%2520tissue%2520binding%2520data%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8238%26epage%3D8248%26doi%3D10.1021%2Fjm5007935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoener, B.-A.</span></span> <span> </span><span class="NLM_article-title">Changes in plasma protein binding have little clinical relevance</span>. <i>Clin. Pharmacol. Ther. (N. Y., NY, U. S.)</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1067/mcp.2002.121829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1067%2Fmcp.2002.121829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=11907485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtFChtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2002&pages=115-121&author=L.+Z.+Benetauthor=B.-A.+Hoener&title=Changes+in+plasma+protein+binding+have+little+clinical+relevance&doi=10.1067%2Fmcp.2002.121829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Changes in plasma protein binding have little clinical relevance</span></div><div class="casAuthors">Benet, Leslie Z.; Hoener, Betty-Ann</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">115-121</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Mosby, Inc.</span>)
        </div><div class="casAbstract">A review, discussing the clin. relevance of changes in plasma protein binding with regard to pharmacokinetics and pharmacodynamics of drugs with different therapeutic indexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnVXegu4HarLVg90H21EOLACvtfcHk0ljlJ1VwmiHkFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtFChtbc%253D&md5=2d475c624354013bf2f2a7b9135dffe0</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1067%2Fmcp.2002.121829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmcp.2002.121829%26sid%3Dliteratum%253Aachs%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26aulast%3DHoener%26aufirst%3DB.-A.%26atitle%3DChanges%2520in%2520plasma%2520protein%2520binding%2520have%2520little%2520clinical%2520relevance%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%2520%2528N.%2520Y.%252C%2520NY%252C%2520U.%2520S.%2529%26date%3D2002%26volume%3D71%26spage%3D115%26epage%3D121%26doi%3D10.1067%2Fmcp.2002.121829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremaine, L. M.</span></span> <span> </span><span class="NLM_article-title">A novel relay method for determining low-clearance values</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1860</span>– <span class="NLM_lpage">1865</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.046425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1124%2Fdmd.112.046425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=22645091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlShur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1860-1865&author=L.+Diauthor=P.+Trapaauthor=R.+S.+Obachauthor=K.+Atkinsonauthor=Y.-A.+Biauthor=A.+C.+Wolfordauthor=B.+Tanauthor=T.+S.+McDonaldauthor=Y.+Laiauthor=L.+M.+Tremaine&title=A+novel+relay+method+for+determining+low-clearance+values&doi=10.1124%2Fdmd.112.046425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A novel relay method for determining low-clearance values</span></div><div class="casAuthors">Di, Li; Trapa, Patrick; Obach, R. Scott; Atkinson, Karen; Bi, Yi-An; Wolford, Angela C.; Tan, Beijing; McDonald, Thomas S.; Lai, Yurong; Tremaine, Larry M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1860-1865</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A novel relay method has been developed using cryopreserved human hepatocytes to measure intrinsic clearance of low-clearance compds.  The relay method involved transferring the supernatant from hepatocyte incubations to freshly thawed hepatocytes at the end of the 4-h incubation to prolong the exposure time to active enzymes in hepatocytes.  An accumulative incubation time of 20 h or longer in hepatocytes can be achieved using the method.  The relay method was validated using seven com. drugs (diazepam, disopyramide, theophylline, timolol, tolbutamide, S-warfarin, and zolmitriptan) that were metabolized by various cytochrome P450s with low human in vivo intrinsic clearance at approx. 2 to 15 mL · min-1 · kg-1.  The results showed that the relay method produced excellent predictions of human in vivo clearance.  The difference between in vitro and in vivo intrinsic clearance was within 2-fold for most compds., which is similar to the std. prediction accuracy for moderate to high clearance compds. using hepatocytes.  The relay method is a straightforward, relatively low cost, and easy-to-use new tool to address the challenges of low clearance in drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz1LvwK-CqOLVg90H21EOLACvtfcHk0ljW3Tj2CQ9XDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlShur7O&md5=faab456749ff398ad63d11eff6412fbc</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.046425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.046425%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DTrapa%26aufirst%3DP.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DBi%26aufirst%3DY.-A.%26aulast%3DWolford%26aufirst%3DA.%2BC.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DMcDonald%26aufirst%3DT.%2BS.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DTremaine%26aufirst%3DL.%2BM.%26atitle%3DA%2520novel%2520relay%2520method%2520for%2520determining%2520low-clearance%2520values%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D1860%26epage%3D1865%26doi%3D10.1124%2Fdmd.112.046425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">In vitro-in vivo correlation for low-clearance compounds using hepatocyte relay method</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2018</span>– <span class="NLM_lpage">2023</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.053322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1124%2Fdmd.113.053322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=23857891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=2018-2023&author=L.+Diauthor=K.+Atkinsonauthor=C.+C.+Orozcoauthor=C.+Funkauthor=H.+Zhangauthor=T.+S.+McDonaldauthor=B.+Tanauthor=J.+Linauthor=C.+Changauthor=R.+S.+Obach&title=In+vitro-in+vivo+correlation+for+low-clearance+compounds+using+hepatocyte+relay+method&doi=10.1124%2Fdmd.113.053322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro-in vivo correlation for low-clearance compounds using hepatocyte relay method</span></div><div class="casAuthors">Di, Li; Atkinson, Karen; Orozco, Christine C.; Funk, Carrie; Zhang, Hui; McDonald, Thomas S.; Tan, Beijing; Lin, Jian; Chang, Cheng; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2018-2023</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In vitro-in vivo correlation (IVIVC) of intrinsic clearance in preclin. species of rat and dog was established using the hepatocyte relay method to support high-confidence prediction of human pharmacokinetics for low-clearance compds.  Good IVIVC of intrinsic clearance was obsd. for most of the compds., with predicted values within 2-fold of the obsd. values.  The exceptions involved transporter-mediated uptake clearance or metabolizing enzymes with extensive extrahepatic contribution.  This is the first assay available to address low clearance challenges in preclin. species for IVIVC in drug discovery.  It extends the utility of the hepatocyte relay method in addressing low clearance issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaNjsAHv2AFLVg90H21EOLACvtfcHk0ljW3Tj2CQ9XDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtbvP&md5=89b3f33fdc8fc1c73ab593dc44612659</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.053322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.053322%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DOrozco%26aufirst%3DC.%2BC.%26aulast%3DFunk%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMcDonald%26aufirst%3DT.%2BS.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DIn%2520vitro-in%2520vivo%2520correlation%2520for%2520low-clearance%2520compounds%2520using%2520hepatocyte%2520relay%2520method%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D2018%26epage%3D2023%26doi%3D10.1124%2Fdmd.113.053322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Novel cytochrome P450 reaction phenotyping for low-clearance compounds using the hepatocyte relay method</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1124/dmd.115.067876</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;key=10.1124%2Fdmd.115.067876" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=460-465&author=X.+Yangauthor=K.+Atkinsonauthor=L.+Di&title=Novel+cytochrome+P450+reaction+phenotyping+for+low-clearance+compounds+using+the+hepatocyte+relay+method&doi=10.1124%2Fdmd.115.067876"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.067876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.067876%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DNovel%2520cytochrome%2520P450%2520reaction%2520phenotyping%2520for%2520low-clearance%2520compounds%2520using%2520the%2520hepatocyte%2520relay%2520method%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26spage%3D460%26epage%3D465%26doi%3D10.1124%2Fdmd.115.067876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-5%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01263%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01263" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679950543ccf3c10","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
